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vRe´sume´ Substantiel
Les lymphocytes T sont une composante essentielle du syste`me immunitaire de
l’organisme. Ils peuvent reconnaˆıtre et re´pondre a` un antige`ne e´tranger en vertu de
leur re´cepteur d’antige`ne. En effet, les cellules T qui n’ont pas encore rencontre´es
des antige`nes, sont appele´es ”na¨ıves”. Lors d’un premier contact antige´nique,
l’expansion clonale des lymphocytes T spe´cifiques a` un antige`ne augmente forte-
ment leur fre´quence, et de´se´quilibre transitoirement de fac¸on plus ou moins intense
le compartiment lymphocytaire T pe´riphe´rique. Cet e´quilibre doit eˆtre re´tabli pour
ne pas menacer a` terme le bon fonctionnement du syste`me immunitaire. Outre le
risque de re´ponse explosive lors d’une re´exposition a` l’antige`ne, l’accumulation de
clones T de taille disproportionne´e geˆnerait conside´rablement le recrutement de lym-
phocytes T spe´cifiques de nouveaux antige`nes. Ainsi, apre`s e´limination de l’antige`ne
ou son confinement dans l’organisme, diffe´rents me´canismes interviennent. Il faut en
effet d’une part assurer le maintien d’un compartiment de cellules T na¨ıves de taille
suffisante pour faire face a` de nouvelles stimulations antige´niques. D’autre part, la
constitution d’un panel de cellules T me´moires est ne´cessaire pour permettre une
re´ponse immunitaire plus rapide et plus efficace lors de re´expositions antige´niques.
Donc les me´canismes d’home´ostasie des cellules T sont essentielles pour maintenir
le nombre de cellules T a` un niveau a` peu pre`s constant en controˆlant la division
cellulaire et la mortalite´ des cellules.
Dans le cas normal, le renouvellement des cellules T na¨ıves est tre`s faible et ces
derniers restent approximativement dans un e´tat de repos. Cependant, une per-
turbation de l’e´quilibre home´ostatique peut re´sulter d’une grande varie´te´ de causes
(infection virale, ou les traitements de chimiothe´rapie), et peut entraˆıner une lym-
phope´nie (i.e. Une carence en lymphocytes T). Dans ces conditions lymphope´niques,
les cellules T na¨ıves subissent la division cellulaire avec un changement de l’expression
de CD44 sur leur surface cellulaire. Ce processus est appele´ ”prolife´ration home´ostatique”
ou en anglais ”lymphopenia induced proliferation” (LIP). Ainsi, le CD44 est un mar-
queur naturel qui caracte´rise la transition des cellules du phe´notype na¨ıf (CD44-)
au phe´notype me´moire (CD44+) durant LIP.
Les travaux de recherche dans les dernie`res de´cennies montrent que l’utilisation de
mode`les mathe´matiques en immunologie a abouti a` de grands progre`s, non seule-
ment sur le plan the´orique, mais aussi sur le plan de la gestion des politiques actuelles
de sante´ publique. Dans la litte´rature, plusieurs e´tudes ont utilise´ avec succe`s la
mode´lisation mathe´matique pour de´crire la re´ponse prolife´rative des cellules T a`
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une lymphope´nie [1–7, 7–10]. En outre, ces e´tudes n’ont pas pris en compte la tran-
sition des cellules du phe´notype na¨ıf au phe´notype me´moire en utilisant le concept
de CD44 au cours du processus home´ostatique. L’objectif de cette the`se est donc
de comprendre la relation complexe entre LIP 1 et le passage du phe´notype na¨ıf
(CD44-) au phe´notype me´moire (CD44+) en utilisant des mode`les mathe´matiques
et des donne´es expe´rimentales. On s’inte´resse en plus au comportement asympto-
tique des cellules T durant le processus d’home´ostasie in vivo.
Mots-cle´s: Mode´lisation Mathe´matique, Analyse Nume´rique, Donne´es Expe´rimentales,
Identification des Parame`tres, Comportement Asymptotique et Controˆle Optimal.
Ce travail est organise´ sous la forme suivante:
- La partie I est divise´e en deux chapitres:
• Le chapitre 1 est consacre´ a` la de´finition des e´le´ments biologiques utilise´s dans
cette the`se (Syste`me immunitaire, Cycle cellulaire, Lymphocyte T, L’home´ostasie,
CD44, les Lymphope´nies).
• Le chapitre 2 reprend les mode`les mathe´matique souvent utilise´s dans la litte´rature
(Les mode`les qui de´crivent la re´ponse immunitaire et les donne´es de CFSE, ”Cyton
model”, Mode`le de Smith-Martin).
- La partie II est divise´e en deux chapitres:
• Dans le chapitre 4, on construit un mode`le in vitro (note´ SMCD44) de´crivant
la dynamique des cellules T dans des conditions lymphope´niques, notamment la
transition des cellules du phe´notype na¨ıf (CD44-) au phe´notype me´moire (CD44+)
durant le processus d’home´ostasie. En effet, on introduit des nouveaux parame`tres
dans le mode`le de Smith-Martin [3, 4, 7, 10] qui repre´sentent l’e´volution de la quan-
tite´ de CD44 a` la surface des cellules durant le processus d’home´ostasie. Cette
croissance de quantite´ de CD44 identifie la transition du phe´notype na¨ıf (CD44-)
au phe´notype me´moire (CD44+).
Comme dans le mode`le de Smith-Martin, le mode`le (SMCD44) conside`re une phase
A (phase de repos) et une phase B (phase de prolife´ration) ou` les cellules T subissent
la division cellulaire sous forme d’un syste`me en cascade (cf. Fig. 1). Le nombre
de fois ou` les cellules sont divise´es, est indexe´ par i. Le temps ou` les cellules restent
dans la phase B, est mesure´e par τ . Ce qui refle`te la maturite´ (i.e l’aˆge) des cellules
1lymphopenia induced proliferation
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Figure 1: Mode`le de prolife´ration des cellules T en conditions lymphope´niques. Ai et Bi sont le nombre
des cellules T, qui ont subi i divisions dans la phase A et B respectivement. ∆ est la dure´e de la phase B (unite´
en heure). Le taux des cellules qui se divisent (λ), est une fonction qui de´pend du nombre total des cellules
(N) [10].
a` ce stade. En plus, cette maturite´ τ a une valeur maximale ∆. Les cellules dans la
phase A et la phase B sont indexe´es encore par s ∈ [0,m] qui repre´sente l’intensite´
de CD44 sur la surface des cellules. La dynamique des cellules entre la phase A et la
phase B est repre´sente´e par des EDOs et EDPs respectivement (cf. System (1-2)).
dA0(t, s)
dt
= −δAA0(t, s)− λ(N)A0(t, s),

for i = 1, ..., I
dAi(t, s)
dt
= 2
∫ ∆
0
µ(τ)Bi−1(t, τ, s) dτ − δAAi(t, s)− λ(N)Ai(t, s),

for i = 0, ..., I
∂
∂t
Bi(t, τ, s) +
∂
∂τ
Bi(t, τ, s) +
∂
∂s
[vi(s).Bi(t, τ, s)] = − (δB + µ(τ))Bi(t, τ, s),
(1)
ou` les variables (t, τ, s) appartiennent a` [0, T ]× [0,∆]× [0,m].
Les conditions au bord et les distributions initiales sont donne´es par

Bi(t, 0, s) = λ(N)Ai(t, s) et vi(0)Bi(t, τ, 0) = 0 pour i = 0, ..., I
Bi(0, τ, s) = 0, for i = 0, ..., I et Ai(0, s) = 0, pour i = 1, ..., I
A0(0, s) = A0,0(s) > 0.
(2)
Les variables d’e´tat Ai et Bi sont le nombre de cellules T ayant subi i divisions dans
la phase A et B respectivement. Pour i = 0, la croissance des cellules dans la phase
A0 vient du nombre initial A0,0(s). En outre, le recrutement stochastique de cellules
de la phase A a` la phase B se fait avec un taux λ qui de´pend du nombre total de
cellules N(t) =
∑I
i=0
(∫ m
0
Ai(t, s)ds+
∫ ∆
0
∫ m
0
Bi(t, τ, s)dτ ds
)
. Dans la phase B, les
cellules re´gularisent leur niveau de CD44 par la ve´locite´ vi(s). En comple´tant le
processus (mitose) dans la phase B, les cellules se divisent avec un taux µ(τ) qui
de´pend de l’aˆge des cellules en phase B. De plus les cellules filles he´ritent du meˆme
niveau d’expression de CD44 que leur cellule me`re (cf. System (1-2) et Fig. 1).
Enfin dans ce chapitre 4, on de´rive la solution implicite des e´quations Ai et la for-
mulation inte´grale des e´quations Bi.
• Dans le chapitre 5, on de´veloppe un sche´ma nume´rique pour approcher la so-
lution du mode`le SMCD44. Une analyse sur les proprie´te´s du sche´ma est propose´e.
- La partie III est divise´e en quatre chapitres:
• Dans le chapitre 6, on de´crit les donne´es expe´rimentales ge´ne´re´es par Hogan et
al. [10]. De plus, on montre dans ce chapitre l’identifiabilite´ the´orique de certains
parame`tres (vi, λ, ∆) dans le mode`le SMCD44.
• Dans le chapitre 7, on pre´sente la dernie`re version de Smith-Martin utilise´e
dans la litte´rature et notre mode`le SMCD44 (sans la structuration de CD44). On
s’inte´resse dans ce chapitre a` la comparaison de ces deux mode`les. En effet, on de´crit
la me´thode utilise´e pour identifier nume´riquement plusieurs parame`tres communs
dans les deux mode`les en utilisant les donne´es de CFSE [10]. Enfin, on montre les
parame`tres et les simulations obtenues a` partir de ces mode`les. Puis on compare
ces simulations aux donne´es expe´rimentales.
• Dans le chapitre 8, on identifie la ve´locite´ de CD44 vi (vitesse de croissance de
CD44) en utilisant les donne´es de CFSE et de CD44 [10]. Cette ve´locite´ est le
parame`tre cle´ qui nous permet de savoir a` partir de quelles divisions les cellules T
sont qualifie´es comme na¨ıves ou me´moires a` partir du mode`le SMCD44.
La me´thode utilise´e pour identifier ce parame`tre consiste a` re´soudre un proble`me
d’identification de parame`tres qui est bien de´taille´ dans ce chapitre. Dans la partie
nume´rique, on montre les parame`tres et les simulations obtenus a` partir du mode`le
et on les compare aux donne´es expe´rimentales. Les parame`tres identifie´s et les simu-
lations nume´riques de SMCD44 fournissent plusieurs interpre´tations biologiques sur
la relation entre LIP et le passage du phe´notype na¨ıf au phe´notype me´moire en
utilisant le mode`le SMCD44.
• Dans le chapitre 9, on prend en compte la de´pendance entre l’intensite´ de CD44 (s)
et le taux d’entre´e en division (λ = λ(s,N(t))) ou le taux de division (µ = µ(τ, s)).
Ici, on s’inte´resse a` identifier ces nouveaux parame`tres qui de´pendent du niveau
de CD44 (s). Comme dans le chapitre pre´ce´dent, les ingre´dients pour re´soudre
les proble`mes d’identification des parame`tres sont donne´s. Enfin, on pre´sente les
simulations et les parame`tres identifie´s, et on de´duit biologiquement le lien entre le
niveau de CD44 sur les cellules et leur taux d’entre´e dans la phase de prolife´ration
ou leur taux de division.
- La partie IV est divise´e en trois chapitres:
• Dans le chapitre 10, on e´tend le mode`le in vitro SMCD44 a` un mode`le in vivo en
introduisant un taux Λ d’exportation de cellules du thymus. Dans ce mode`le, on
conside`re un grand nombre de divisions (I >> 0), et un taux d’entre´e en division
en fonction du nombre de division (i) et de nombre total de cellules (N = N(t)).
En utilisant la me´thode du point fixe, on de´montre l’existence locale et l’unicite´
de la solution du syste`me e´tendu. Enfin, on de´duit l’existence globale en utilisant
l’intervalle maximal d’existence.
• Dans le chapitre 11, on re´e´crit le mode`le e´tendu comme un syste`me structure´ en
aˆge et sans la structuration en CD44. Ici, on s’inte´resse a` investiguer l’e´tude asymp-
totique du mode`le re´duit. On trouve qu’il existe une ou trois solutions stationnaires
quand les cellules subissent au moins cinq divisions, et seulement une seule quand
les cellules subissent au plus trois divisions. Le cas limite de quatre divisions est
nume´riquement traite´. En appliquant la me´thode de Lyapunov, on montre dans cer-
tains cas d’unicite´ que la solution stationnaire est globalement asymptotiquement
stable.
• Dans le chapitre 12, on reformule le mode`le in vivo propose´ dans le chapitre 10
en une version plus re´aliste avec une strate´gie de vaccination. Le but de ce chapitre
est de re´soudre un proble`me de controˆle optimal qui renforce l’immunite´ durant
le processus d’home´ostasie. Premie`rement, on discute la fonction couˆt et on ob-
tient les conditions d’optimalite´s. Deuxie`mement, on exe´cute quelques simulations
nume´riques pour calculer la vaccination optimale.
- Enfin dans le chapitre 13, on re´sume les principaux re´sultats de cette e´tude
et on donne les perspectives et les nouveaux proble`mes induits par ce projet de
recherche.
The`se pre´pare´e a`
l’Institut de Mathe´matiques de Bordeaux
UMR CNRS 5251, Universite´ de Bordeaux
33076 Bordeaux cedex, France
Abstract
T lymphocytes are a fundamental component of the immune system that can
recognise and respond to foreign antigens by virtue of their clonally expressed T cell
antigen receptor (TCR). T cells that have yet to encounter the antigen they recog-
nise are termed ’naive’ as they have not been activated to respond. Homeostatic
mechanisms maintain the number of T cells at an approximately constant level by
controling cell division and death. In normal replete hosts, cell turnover within the
naive compartment is very low and naive cells are maintained in a resting state.
However, disruption of the homeostatic balance can arise from a wide variety of
causes (viral infection (e.g. HIV), or drugs used in peritransplant induction therapy
or cancer chemotherapy) and can result in T cell deficiency or T lymphopenia. Un-
der conditions of T lymphopenia, naive T cells undergo cell division with a subtle
change in the cell surface phenotype (CD44 expression), termed homeostatic prolif-
eration or lymphopenia induced proliferation (LIP). In this thesis, our purpose is
to understand the process of T cell homeostatic through mathematical approach. At
first, we build a new model that describes the proliferation of T cells in vitro under
lymphopenic conditions. Our nonlinear model is composed of ordinary differential
equations and partial differential equations structured by age (maturity of cell) and
CD44 expression. To better understand the homeostasis of T cells, we identify the
parameters that define T cell division by using experimental data. Next, we consider
an age-structured model system describing the T cell homeostatic in vivo, and we
investigate its asymptotic behaviour. Finally, an optimal strategy is applied in the
in vivo model to rebuild immunity under conditions of T lympopenia.
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General Introduction
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Chapter 1
Biological Background
1.1 Immune system
The immune system is a collection of organs, cells and tissues that work together
to protect the body from disease caused mostly by pathogens (bacteria, viruses,
parasites,...). The human body is protected by two main types of immunity.
• Innate immunity is the protection system present at birth which defends us
against disease.
– The skin and other tissues which cover the body (such as the lining of
the nose and mouth), are a barrier which repels invaders.
– The white blood cells respond to invaders such as bacteria and viruses,
and expel or destroy them.
• Acquired immunity is the protection system which the body acquired, when
it is exposed to certain diseases.
– When the body makes contact with a bacterium, a virus or another
antigen, it learns to recognize this antigen. When it is invaded again by
this strange, the immune system remembers these organisms, and makes
a stronger reaction against them, and can combat them faster.
– The vaccines are based on acquired immunity. They contain small amounts
of proteins (antigens) from an organism which can cause disease. If the
organism invades the body again, the immune system will recognize and
fight them even faster and better.
3
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1.2 Structure of the immune system
The organs of the immune system (Fig. 1.1) are positioned throughout the body.
They are called lymphoid organs because they are home to lymphocytes, small
white blood cells that are the key players in the immune system. Bone marrow,
the soft tissue in the hollow center of bones, is the ultimate source of all blood
cells, including lymphocytes. The thymus is a lymphoid organ that lies behind
the breastbone. Lymphocytes known as T lymphocytes or T cells (T stands for
Figure 1.1: Organs of the immune system (www.niaid.nih.gov).
thymus) mature in the thymus and then migrate to other tissues. B lymphocytes,
also known as B cells, become activated and mature into plasma cells, which make
and release antibodies.
Lymph nodes (Fig. 1.2), which are located in many parts of the body, are lymphoid
tissues that contain numerous specialized structures.
• T cells from the thymus concentrate in the paracortex.
• B cells develop in and around the germinal centers.
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• Plasma cells occur in the medulla.
Figure 1.2: The lymph node contains numerous specialized structures. T cells concentrate in the
paracortex, B cells in and around the germinal centers, and plasma cells in the medulla (www.niaid.nih.gov).
Lymphocytes can travel throughout the body using the blood vessels. The cells can
also travel through a system of lymphatic vessels that closely parallels the bodys
veins and arteries.
Cells and fluids are exchanged between blood and lymphatic vessels, enabling the
lymphatic system to monitor the body for invading microbes. The lymphatic vessels
carry lymph, a clear fluid that bathes the bodys tissues.
Small, bean-shaped lymph nodes are laced along the lymphatic vessels, with clusters
in the neck, armpits, abdomen, and groin. Each lymph node contains specialized
compartments where immune cells congregate, and where they can encounter anti-
gens.
Immune cells, microbes, and foreign antigens enter the lymph nodes via incoming
lymphatic vessels or the lymph nodes tiny blood vessels. All lymphocytes exit lymph
nodes through outgoing lymphatic vessels. Once in the bloodstream, lymphocytes
are transported to tissues throughout the body. They patrol everywhere for foreign
antigens, then gradually drift back into the lymphatic system to begin the cycle all
over again.
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1.3 Cell cycle
The cell cycle, or cell-division cycle, is the series of events that take place in a
cell leading to its division and duplication (replication) that produces two daughter
cells. The biological cell cycle describes five distinct phases G0, G1, S, G2 and M
grouping interphase and mitosis (see Fig. 1.3).
Figure 1.3: Schematic of the cell cycle [11].
Quiescence: Cells which are not proliferating are said to be quiescent or
in ”G0” phase. The metabolic demands of G0 phase varies according to the
specialized functions being carried out by the quiescent cell, but there are
often lower levels of gene expression, macromolecular biosynthesis and energy
consumption compared with actively dividing cells.
Interphase: Before a cell can enter cell division, it needs to take in nutri-
ents. All of the preparations are done during interphase. Interphase is a series
of changes that takes place in a newly formed cell and its nucleus, before it
becomes capable of division again. It is also called preparatory phase or in-
termitosis. Previously it was called resting stage because there is no apparent
activity related to cell division. Typically interphase lasts for at least 90% of
the total time required for the cell cycle. Interphase proceeds in three stages,
G1, S, and G2, preceded by the previous cycle of mitosis and cytokinesis. The
most significant event is the replication of genetic material (DNA) in S phase.
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– G1 phase: The first phase within interphase, from the end of the pre-
vious M phase until the beginning of DNA synthesis, is called G1 (G
indicating gap). It is also called the growth phase. During this phase,
the cells passes through the restriction point. Here, the cell is irreversibly
committed to the division, which no longer depends on the mitogenic fac-
tors.
– S phase: In this phase, the cell replicates their DNA and each chromo-
some is copied.
– G2 phase: This phase is a period of rapid cell growth and protein
synthesis during which the cell makes itself ready for mitosis. Curiously,
G2 phase is not a necessary part of the cell cycle, as some cell types
(particularly young Xenopus embryos and some cancers [12]) proceed
directly from DNA replication to mitosis.
Mitosis or M phase: Mitosis is the phase of the cell cycle in which cells
physically divide into two separate daughter cells. In order to do so they first
dissolve the nuclear membrane which will later reform once cell division is
complete. The DNA-containing chromosomes then condense into structures
so compact that they can seen with a light microscope. The chromosomes
then precisely segregate to two sides of the cell, such that each half of the
cell gets exactly one copy of each chromosome. At the completion of mitosis,
cells undergo cytokinesis or separation into two halves. This occurs as a
band forms around the circumference outer plasma membrane which gradual
constricts like a belt until the cell pinches in two. The B-type cyclins remain
active throughout M-phase, but their activity immediately ceases once cell
division is complete and the two daughter cells once again enter G0 or G1.
1.4 T lymphocytes
T lymphocytes form an integral part of the adaptive immune system. The adaptive
immune system allows the body to mount a response that is specific to invading
pathogen and confers long-term protection to re-infection with the same antigen.
Each T cell expresses a receptor on its surface that enables it to recognise specific
antigen-peptides in association with major histocompatibility (MHC) molecules.
Together, the receptors on all lymphocytes cover a broad repertoire of antigens.
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1.4.1 The naive T cell pool
Naive T cells are the direct export product from the thymus. These cells have, by
definition, not encountered antigen. Thus, these cells represent the naive repertoire
present in the peripheral pool, that should allow a response to newly encountered
antigens. In order to perform, these cells should be able to encounter the antigen,
and it is then important that naive cells re-circulate, migrating continuously from
one secondary lymphoid organ to another (reviewed in [13]). Importantly, these
cells have been shown to express receptors for entry into the lymph nodes (CD62L)
or for chemokines (CCR7), suggesting the type of signals responsible for the circu-
lation pattern of naive T cells [13].
Accordingly, the phenotype of the naive T cells (CD4+ and CD8+ T cells) includes
some of these molecules. In C57Bl6 mice (some markers vary depending on the
mouse strain), naive T cells are typically defined as CD44− (this glycoprotein is de-
tailed in Sec. 1.6), CD62Lhigh, CD45RBhigh, CD25−, CD69−, small, resting cells.
However, some of these markers can be shared with subsets of activated or mem-
ory cells, as is true for CD62Lhigh, described in a subset of human memory CD4+
and CD8+ T cells [14] and some cells can be activated as a result of homeostatic
proliferation (homeostatic proliferation will be discussed later in this introduction)
defying the definition of both naive and of effector T cells [15]. The result is a
difficulty to define a naive T cell using a single cell surface marker. Thus, in most
situations, combinations of the markers referred to above are used. When only a
single marker is used the CD45RB marker for CD4+ T cells and the CD44 marker
for CD8+ T cells are the ones most currently used.
The function of naive T cells depends on their activation which, in turn, depends on
the encounter of these cells with antigen, processed and presented as MHC-peptide
complexes at the surface of APCs (Antigen presenting cells). Together with sig-
nalling provided by co stimulatory molecules and cytokines, activation will result in
proliferation and differentiation of T cells along the pathway to cytotoxic or helper
cells (for CD8+ T cytotoxic killer and CD4+ helper T cells, respectively) [14].
1.4.2 The effector pool
Upon TCR (T cell receptor) mediated activation, T cells loose their naive status
and integrate the effector compartment, differentiating into CD8+ T cytotoxic killer
or CD4+ helper T cells.
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The definition of the phenotype of effector cells is difficult, as it often coincides
with that of the phenotype of memory cells. Effector T cells are large blastic cells,
expressing activation markers, like CD25 or CD69 (often transitory for the first and
short term for the second), express CD44 and have down-regulated CD45RB (some
variations in this marker are dependent on the mouse strain used) and CD62-L
expression [16]. This phenotype is shared with some memory cells and in part,
with cells that are activated as a result of homeostatic proliferation [15, 17, 18].
For this reason, it is useful to consider in the peripheral T cell pool, naive versus
activated/memory cells, thereby avoiding the difficulty in defining the line that
phenotypically separates effector from memory cells.
The homing of effector cells also reflects their function and, here again, part of
the phenotypic alterations observed, namely CD62L down-regulation are related
to homing (reviewed in [13]). Thus, contrary to naive T cells, effector cells have
the ability to circulate through extra-lymphoid immune effector sites [19], and as
opposed to naive T cells, effector (and memory) T cells display great heterogeneity,
with subsets often displaying a tissue-specific pattern of circulation [19].
1.4.3 The memory T cell pool
Immunological memory can be defined as an antigen-induced alteration in the re-
active state of the immune system, occurring in such a way that the memory re-
sponses are more rapid on inset and more effective in antigen clearance [20]. Thus,
it is important to consider the factors that are behind this faster and more efficient
response. Two levels must be probed, namely the alterations in the frequency of
antigen specific T cells and the qualitative differences that distinguish a memory T
cell. By definition, a memory response is a secondary response. This means that a
primary response occurred and thus, that responding T cell clones underwent con-
siderable expansion (Fig. 1.4). This expansion is followed by a contraction phase,
responsible for the death of > 90% of the effector cells (reviewed in [21]). After the
contraction phase of an immune response, the memory phase follows (Fig. 1.4). By
the end of the contraction phase, there are still enough cells from the responding T
cell clone to increase the frequency of the T cell specificity in the order of 5 to 100
fold [21], it is thus a quantitative transformation. From this it can also be deduced
that the repertoire of the memory compartment is less diverse than the repertoire
of the naive compartment [23].
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Figure 1.4: Immune responses. The Imuune response consists of three distinct phases. See text for the
quantitative correspondence. (Modified from [22]).
1.4.4 T cell function and activation
The role of a T cell is to recognise foreign antigen expressed on antigen present-
ing cells (APCs) in association with the MHC complex and initiate an appropriate
response. The initial interaction between a T cell and antigen-MHC complex will
typically occur in the lymphoid organs. Each T cell has a different antigen-binding
specificity and the number of T cells that can respond to a specific antigen is limited.
As a result, the first stage of T lymphocyte activation involves clonal expansion of
the relevant T cell receptor clone (Fig. 1.5).
Figure 1.5: As a major part of the adaptive immune system, T-cells scan the intracellular environment
in order to target and destroy infected cells. Small peptide fragments, representing the entire cellular content,
are transported to the cell surface as pMHCs, allowing T-cell surface expressed antigen specific TCRs to scan
for foreign signals. T-cells interact with a large number of different cell types and recognise a diverse array
of pathogens. This diversity has lead to distinct antigen recognition pathways which generate the appropriate
T-cell response. T-cell activation can lead to a number of immune responses such as antibody production,
activation of phagocytic cells and direct cell killing. In this way, the appropriate immune response for different
types of diseases is implemented. (www.tcells.org)
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Activated naive T cells undergo extensive proliferation and differentiation produc-
ing effector and memory T cells (see Fig. 1.6).
The lineage relationship between naive, effector and memory T cells is not com-
pletely understood [24], however, it is widely accepted that antigen specific T cell
populations can expand up to 1000 fold producing vast numbers of effector T cells
that are able to destroy infected cells and release cytokines that stimulate B cells.
Following the clearance of infection, the majority of effector T cells are thought to
be lost to apoptosis, while a small fraction of antigen specific T cells will persist in
the memory T cell pool [25]. The intensity of this response and the size and function
of memory cells induced will depend upon the strength of TCR activation, duration
of exposure to the MHC-peptide complex, the extent of binding, co-stimulation,
inflammatory factors, intrinsic expression of signalling proteins, possibly the prox-
imity of other cells and environmental stimuli.
Figure 1.6: 1. After the naive T cell (N) encounters an antigen it becomes activated and begins to
proliferate (divide) into many clones or daughter cells. 2. Some of the T cell clones will differentiate into
effector T cells (E) that will perform the function of that cell (e.g. produce cytokines in the case of helper T
cells or invoke cell killing in the case of cytotoxic T cells). 3. Some of the cells will form memory T cells (M)
that will survive in an inactive state in the host for a long period of time until they re-encounter the same
antigen and reactivate.
1.5 Homeostasis in the immune system
Homeostasis refers to the tendency of the body to preserve its internal steady state,
allowing it to return to a normal set point following perturbation. The term was first
used by the American physiologist Walter Canon in his seminal work, Wisdom of the
Body, in 1932 [26]. He emphasized the dynamic nature of homeostasis, stating that
while it ensures stability of the organism, homeostasis does not imply something
set and immobile, a stagnation. This dynamism is evident in the homeostasis of
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the adaptive immune system where rapid fluctuations in the number, diversity,
and function of lymphocytes occur during immune responses. Yet, for the efficient
function of the immune system, the population and activation states of T cells need
to remain relatively stable in the long term [27]. The term lymphocyte homeostasis
has been used to refer to the maintenance of lymphocyte numbers as well as the
maintenance of lymphocyte diversity [28, 29]. Increasing evidence suggests that the
homeostasis of both T cell number and diversity is regulated through competition for
limiting resources, including self-peptide-MHC complexes (spMHC) and cytokines
such as IL-7 and IL-15 [30].
1.6 Cluster of differentiation (CD44)
The CD44 antigen is a cell-surface glycoprotein involved in cell-cell interactions,
cell adhesion and migration. In humans, the CD44 antigen is encoded by the CD44
gene on chromosome 11 [31].
Multifunctionality of CD44
The CD44 expression is upregulated on naive T cells after activation via the T
cell receptor (TCR) and high expression is maintained indefinitely on memory cells
[32]. As a consequence, elevated expression of CD44 is generally used to identify
antigen-experienced T cells. CD44 is associated with cell migration and together
with HA (hyaluronic acid) has been implicated in numerous biological processes
that are regulated by migrating cells [33]. The function of CD44 differs for differ-
ent cell types and additional roles in the regulation of proliferation and apoptosis
have been described [34]. Whereas CD44 has the potential to participate in several
processes associated with immune responses, the physiological functions of CD44
in T cells in vivo remain ill defined. It has been established that T cells bind HA,
and that either HA binding or TCR signaling can augment the adhesive function
and expression of CD44 [35, 36]. CD44 can regulates T cell migration into sites of
inflammation [37]. Therefore, CD44 is a multistructural and multifunctional cell
surface molecule involved in cell proliferation, cell differentiation, cell migration,
angiogenesis, presentation of cytokines, chemokines, and growth factors to the cor-
responding receptors, and docking of proteases at the cell membrane, as well as in
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signaling for cell survival. All these biological properties are essential to the physi-
ological activities of normal cells, but they are also associated with the pathologic
activities of cancer cells [32].
1.7 Lymphopenia
Lymphopenia, or lymphocytopenia , is the condition of having an abnormally low
level of lymphocytes in the blood. The quantity of circulating lymphocytes must
be interpreted as a function of age: they are between 1500 and 4000/mm3 in adults
and they can reach 6000/mm3 in children and 11000/mm3 in the new born. Lym-
phopenia is defined by a number of blood lymphocytes < 1500/mm3 in adults and
4500/mm3 in children having an age less than 8 months [38].
1.7.1 Classification
In some cases, lymphopenia can be further classified according to which kind of
lymphocytes are reduced. If all three kinds of lymphocytes are suppressed, then the
term is used without further qualification.
• In T lymphopenia, there are too few T lymphocytes, but normal numbers of
other lymphocytes. It causes, and manifests as, a T cell deficiency. This is
usually caused by HIV infection (resulting in AIDS), but may be Idiopathic
CD4+ lymphocytopenia (ICL), which is a very rare heterogeneous disorder
defined by CD4+ T-cell counts below 300 cells/muL in the absence of any
known immune deficiency condition, such as human immunodeficiency virus
(HIV) infection or chemotherapy [39].
• In B lymphocytopenia, there are too few B lymphocytes, but possibly normal
numbers of other lymphocytes. It causes, and manifests as, a humoral immune
deficiency. This is usually caused by medications that suppress the immune
system.
• In NK lymphocytopenia, there are too few natural killer cells, but normal
numbers of other lymphocytes. This is very rare.
Chapter 1. Biological Background 14
1.7.2 Causes
The most common cause of temporary lymphopenia is a recent infection. Lym-
phopenia is a frequent, temporary result of many types of chemotherapy, such as
using cytotoxic agents or immunosuppressive drugs. Some malignancies that have
spread to involve the bone marrow, such as leukemia or advanced Hodgkin’s disease,
also cause lymphopenia. In addition, large doses of radiation, such as those involved
with nuclear accidents or medical whole body radiation, may cause lymphopenia.
1.7.3 T cell homeostasis
Homeostatic mechanisms maintain the number of T cells at an approximately con-
stant level by controling cell division and death. In normal replete hosts, cell
turnover within the naive compartment is very low and naive cells are maintained
in a resting state [40]. However, disruption of the homeostatic balance can arise
from a wide variety of causes and can result in T cell deficiency or T lymphopenia.
Under conditions of T lymphopenia, naive T cells undergo cell division, termed
homeostatic proliferation or lymphopenia induced proliferation (LIP).
1.7.4 Lymphopenia induced T cell proliferation
Slow turnover of naive CD8 T cells is essential for the maintenance of the naive T
cell pool. Two types of proliferation have been described: the basal proliferation
in lymphorepleted hosts and the homeostatic proliferation in lymphodepleted hosts
[27, 41]. In fact, the basal proliferation of the naive T cell pool reflects the slow
turnover of these cells and is minimal when we consider the CD44low population
of CD8 T cells. On the other hand, the capacity of the naive CD8 T cells to
replenish the peripheral pool in situations of severe lymphopenia allows for the
return to homeostasis. Even though basal proliferation and lymphopenia induced
proliferation (LIP) were often considered to be equivalent, they are not. In fact,
the adoptive transfer of naive CD8 T cells in a lymphopenic environment leads
to the acquisition of phenotypic and functional characteristics of memory T cells
(CD44high), which is distinctly different than the maintenance of a naive T cell
pool.
Chapter 2
Mathematical models for the
immune response of T cells
2.1 Introduction
Peripheral T cell populations are maintained by production of naive T cells in the
thymus, clonal expansion of activated cells, homeostatic proliferation, and density
dependent cell life spans. Despite great advances in immunological research during
the last decades, relatively little is known about the quantitative characteristics
of lymphocyte population kinetics [42]. There are widely divergent estimates of
the growth rates, division rates, and life spans of mouse and human lymphocyte
populations [43]. As a consequence, fundamental issues like the maintenance of a
diverse naive lymphocyte repertoire, the maintenance of memory, and the nature
of homeostatic mechanisms remain largely unresolved, and may be different in dif-
ferent species according to [42]. In fact, the mice are the most frequently studied
experimental animal in immunology, but they may not provide information directly
applying to humans [44].
Recently, several experimental techniques have been developed that have enabled
the generation of quantitative data on lymphocyte dynamics. Some have made use
of different lymphocyte labelling techniques, using agents such as the fluorescent dye
carboxy-fluorescein diacetate succinimidyl ester(CFSE), the base analog 5-bromo-
20-deoxyuridine (BrdU), deuterated glucose (2H2-glucose), or heavy water (
2H2O).
Although the techniques are used widely, the interpretation of kinetic data obtained
using these labeling methods has turned out to be difficult [42]. In this chapter, we
15
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review the various models in the literature that have given insights into the possi-
bilities and limitations of the different experimental techniques, and have thereby
helped the quantitative interpretation of immunological data. The reviewing of the
literature in this chapter is inspired from the article of De Boer and Perelson [42].
2.2 General models for the immune response
The mathematical models used for describing the population of T lymphocytes
are typically written as ordinary differential equations defining the rate at which
the populations change over time. Most models that describe the immune response,
resemble ecological predator-prey models where the immune effectors are the preda-
tors clearing a prey-like pathogen that is stimulating the effectors to grow [45–47].
The general predator-prey type model for the immune response to an exponentially
growing pathogen B (for bacteria), can be written as
dB
dt
= rB − kBA, (2.1)
dN
dt
= σ + rNN − aNF (B)N − dNN, (2.2)
dA
dt
= F (B) [aNN + aMM + pA]− dAA− (1− F (B))mA, (2.3)
dM
dt
= (1− F (B))mA+ rMM − aMF (B)M − dMM, (2.4)
F (B) =
B
B + h
, (2.5)
where 0 ≤ F (B) ≤ 1 is a saturation function of the concentration of the pathogen,
and h defines the pathogen concentration where the function is half-maximal; i.e,
when B = h, F (B) = 1
2
. The variables N , A and M are the naive, activated, and
memory T cells. It is assumed that naive T cells become activated by the pathogen
at rate aNF (B), the activated cells then proliferate at rate pF (B), and enter the
memory pool at rate (1−F (B))m [48]. Memory T cells are assumed to self-renew at
rate rM and become activated at rate aMF (B). Naive , activated and memory cells
die at rate, dN , dA, and dM , respectively. The activation, a, and proliferation, p,
rates were made proportional to F (B) whereas the deactivation rate m, of activated
cells into memory cells was made proportional to (1 − F (B)) [48]. The source of
naive cells from the thymus, σ, is small, and it is treated as a stochastic variable.
The pathogen is killed by the activated cells, which are supposed as immune effector
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cells, according to a mass action term kBA, where k is a killing rate [49]. The r and
d parameters in this model are renewal rates, and death rates, respectively. This
model forms a basis where De Boer et al. [42] have simplified this model in order
to study a specific acute immune response, and to study the average turnover rates
of naive and memory T cells with labeling techniques.
De Boer et al. [42] have assumed that the activation function is dependent on real
time (t).
F (t) =

1 if τ0 6 t 6 τ,
0 else,
(2.6)
where the time point τ0, at which all naive T cells start to proliferate at the maximal
rate [48] and τ is the time point at which the infections of all immune responses seem
to shut down, which is called the peak of the response [42]. To fit the experimental
data from acute immune responses to viruses and bacteria, De Boer et al. [42] have
used Eq. (2.6) to reformulate Eqs. (2.2)-(2.4) of the general model into a piecewise
linear model for the response to one specific epitope1
dA
dt
= F (t)pA− (1− F (t))(dA +m)A,
dM
dt
= (1− F (t))(mA− dMM), (2.7)
where A is the number of activated cells, and M is the number of memory cells of
a population of T cells that are specific for the epitope of interest, and the total
size of the immune response is defined by T = A + M . For a primary immune
response, the initial number of cells can be defined as M(0) = 0 and A(0) = A(τ0).
Then, A(τ) = M(τ) is the total number of cells at the peak of the response, since in
this strict on/off model, memory cells only start to form after the peak [48]. Their
results (De Boer et al. [42]) show that the experimental data provide typically the
total number of T cells that are specific for one particular epitope, which in Eq.
(2.7) corresponds to A(t) when t ≤ τ and A(t) +M(t) after the peak.
Another approach for modeling the clonal expansion phase of an immune response
is to explicitly write a cascade of equations that follow every division that the cells
have completed [50]. Activation of naive or memory T cells recruits the cells into
the first stage of the proliferation cascade, P0, where the index denotes the number
1A localized region on the surface of an antigen that is capable of eliciting an immune response
and of combining with a specific antibody to counter that response.
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of completed divisions. For the closure of clonal expansion, it is assumed that after
a certain number of divisions the cells differentiate into effector cells, E, that will
leave the lymphoid tissue to clear antigen, and become memory cells.
dP0
dt
= F (.) [aNN + aMM ]− (p+ dP )P0, (2.8)
dPn
dt
= 2pPn−1 − (p+ dp)Pn for n = 1, ..., nmax, (2.9)
dE
dt
= 2pPnmax − dEE − (1− F (.))mE, (2.10)
where F (.) can be either a function of time, or the concentration of antigen, and
nmax is the number of divisions cells complete during clonal expansion. Eq. (2.2) for
the naive T cells in the general model ODEs can stay the same, but the first term
in the memory cell equation, Eq. (2.4), has to become (1− F (.))mE. Because the
birth-death ODE model of Eq. (2.9) is linear, it implicitly assumes an exponential
distribution of cell cycle times. This allows cells to rapidly proceed through the
whole division cascade [51].
This model therefore does not allow for a strict time window of clonal expansion,
it needs a strict time delay representing the minimal time to complete cell division
[51]. Diekmann et al. [52] and later on Ganusov et al. [6] have formulated the
previous model as a system of delay differential equations (DDEs). Indeed, the
activated cells of Eq. (2.3) are divided here in proliferating activated cells, P , and
effector cells, E. Then, their behaviour is described as follows
dP
dt
= F (t) [aNN + aMM ] + pP − dPP − aNH(t− τN)N(t− τN)e(p−dp)τN
−aMH(t− τM)M(t− τM)e(p−dp)τM , (2.11)
dE
dt
= aNH(t− τN)N(t− τN)e(p−dp)τN + aMH(t− τM)M(t− τM)e(p−dp)τM
−dEE − (1− F (t))mE. (2.12)
According to this model primed naive T cells, N , are involved in clonal expansion
for a period of τN days during which time they divide at rate p and die at rate
dp. At the end of this proliferative phase, they move into the effector population.
The e(p−dp)τ terms are the net dimension less clonal expansion factors describing
the expected clone size per primed cell given, the division rate p and the death
rate dp [42]. The H(t − τ) terms are Heaviside functions preventing the usage of
negative time points, i.e, H(t) = 0 if t < 0 and H(t) = 1 otherwise. Memory cells,
M , maintain themselves by division (i.e, self-renewal), at rate rM , die at rate dM
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and may become primed by antigen at rate, aM , to perform another round of clonal
expansion for τM days.
Finally, division cascade models like Eq. (2.9) have been used many times for
modeling immune responses and renewing cells in a homogeneous population [4,
51, 53–57]. Because self-renewal is in theory not bounded by a maximum number
of divisions, unless cells run into the Hayflick limit [42]. De Boer et al. [42] have
proposed an infinite cascade of random birth-death equations that keep track of the
number of divisions cells have completed.
dP0
dt
= −(p+ d)P0, (2.13)
dPn
dt
= 2pPn−1 − (p+ d)Pn, n = 1, ...,∞, (2.14)
where n is the number of divisions cells have completed. Let P (t) be the total
number of cells at time t, then
dP
dt
=
∑
n
dPn
dt
= (p− d)P.
For the initial condition P0(0) = T (0) and Pn(0) = 0 for n = 1, ..,∞, where T (0) is
the initial number of undivided cells, the general solution is
Pn(t) = P (t)× (2pt)
n
n!
e−2pdt,
where P (t) =
∑
n Pn(t) = T (0)e
(p−d)t is the total number of divided cells, and the
second term of the right hand side of the above equation gives the distribution of
the cells over the division numbers.
This simple models (2.13-2.14) is very general and has been used widely in the
literature to describe several data like CFSE (it is detailed in the next section) or
BRdU [4, 51, 53–57].
2.3 CFSE
Carboxyuorescein succinimidyl ester (CFSE) is an intracellular fluorescent dye that
dilutes 2-fold when a cell divides [58]. Cells are typically labeled with CFSE in vitro,
and labeled cells can be followed thereafter in vitro or in vivo. Harvesting the cells
and sorting them by the CFSE intensity generates profiles with maximally 7 or 8
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peaks, each reflecting the number of divisions the cells have undergone [42]. CFSE
is currently the most informative technique for characterizing the division kinetics
of cells in the immune system. A number of reviews address the experimental
procedures [59, 60]. The interpretation of CFSE data has resulted in many different
mathematical approaches. Here, we give some approaches from the literature.
Asquith et al. [56] wrote a random birth-death model like Eqs. (2.13-2.14), and
estimated the number of divisions that were required for a CFSE+ cell to become
CFSE− from the ratio of the median fluorescence intensity (MFI) of all CFSE+
cells over all CFSE− cells. Finding 25-fold ratio, they truncated Eqs. (2.13-2.14)
at the fifth division,
dP0
dt
= −(p+ d)P0, dPn
dt
= 2pPn−1 − (p+ d)Pn,
dP5
dt
= 2pP4 + (p− d)P5 + σ,
for n = 1, ..., 4, and included a possible source, σ of CFSE− cells for P5 equation.
This model predicts two observables, the fraction of CFSE+ cells and the ration of
the MFIs of CFSE+ to CFSE− cells. These two observables were successfully fit
to B cell data [56].
Luzyanina et al. [61] defined a model directly describing the kinetics of the CFSE
intensity profile using a label-structured population model. Their models is com-
prised of a CFSE structured PDE allowing for cell death, for the 2-fold dilution
per division, and for CFSE loss by normal catabolism. This has the immediate
advantage of not having to classify CFSE profiles into individual peaks, which is
particularly helpful when the data is not nicely fingered. Assuming that each CFSE
peak represents a cohort of cells that entered their first division at approximately
the same time. Luzyanina et al. [61] wrote a label structured population model for
the density of cells with CFSE intensity x
∂n(t, x)
∂t
+ v(x)
∂n(t, x)
∂x
= − [p(x) + d(x)]n(t, x) + 2γp(γx)n(t, γx), xmin ≤ x ≤ xmax/γ,
∂n(t, x)
∂t
+ v(x)
∂n(t, x)
∂x
= − [p(x) + d(x)]n(t, x), xmax/γ ≤ x ≤ xmax, (2.15)
where the v(x) term describes the natural decay of the CFSE intensity, the prolif-
eration p(x) and death d(x) rates depend on the CFSE expression of the cell, and
γ is the CFSE dilution factor. If cells divide into two daugther cells, then γ = 2.
Fitting this PDE model directly to CFSE intensity profiles required smoothing of
the data, and required non-trivial numerical integration methods for solving the
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PDEs [61]. Two data sets obtained from in vitro proliferation of T cells following
polyclonal activation were fit using this model. The loss rate of CFSE, v(x), was
not exponential. The death rate hardly depended on the CFSE intensity, whereas
the division rate was found to be a bell-shaped function of the CFSE intensity x,
with relatively slow maximum division rates of 0.55 day−1 and 0.8 day−1 at the
third or fourth division. Finally, the dilution factor, γ, was less than two in both
data sets [61].
The general label structured population approach of [61] has been extend by several
authors [62–66]. For example, Schittler et al. [64] and Hasenauer et al. [65] extend
Luzyanina et al. [61] model with discrete populations for each division, and this
extension leads to the much more intuitive model.
∂P0(t, x)
∂t
+
∂ (v(x)P0(t, x))
∂x
= − [p0(t) + d0(t)]P0(t, x),
∂Pn(t, x)
∂t
+
∂ (v(x)Pn(t, x))
∂x
= − [pn(t) + dn(t)]Pn(t, x)
+2γpn−1(t)Pn−1(t, γx), (2.16)
for n = 1, ..., nmax, and where x is the amount (or concentration) of CFSE in each
cell, which decreases at a rate v(x). The number of cells contained in the nth
subpopulation is defined as Pn(t) =
∫∞
0
Pn(t, x)dx, and the number of cells having
an amount x of CFSE is given by P (t, x) =
∑nmax
n=0 Pn(t, x). After adding the
autofluorescence, the latter can be fitted directly by measured CFSE profiles, such
that the total cell number in the data is predicted by P (t) =
∑
Pn(t) [65].
Furthermore, other models are proposed in the literature to analyse CFSE data,
like the Cyton model and the Smith-Martin model. These two models are described
briefly in the next sections.
2.4 Cyton model
Gett and Hodgkin [1] proposed a simple mathematical model for CFSE data anal-
ysis. This model was then compared with a relatively simple branching process
model in Hyrien and Zand [67]. The key model assumption in Gett and Hodgkin
[1] of a normal distribution of the time to first division turned out to be likely in-
appropriate [68]. The recent work of Hawakins et al. [59] extends the work of Gett
and Hodgkin [1] by directly modeling the time to division and time to death of cell
generations using independent single mode continuous distributions. This is called
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Cyton model. Thus, the Cyton model does not require the assumption of a normal
distribution and it is flexible enough to model different generations with different
kinetic parameter values (e.g, different proliferation or death rates for different cell
generations)[68]. In this section, the Cyton model is briefly reviewed and discussed.
Let n = 0, 1, ... denote the nth generation of cells. For the nth generation, a contin-
uous distribution φn(t) is assigned to model the distribution of the time to divide,
and ψn(t) is assigned to model the distribution of time to die. To calculate the cell
number in each generation at time t, this model consists in starting with the first
generation. Given N(0) cells of age zero at time zero, then, at time t, the rates of
cell division or death in the first generation are given by
rdiv0 (t) = f0N(0)
(
1−
∫ t
0
ψ0(τ)dτ
)
φ0(t),
rdie0 (t) = N(0)
(
1− f0
∫ t
0
φ0(τ)dτ
)
ψ0(t),
where f0 represents the probability that a cell will divide in response to the given
stimulus. Then for later generations, the rates of cell division and death are given
by
rdivn (t) = 2fn
∫ t
0
[
rdivn1 (τ)
(
1−
∫ t−τ
0
ψn(ζ)dζ
)
φn(t− τ)
]
dτ,
rdien (t) = 2
∫ t
0
[
rdien−1(τ)
(
1− fn
∫ t−τ
0
φn(ζ)dζ
)
ψn(t− τ)
]
dτ.
Thus the number of cells in each generation can be calculated as follows
N0(t) = N(0)−
∫ t
0
(
rdiv0 (τ) + r
die
0 (τ)
)
dτ,
Nn(t) =
∫ t
0
(
2rdivn−1(τ)− rdivn (τ)− rdien (τ)
)
, n = 1, 2...
The construction of the model above is straightforward. See Hawakins et al. [59]
for more details. Note that, φn(t) and ψn(t) in the Cyton model are the probability
density functions of some continuous distributions.
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2.5 Smith-Martin model
The model for the cell cycle developed by Smith and Martin [69] has been suc-
cessfully used for analyzing the population dynamics of dividing cells as it prevents
too rapid progression through the cell cycle by introducing the equivalent of a time
delay, i.e, a fixed length for the S, G2 and M phases of the cell cycle [42].
The Smith-Martin model allows for two phases of the cell cycle: cells in the ”A”
state, which approximately corresponds to the G0 or G1 phase of the cell cycle, are
randomly activated to divide, and dividing cells in the ”B” phase remain in this
phase for a fixed time ∆. Later on, they yield two daughter cells in the A-state.
Based on the Smith-Martin model, several investigations have developed mathemat-
ical models for the purpose of CFSE data analysis [3, 8, 51, 70], including determin-
istic models as well as stochastic models. However, the Smith-Martin model has
been criticized for its simplicity and inaccuracy [67, 71–73] and more complicated
cell cycle models have been proposed [74–76]. The recent work of Lee and Perelson
[8] greatly extended the Smith-Martin model by introducing the gamma distribution
for the A phase generation, generation dependent death rates, and variables length
of the B phase. Three models were developed in Lee and Perelson [8], including the
time to first division (TFD) model, generalized Smith-Martin (GSM) model and
the heterogeneous generalized Smith-Martin (HGSM) model. Although the GSM
and HGSM models are more flexible to accommodate variations from generation to
generation, some assumptions in Lee and Perelson [8] have been made to simplify
the analysis of models, which may not hold in practice. For example, it was as-
sumed that after the first division, cells of different ages have the same average A
and B phase lengths. Also, more complex Smith-Martin models were shown to be
comparable to the Cyton model [9]. The Smith-Martin model in [8], is written as
follows
dA0(t)
dt
= −(λ+ δA)A0(t),
dAi(t)
dt
= 2λe−δB∆Ai−1(t−∆)− (λ+ δA)Ai(t), i > 1,
dBi(t)
dt
= λAi(t)− λe−δB∆Ai(t−∆)− δBBi(t), i > 0,
where Ai(t) and Bi(t) (i = 0, 1, 2, ...) denote the number of cells in the A-state
and the B-phase in the ith generation, respectively. The cells in the A-state and
B-phase have death rates δA and δB respectively. Cells in the A-state are triggered
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to enter the B-phase at a rate λ and divide when they complete the process in B
phase. This Smith-Martin model has four parameters, with the length of the cell
cycle defined as p−1 +∆, and two different death rates. According to [42], the death
rates δA and δB, cause a problem of identifiability by using CFSE data. This version
of Smith-Martin model will give unique fits to CFSE data if the model is simplified
to three parameters, e.g, by assuming that δA = δB, δA = 0 or δB = 0 [4, 70]. Note
that the similar problems with the uniqueness of fits exist in the Cyton model [59],
and that one needs more information, like the number of dead cells per division, to
resolve these parameter identification problems.
Luzyanina et al. [77] compare fits obtained with a classical Smith-Martin model,
with fits obtained with a heterogeneous random birth-death model, i.e, Eqs. (2.13-
2.14) extended division and death rates, pn and dn, that depend on the division
number n. They find that the random birth-death models fits their data better.
This is not a fair comparison, however, because the heterogeneous model has many
parameters, that could compensate for the absence of the time delay, ∆, of the
Smith-Martin model [42].
De Boer et al. [5], Ganusov et al. [6] and Lee et al. [8] have shown that the
quiescent cells are in the G0 state of the cell cycle, and need more time to enter the
G1 state of the cell cycle, and their first B-phase could take longer than subsequent
B phases. Then, the Smith-Martin can be extended with a longer first division
by implementing a recruitment function R(t), defining the distribution of times to
complete the first division.
dA1(t)
dt
= R(t)− (λ1 + δ1)A1(t),
dAi(t)
dt
= 2λi−1e−δi−1∆Ai−1(t−∆)− (λi + δi)Ai(t), i > 1,
dBi(t)
dt
= λiAi(t)− λne−δi∆Ai(t−∆)− δiBi(t), i > 1,
where λi and δi are the division and death rates at the ith division, respectively.
Fitting either a time-shifted log-normal [6] or a gamma distribution [6, 8] for R(t)
to experiments explicitly measuring the time to first division, this heterogeneous
Smith-Martin model was successfully fitted to CFSE data from T cells stimulated
in vitro with various concentrations of the cytokine IL-2 [78].
Furthermore, Bernard et al. [3] and Ganusov et al. [4] have formulated the Smith-
Martin model in terms of PDEs to take into account the continuous age of cells in
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B-phase. The latter is written as follows
(SM)

dA0
dt
= −(λ+ δA)A0(t), {A0(0) > 0}
dAi
dt
= 2Bi−1(t,∆)− (λ+ δA)Ai(t), {Ai(0) = 0}, i = 1, ..., I

∂
∂t
Bi(t, τ) +
∂
∂τ
Bi(t, τ) = −δBBi(t, τ), i = 0, ..., I
Bi(t, 0) = λAi(t), Bi(0, τ) = 0
where ∆ is the duration of cells in B-phase, λ is the rate of entry into division,
and, δA, δB are the death rate in A-state and B-phase respectively. Ganusov et al.
[4] have shown that no general robust method exists to estimate all parameters of
the SM model by using CFSE data alone. It is, however possible to estimate the
duration of division ∆, probability of cell death during the cell cycle δ (by assuming
δ = δA = δB), and in some cases the average division time T . In addition, measuring
an additional parameter, like the fraction of cells in division (i.e, fraction of cells
that are in the S + G2 + M phase of the cell cycle), may allow estimation of all
parameters of the SM model [4].
Models of T cell homeostatic proliferation
The homeostatic proliferation (or lymphopenia induced proliferation) that naive T
cells undergo following adoptive transfer into an environment with low T cell num-
ber was studied by Yates et al. [7] and Hogan et al. [10].
In [7], they labeled F5 TCR transgenic naive CD8+ T cells, which are specific for
an influenza peptide, with CFSE and transferred these cells into Rag1 knockout
mice that have no endogenous T cells. At different time points, lymph nodes were
recovered from the recipient mice to record the CFSE profiles and expression of
CD44 were assessed by flow cytometry. In the presence of cognate antigen, i.e, the
influenza virus, CFSE dilution was rapid due to the vigorous clonal expansion of
the F5 T cells. In its absence, the F5 cells started to grow exponentially after a few
days. The mean division number increased linearly with time, with some evidence
for a slowing-down after about two weeks. Furthermore, using the CFSE profile
to calculate the precursor frequency (see Materials and Methods in [7]) revealed
that the CD44high population arise from only 17% of the precursor population.
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The remaining 83% pool remained CD44low and divided more slowly or not at all.
Therefore, their data in [7] suggest that F5 TCR transgenic CD8+ T cells divided
slowly, or not at all, without up-regulating activation markers like CD44.
To analyse the regulation of LIP, Yates et al. [7] fitted a series of mathematical
models of cell division to their data. At first, they compared the time course of
cell division predicted by Cyton model to the response observed experimentally, the
model appeared to provide a very poor description of the data [7]. The second class
of model used in their study, is the SM model, in which cells spend exponentially
distributed times in a quiescent A-state (corresponding approximately to the G0/G1
states of the cell cycle) and then progress through a B-phase (S, G2 and M) before
dividing and returning to the A-state. The B-phase was taken to be of fixed dura-
tion ∆. The rate of transition from A-state to B-phase is represented by a constant
term λ. This assumption of a constant mean rate of entry into division (λ) gave
a reasonable fit to the data [7]. The third class of model is a modified SM model
where they extend the SM model. Indeed, they considered that the rate of entry
into division depends on the time t (λ = λ0e
−ηt). This improved the fit significantly.
Furthermore, Hogan et al. [10] analysed two TCR transgenic of T cells (OT-1
cells and F5 cells). Their data allow to conclude that the undivided OT-1 cells
expressed a similar level of CD44 to naive CD8+ T cells, and began to upregulate
expression of this marker after the 4th-6th division in response to lymphopenia.
However, F5 T cells retained a low level of CD44 expression throughout division.
The expression of CD44 by OT-1 T cells at approximately 4-6 divisions in response
to lymphopenia, indicates the acquisition of a memory like phenotype, which is not
observed for F5 T cells under the same conditions. This result is consistent with
the result of F5 T cells deduced by Yates et al. [7]. In addition, Hogan et al. [10]
extended the modified SM model proposed by Yates et al. [7] (it is denoted by
SM1 model). This new version of Smith-Martin consists to take into account the
competition between cells to enter B-phase, then the rate of entry into division is
considered as a function of the cell number (λ = λ0e
−η N(t) where N(t) is the total
cell number in A-state and B-phase). In their work, they compared this new version
of Smith-Martin model (SM1 model) to Cyton model for OT-1. They concluded
that LIP by OT-1 was much better modeled with the SM1 model than the Cyton
model, as reflected in the lower CrV for the SM1 model fit, which is a measure of
goodness of fit.
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2.6 Discussion and Motivation
Throughout adult life, the size and composition of the peripheral lymphocyte pool is
tightly regulated and, in the absence of disease, is maintained at relatively constant
levels [40, 79]. The correct representation of the T-cell pool is essential to maintain
adequate immune competence against pathogens, since it has to maintain a suffi-
ciently diverse repertoire of naive T cells to recognize a broad range of antigens,
while efficient immune responses against previously encountered pathogens depend
on the memory T-cell pool. For these demanding tasks, homeostatic mechanisms
have evolved to maintain distinct populations of naive and memory cells and to
retain an appropriate mixture of CD4+ helper T cells and CD8+ cytotoxic T cells.
A few general principles govern the physiologic response to perturbations of the
balance between T cells. For example, viral infections (HIV, Tuberculosis,...), or
drugs used in peritransplant induction therapy or cancer chemotherapy, are the
main factors that disrupt the balance of T cells. This perturbation results in Lym-
phocytopenia or lymphopenia (i.e. the condition of having an abnormally low level
of lymphocytes in the blood) which induces a rapid in vivo proliferation of T cells
with a recruitment of naive T cells from the thymus.
As proved in the last decades, the use of mathematical models in immunology has
allowed great advances, not only on the theoretical side, but also on the side of the
management of actual public health policies. As summarized in this chapter, several
studies have successfully used mathematical modeling to describe the proliferative
response of T cells to lymphopenia [7, 10] and greatly facilitated our understanding
of the cell cycle control involved. However, these studies have not taken into ac-
count the transition from naive to memory status by using the concept of a relevant
phenotype as structuring during the homeostatic process. This transition can be
assessed phenotypically by measuring expression levels of several surface markers
such as CD44.
In this thesis, our research objectives are to elaborate some answers to the following
immunological subjects:
- Understanding the complex relationship between LIP2 and the switch
from a naive to memory phenotype through mathematical models.
- Studying the asymptotic behaviour of T cells during the homeostatic
process in vivo.
2Lymphopenia Induced Proliferation
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The key tools used in this work are: Mathematical Modeling, Numerical Anal-
ysis, Experimental Data, Parameter Identification Problem, Asymptotic
Behaviour and Optimal Control.
Chapter 3
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Plan of Thesis
T Cell Homeostasis in Vivo 
 Mathematical model and its well-posedness 
 Asymptotic behaviour for an age structured model 
 An optimal strategy of rebuilding immunity 
 
P
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T 
II 
T Cell Proliferation in Lymphopenia Conditions 
 Mathematical modeling 
 Numerical analysis 
P
A
R
T 
III 
 
P
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R
T 
IV 
 
Parameters Identification 
 Experimental data and theoretical identifiability 
 A comparison of two versions of Smith-Martin model 
 Identification of the upregulation of CD44 (i.e. switch from naïve 
to memory phenotype) 
 Identification of the recruitment rate and the division rate 
Objectives:  
 Understanding the complex relationship between LIP and the switch from a naive 
(CD44 low) to memory (CD44 high) phenotype through mathematical models.        
 Studying the asymptotic behaviour of T cells during the homeostatic process in 
vivo. 
Flowchart of thesis. Items in blue, red and yellow resume the articles [80] (Pub-
lished), [81] (Accepted), [82] (Submitted) issues from this thesis respectively.
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This work is organised as follows.
- Part II is divided in two chapters:
• In Chapter 4, we build a new in vitro model (noted SMCD44) to include the
transition from naive (CD44 low) to memory (CD44 high) cells. By including
in the Smith-Martin model [3, 4, 7, 10] new parameters which link the pheno-
typic (i.e. gradual upregulation of CD44 expression) and functional conversion
of cells with their number and/or rate of division, we explore the nature of
the LIP response that generate CD44 phenotype expression in T cells.
As in the Smith-Martin model, the SMCD44 model includes an A-state (rest-
ing phase) and a B-phase (proliferative phase) where cells undergo division
such as a cascade system. The number of times cells transfer between the
A-state to the B-phase is indexed by i, which is the number of times a cell
has undergone division. The time since entering the B-phase (either the first
time or any subsequent time) is measured by τ which reflects the maturity of
the cells at this stage and has a maximum value ∆. Both the cells in A-state
and B-phase are also indexed by s ∈ [0,m], the intensity of CD44 expression.
The A-state and B-phase are described by ODEs and PDEs respectively. The
different A-state and B-phase components are given by Ai(t, s) and Bi(t, τ, s)
respectively for i = 0, 1, ..., I (depending on how many times the cells have
undergone division). For i = 0 the growth of the A0 component in this in
vitro model comes from the initial number of cells in A0 phase. Furthermore,
the stochastic recruitment of cells from A-state into B-phase is done with a
rate λ that depends on the total cell number N(t). In B-phase, the cells are
up-regulating their level of CD44 with a velocity vi(s). After completing the
process (mitosis) in B-phase, the cells divide with rate µ(τ) which depends
on the age of cells in B-phase, and the daughter cells inherit the same level of
CD44 of their mother cells (See (4.2-4.3) and Fig. 4.1 in Chapter 4). For this
structured system, we derive an implicit solution of the Ai equation and the
integral formulation of the Bi equation.
• In Chapter 5, we build a numerical scheme to approximate the solution of
SMCD44 model. Furthermore, an analysis of properties of the scheme is pro-
posed. Indeed, the proofs of stability, consistency and convergence of the
scheme to an analytical solution of the model, are established in this chapter.
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- Part III is divided in four chapters:
• In Chapter 6, we describe the data generated by Hogan et al. [10]. Next, we
prove the identifiability of some parameters (vi, λ, ∆) in SMCD44 model.
• In Chapter 7, we present the latest version of Smith-Martin in the literature
and our reduced SMCD44 model (i.e without the CD44 structure). In addi-
tion, we describe the method used to identify numerically several common
parameters in both models by using the CFSE data [10]. Finally, we show the
parameters and the simulations that we obtain from the models, and compare
them to experimental data.
• In Chapter 8, we interest to identify the velocity of CD44 up-regulation dur-
ing lymphopenia induced proliferation. This velocity is the key parameter
that distinguishes from which divisions, T cells can be considered as naive or
memory through the mathematical model SMCD44.
The methodology used to identify this parameter consists to solve a param-
eter identification problem where it is well detailed in this chapter. In the
numerical results, we show the parameters and the simulations that we obtain
from the model and compare them to experimental data. Finally, the iden-
tified parameters and the simulations of SMCD44 provide several biological
interpretations of the complex relationship between LIP and the switch from
a naive to memory phenotype through SMCD44 model.
• In Chapter 9, we connect the intensity of CD44 with the rate of entry into
division (λ) and the rate of division (µ). Here, we interest to identify these
new parameters which depend on the level of CD44 (s). As in the previous
chapter, the ingredients to solve the parameters identification problems are
given. Finally, we present the simulations and the identified parameters, and
we conclude by biological interpretations about the link between the level of
CD44 on the cells and their rate of entry into the proliferative phase or their
division rate.
- Part IV is divided in three chapters:
• In Chapter 10, we extend the SMCD44 model to an in vivo model by imple-
menting a rate Λ of export of cells from the thymus. In addition, we consider
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a large number of division (I >> 0) with a rate of entry into division depend-
ing on the number of division (i) and the total cell number (N). By using
the fixed point method, we prove the local existence and uniqueness of the
solution of the extended model system. Finally, we conclude on the global
existence of solutions by using the maximal interval of existence.
• In Chapter 11, we rewrite the extended model system as an age-structured
model system without the CD44 structure, and we investigate its asymptotic
behaviour. We find that there exists one or three stationary solutions when
cells undergo at least five divisions and only one stationary solution when
cells undergo at most three divisions, the limiting case with four divisions is
numerically handled. By applying the Lyapunov method, we prove in some
cases of uniqueness that the stationary solution is globally asymptotically
stable.
• In Chapter 12, we reformulate the in vivo model proposed in Chapter 10 into a
more realistic version with vaccination strategy. The purpose of this chapter
is to address the problem of determining an optimal strategy that lead to
enhanced immunity during the homeostatic process. Firstly, we discuss the
cost function and we derive the optimality conditions. Secondly, we perform
some simulations to compute the optimal vaccination.
- Finally in Chapter 13, we summarize the main results of this study and we
give perspectives and new problems induced from this research project.

Part II
T Cell Proliferation in
Lymphopenia Conditions:
Mathematical Modeling and
Numerical Analysis
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Chapter 4
Mathematical modeling of
Lymphopenia induced
proliferation
4.1 Introduction.
T lymphocytes are a fundamental component of the immune system that can recog-
nise and respond to a foreign antigen by virtue of their clonally expressed T cell
antigen receptor (TCR). T cells that have yet to encounter the antigen they recog-
nise are termed ’naive’ as they have not been activated to respond.
Homeostatic mechanisms maintain the number of T cells at an approximately con-
stant level by controling cell division and death. In normal replete hosts, cell
turnover within the naive compartment is very low and naive cells are maintained
in a resting state [40]. However, disruption of the homeostatic balance can arise
from a wide variety of causes and can result in T cell deficiency i.e T lymphopenia.
Under conditions of T lymphopenia, naive T cells undergo cell division, termed
homeostatic proliferation or lymphopenia induced proliferation (LIP).
The homeostatic proliferative response of naive T cells is complex and depends on
the affinity of the TCR for self antigens. Studies on TCR transgenic mouse models
reveal a spectrum of responses. T cells expressing some TCR transgenes fail to
proliferate in lymphopenia [28]. T cells expressing other transgenic TCR undergo
cell divisions at a slow rate [83] whereas some others undergo more rapid divisions
accompanied by changes in the cell surface phenotype including increased CD44
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expression, which is commonly associated with a ”memory like” phenotype [84–86].
This transition can be assessed phenotypically by measuring expression levels of
several surface markers such as CD44 on which this thesis is focused. Understand-
ing the complex relationship between LIP and the switch from a naive to memory
phenotype is an important question to address. There have been several studies
modelling the cell cycle in lymphopenia conditions [7, 10]. However these studies
did not take into account the changes in phenotype.
An important step in using the mathematical approach is the estimation of model
parameters using experimental data. Several types of data have been used in this
context. Using cell dyes, such as Carboxy Fluorescein diacetate Succinimidyl Ester
(CFSE), is currently one of the most informative methods to characterize the dy-
namics of cell division in the immune system. Following each division, CFSE divides
equally between daughter cells, resulting in a two-fold decrease in the intensity of
cellular fluorescence in each successive generation. This property of CFSE allows
accurate tracking of the number of divisions that a given cell has undergone either
in vitro or following transfer in vivo [87].
Several authors have tried to understand T cells homeostasis by using mathematical
models with CFSE data and employing many methods for the estimation of model
parameters [1, 4, 5, 8–10, 51, 59, 78].
Gett and Hodgkin [1] used a different class of model (GH model) in which het-
erogeneity in proliferation stems from variable times to first division, with quasi-
deterministic division from then onwards. This has been used successfully to de-
scribe antigen-driven ’programmed’ cell division [1, 78, 88].
The Smith-Martin model (Smith and Martin [69]) is another standard mathemati-
cal model for analysing the kinetics of the cell cycle, which allows two phases of the
cell cycle. Cells in ”A-state” are in rest and are recruited stochastically to divide
in the proliferative ”B-phase”. This phase has a fixed total duration.
The Smith-Martin model has been applied widely to CFSE data [2–9], and the dura-
tion of deterministic phase (B-phase) and the probability of cell death has been esti-
mated from experimental data mainly based on CFSE cell division profiles. Hogan
et al [10] improved the technique and accuracy of the parameters estimations from
the Smith-Martin model. The DNA binding dye, 7-Aminoactinomycin D (7AAD),
was used with CFSE to distinguish the proliferating and non-proliferating cells,
therefore enabling estimations of the rate of recruitment of cells from A-state into
B-phase.
In this chapter, we build a new model for including the transition from naive (CD44
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low) to memory (CD44 high) cells. By including new parameters to the Smith-
Martin model which link the phenotypic (i.e. gradual upregulation of CD44 expres-
sion) and functional conversion of cells to their number and/or rate of division, we
explore the nature of the LIP response that generate CD44 expression phenotype
cells.
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Figure 4.1: Model of T cell proliferation in lymphopenia conditions. Ai and Bi are the number of T
cells, having undergone i divisions in A-state and B-phase respectively. ∆ is the duration of B-phase (unit in
hour). The rate of entry into division (λ) is described by a function of the total cell number (N), which is
linked to all phases and all divisions [10].
4.2 The model (noted SMCD44)
The biological cell cycle describes five distinct phases G0, G1, S, G2 and M grouping
interphase and mitosis. Phase G0 is a quiescent phase as cells are in a non dividing
state and require a specific extrinsic signal to enter the cell cycle. In G1, cells grow
in size and make the cytoplasmic proteins necessary for cell division. The phases
S, G2 and M are the proliferative phases where a cell duplicates its genome and
divides in two daughter cells.
In the case of T cell division, a mother cell gives rise to two new cells called daughter
cells. This process can be modeled by two phases, proliferative phase and resting
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phase. The proliferative phase is the active phase of DNA synthesis and cell di-
vision. A cell cannot stay indefinitely in the proliferative phase, it divides when
it completes the process of mitosis. After cell division, daughter cells re-enter the
resting phase. In contrast to the proliferation phase, cells in the resting phase may
remain stable and viable indefinitely.
In lymphopenic conditions (Fig. 4.1), the progression of cells through the cell cycle
involves a stochastic recruitment of cells from A-state (corresponding approximately
to the G0/G1 phase of the cell cycle) into the dividing B-phase (approximately
equivalent to the S, G2, and M phases of the cell cycle) [5, 7]. The B-phase has
a fixed duration ∆. It is assumed that a cell in B-phase has an age τ ∈ [0,∆].
After completing the deterministic B-phase, a cell delivers two daughter cells into
the stochastic A-state from which the cells may be recruited for another round of
division. Cells in the A-state and B-phase have death rates δA and δB respectively.
To better understand the dynamics of memory T cell generation in lymphopenic
conditions, we model the transition of cells from a naive (CD44 low) to a memory-
like (CD44 high) phenotype as a consequence of LIP. The dynamics of this transition
has been measured by the phenotypic (CD44) change on the surface of T cells. For
this reason, we take into account the CD44 expression in the Smith-Martin model.
We suppose that cells have an expression of CD44, s ∈ [0,m], where m is the max-
imum CD44 expression.
We denote by
• Ai(t, s) is the number of cells at time t having undergone i divisions in A-state
and having an intensity s of CD44 expression.
• Bi(t, τ, s) is the number of cells at time t having undergone i divisions, having
spent time τ in B-phase and having an intensity s of CD44 expression.
Subscripts i = 0, ..., I refer to division or generation number, I is the maximum
number of divisions that can be performed (8 - 9 with CFSE labelling) [7, 10].
The total number of cells is given at time t by
N = N(t) =
I∑
i=0
(∫ m
0
∫ ∆
0
Bi(t, τ, s)ds dτ +
∫ m
0
Ai(t, s)ds
)
. (4.1)
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Rate of entry into division
Recruitment of cells from A-state into the B-phase occurs at a rate λ. As the cellular
population increases, the amount of resources per cell decreases and the recruitment
rate is reduced. A smaller division rate corresponds to the smaller transfer rate λ
of the model [10]. Therefore, λ depends on the total number of cells N = N(t).
Division rate
In the Smith-Martin model, cells are triggered from A-state to enter the prolifera-
tive B-phase. They spend some time, indexed by τ ∈ [0,∆] to divide in B-phase.
A proliferative cell divides into two daughter cells only when it has completed the
process of mitosis (∆ is approximately the time to finish the process). More specif-
ically, when a cell divides, it disappears from the B-phase.
In this study, we introduce a function µ in order to remove the cells that have di-
vided. Therefore, µ(τ) represents the rate of cells which divided at age τ and have
given rise to two daughter cells in the resting phase.
The cumulative probability that a cell is still in B-phase at time τ , having not
divided (µ) nor been killed (δB) until this time point, is
Π(τ) = e−
∫ τ
0 (δB+µ(a))da,
and the cumulative probability that a cell has divided until time point τ , is
d(τ) = 1− e−
∫ τ
0 µ(a)da.
Velocity of CD44 up-regulation
To describe the CD44 expression and its accumulation on the surface of T cells, a
velocity (vi) was introduced in the model which depends on the CD44 expression
(s) and the number of divisions (i). This velocity is used to represent the extent of
up-regulation of CD44 expression in the proliferation process. Indeed, we assume
that cells are up-regulating CD44 during the proliferating phase [89]. This velocity
can take into account the level of receptors that have been already presented on the
surface of cells at the beginning of the phase.
Then, the dynamics of T cells in lymphopenia conditions is given in
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the following model
dA0(t, s)
dt
= −δAA0(t, s)− λ(N)A0(t, s),

for i = 1, ..., I
dAi(t, s)
dt
= 2
∫ ∆
0
µ(τ)Bi−1(t, τ, s) dτ − δAAi(t, s)− λ(N)Ai(t, s),

for i = 0, ..., I
∂
∂t
Bi(t, τ, s) +
∂
∂τ
Bi(t, τ, s) +
∂
∂s
[vi(s).Bi(t, τ, s)] = − (δB + µ(τ))Bi(t, τ, s),
(4.2)
where the variables (t, τ, s) lie in [0, T ]× [0,∆]× [0,m].
The boundary and initial distributions are

Bi(t, 0, s) = λ(N)Ai(t, s) and vi(0)Bi(t, τ, 0) = 0 for i = 0, ..., I
Bi(0, τ, s) = 0, for i = 0, ..., I and Ai(0, s) = 0, for i = 1, ..., I
A0(0, s) = A0,0(s) > 0.
(4.3)
We denote (4.2-4.3) by SMCD44 model.
4.3 Integral formulation
In this section, one derives an integral formulation of the solution of System (4.2-
4.3).
By using the Lagrange method, one obtains implicit solutions of the ordinary dif-
ferential equations that are in System (4.2-4.3)
A0(t, s) = A0,0(s) e
− ∫ t0 (δA+λ(N(u)))du, (4.4)
Ai(t, s) = 2
∫ t
0
∫ ∆
0
e−
∫ t
r (δA+λ(N(q)))dqµ(τ)Bi−1(r, τ, s)dτ dr, i = 1, ..., I.
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In addition, consider the following ordinary differential equations
ds1i (t)
dt
= vi(s
1
i (t))
s1i (t0) = s
1
i,0 > 0,

ds2i (τ)
dτ
= vi(s
2
i (τ))
s2i (τ0) = s
2
i,0 > 0.
(4.5)
s1i (t; t0; s
1
i (t0)) and s
2
i (τ ; τ0; s
2
i (τ0)) are the curves which go through (t0, s
1
i (t0)) and
(τ0, s
2
i (τ0)) respectively. The curves, Z
1
i (t) := s
1
i (t; 0; 0) and Z
2
i (τ) := s
2
i (τ ; 0; 0)
are the characteristic through the origin. The solutions of (4.5) are given by the
following equations
s1i (t) = s
1
i (t0) +
∫ t
t0
vi(s
1
i (z))dz, s
2
i (τ) = s
2
i (τ0) +
∫ τ
τ0
vi(s
2
i (r))dr.
Assumption 4.3.1.
- Natural mortalities rates δA and δB are non-negative constants.
- Function µ(.) is bounded, non-negative and satisfies the following inequality
0 ≤ µ ≤ µ(τ) ≤ µ¯, ∀ τ ∈ [0,∆].
- Function λ(N) is non-negative, bounded and Lipschitz continuous with constant
k
|λ(N)− λ(N∗)| 6 k|N −N∗|, N > 0, N∗ > 0.
- Function vi is bounded, non-negative for all i ∈ NI := {0, ..., I}, satisfies the
condition
vi(0) = 0, and 0 < vi ≤ vi(s) ≤ v¯i, ∀s ∈]0,m],
and continuously differentiable with respect to the variable s. In addition, there
exists a positive constant dvi , ∀ i ∈ NI , such that
|∂vi
∂s
| 6 dvi , ∀ s ∈ [0,m].
- Initial condition A0,0(.) is non-negative and belongs to L
1
+((0,m)).
Let Assumption 4.3.1 be satisfied. By using the method of characteristics, one has:
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1-) Let ui(t) := Bi(t, t + c, s
1
i (t)), where c > 0. Using the PDEs in System (4.2-
4.3), one obtains
dui(t)
dt
= −
[
δB + µ(t+ c) +
∂vi(s
1
i (t))
∂s1i (t)
]
ui(t).
Using ui(0) = Bi(0, c, s
1
i (0)) = 0, then Bi(t, τ, s) = 0 for all t ≤ τ and
Z1i (t) < s.
2-) Let wi(τ) := Bi(τ + c, τ, s
2
i (τ)), where c > 0. Using the PDEs in System
(4.2-4.3), one obtains
dwi
dτ
= −
[
δB + µ(τ) +
∂vi(s
2
i (τ))
∂s2i (τ)
]
wi(τ),
which implies Bi(τ + c, τ, s
2
i (τ)) = Bi(c, 0, s
2
i (0)) e
− ∫ τ0 (δB+µ(r))dr e−
∫ τ
0
∂vi(s
2
i (r))
∂s2
i
(r)
dr
.
Performing the change of variable σ = s2i (r), one gets
Bi(τ + c, τ, s
2
i (τ)) = Bi(c, 0, s
2
i (0)) e
− ∫ τ0 (δB+µ(r))dr e−
∫ s2i (τ)
s2
i
(0)
∂vi(σ)
∂σ
1
vi(σ)
dσ
=
Bi(c, 0, s
2
i (0)) vi(s
2
i (0))
vi(s2i (τ))
e−
∫ τ
0 (δB+µ(r))dr.
For t := τ + c and s := s2i (τ), one obtains
Bi(t, τ, s) =
λ(N(t− τ))Ai(t− τ, ζi) vi(ζi)
vi(s)
e−
∫ τ
0 (δB+µ(r))dr, ∀ 0 ≤ τ < t, Z2i (τ) < s
where ζi := s
2
i (0) = s− Z2i (τ).
3-) Let $i(s) := Bi(t(s), τ(s), s), where t(s) and τ(s) are the inverse functions of
s1i (t) and s
2
i (τ) respectively. Using the PDEs in System (4.2-4.3), one obtains
Bi(t, τ, s) = 0, ∀ s ≤ Z1i (t), s ≤ Z2i (τ).
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Then, the integral formulation of Bi, ∀ i = 0, ..., I, is
Bi(t, τ, s) =

0 t ≤ τ, Z1i (t) < s
λ(N(t−τ))Ai(t−τ,ζi) vi(ζi)
vi(s)
f(τ) 0 ≤ τ < t, Z2i (τ) < s
0 s ≤ Z1i (t), s ≤ Z2i (τ)
(4.6)
where ζi = s− Z2i (τ) and f(τ) := e−
∫ τ
0 (δB+µ(r))dr.
Assuming that the solution (Ai(t, .), Bi(t, ., .)) of System (4.4-4.6) belongs to L
1(0,m)×
L1((0,∆), (0,m)) for all t > 0.
Definition 4.1. Let T > 0 and i ∈ NI := {0, ..., I}, the norms of Ai and Bi in the
Banach spaces,
H1T := L
∞((0, T );L1(0,m))
L1T := L
∞((0, T );L1((0,∆), (0,m)))
are defined respectively by
‖Ai‖H1T = sup
06t6T
‖Ai(t, .)‖L1(0,m),
‖Bi‖L1T = sup
06t6T
‖Bi(t, ., .)‖L1((0,∆),(0,m)).
Definition 4.2. For all T > 0. (Ai, Bi), ∀ i ∈ NI := {0, ..., I} is called a global
solution of (4.2-4.3) (in the sense of the expressions (4.4)-(4.6)), if it belongs to
L∞(0, T, L1(0,m)) and L∞(0, T, L1((0,∆)×(0,m))) respectively and it satisfies Sys-
tem (4.4)-(4.6).
Theorem 4.3. Let Assumption 4.3.1 be satisfied. Then, there exists a unique so-
lution of System (4.4)-(4.6) for all t ∈ (0,∞).
Proof. The existence of global solution of System (4.4)-(4.6) is deduced from the
general result in Part IV - Chapter 10.
Remark 4.4. Using (4.4), (4.6) and Assumption 4.3.1, one may check by induction
over i the positivity of (Ai, Bi) for all i ∈ NI .

Chapter 5
Numerical analysis of the SMCD44
model
5.1 Introduction
In this chapter, we build a numerical scheme to approximate the solution of SMCD44
model. Furthermore, an analysis of properties of the scheme is proposed.
In the literature, the numerical schemes of the structured models are constructed
from the equations or the solution calculated by the characteristic method. Douglas
and Milner [90] have developed a finite difference scheme (FD) of the equation of
McKendrick-Von Forster, with a mortality function that depends on the total pop-
ulation. Know et al. [91] have improved this scheme to a second order accuracy.
Later on, Sulky [92] has applied this approximation method to the model of Sinko
and Streifer [93]. The non-linear structured models of the populations dynamics
have been studied by Angulo et al. [94, 95] and Kostova [96] for example. The
accuracy of these schemes has order 2 for Angulo et al. [94, 95] and 3 for Kostova
[96].
In this chapter, we provide a finite difference method to approximate the equations
of our SMCD44 model. This method is used widely in case of hyperbolic equations,
such as the PDEs that constitute our model. The proofs of stability, consistency
and convergence of scheme to an analytical solution of the model, are established
in this chapter.
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5.2 Numerical approximation scheme
In this section, we build an approximate solution of System (4.2-4.3). To establish
our scheme, we define a mesh in [0, T ]× [0,∆]× [0,m]. Let ∆t, ∆τ and ∆s be the
time, age and CD44 expression mesh sizes respectively. We subdivide the intervals
[0, T ], [0,∆] and [0,m] in NT + 1 points t
n, Nτ + 1 points τ
j and Ns + 1 points s
k
respectively. Such that for n = 0, j = 0, k = 0 one has t0 = 0, τ 0 = 0, s0 = 0 and
for n = NT , j = Nτ , k = Ns one has t
NT = T , τNτ = ∆, sNs = m. The grid points
are defined by
tn = n∆t, n = 0, ..., NT ,
τ j = j∆τ, j = 0, ..., Nτ ,
sk = k∆s, k = 0, ..., Ns.
We introduce the following approximations for all i ∈ NI := {0, ..., I}, 0 6 n 6 NT ,
0 6 j 6 Nτ and 0 6 k 6 Ns
Ai,nk = Ai(t
n, sk), Bi,nj,k = Bi(t
n, τ j, sk), µj = µ(τ j), λn = λ(N(tn)).
Let vNs = (v0,Ns , ..., vI,Ns) be the approximate function v = (v0, ..., vI). It belongs
to the space KNs = (C
u¯,Ns
+ )
I where
C u¯,Ns+ = {u(sk) = uk, u0 = 0, 0 < uk 6 u¯, k = 1, .., Ns}.
The equations of System (4.2-4.3) are approximated by
Bi,n+1j+1,k =
(1− ∆t
∆s
vki )B
i,n
j,k +
∆t
∆s
vk−1i B
i,n
j,k−1
1 + ∆tδB + ∆tµj
, k = 1, ..., Ns, i = 0, ..., I,
v0iB
i,n
j,0 = 0,
Bi,n+10,k = λ
nAi,nk .
(5.1)

A0,n+1k =
A0,nk
1 + ∆tδA + ∆tλn
,
Ai,n+1k =
Ai,nk + 2∆t∆τ
∑
j µ
jBi−1,nj,k
1 + ∆tδA + ∆tλn
, i = 1, ..., I.
(5.2)
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for n from 0 to NT − 1 and j from 0 to Nτ − 1.
The CFL condition is
0 <
∆t
∆s
‖vi,Ns‖∞ 6 1 for i = 0, ..., I. (5.3)
The initial condition A0,0 is approximated by its mean value on each mesh k, for all
k = 1, ..., Ns.
Ak0,0 =
∫ sk
sk−1
A0,0(s)ds. (5.4)
For all n = 0, ..., NT − 1, j = 0, ..., Nτ − 1 and i = 0, ..., I fixed, the first equation of
System (5.1) can be written in the following matrix form
Bi,n+1j+1,1
:
:
:
:
Bi,n+1j+1,Ns

=

(1−∆t
∆s
v1i )
1+∆tδB+µj
0 . . . 0
∆t
∆s
v1i
1+∆tδB+µj
(1−∆t
∆s
v2i )
1+∆tδB+µj
. . . 0
...
. . . 0
0 .......
∆t
∆s
v
Ns−1
i
1+∆tδB+µj
(1−∆t
∆s
vNsi )
1+∆tδB+µj


Bi,nj,1
:
:
:
:
Bi,nj,Ns

where the above matrix is defined positive under condition (5.3).
5.3 Numerical analysis of scheme
In this section, we study the positivity and the stability of our scheme. These pro-
prieties will be used to proof the convergence of the discrete solution of our scheme
to the continuous solution of SMCD44 model.
Let us define the following discrete norms
‖Bi,n‖1 =
Nτ∑
j=0
Ns∑
k=1
|Bi,nj,k |, ‖Ai,n‖1 =
Ns∑
k=1
|Ai,nk |,
‖Bi,n‖∞ = sup
06j6Nτ
sup
16k6Ns
|Bi,nj,k |, ‖Ai,n‖∞ = sup
16k6Ns
|Ai,nk |,
and for all i ∈ NI , n > 0, j > 0
Bi,nj ∈ BV ([0,m])⇔
Ns−1∑
k=0
|Bi,nj,k+1 −Bi,nj,k | 6 c, c > 0.
Chapter 4. Numerical analysis of the SMCD44 model. 50
In what follows, we will make use the following assumption.
Assumption 5.3.1.
- 0 < ‖A0,0‖∞, ‖A0,0‖1 <∞, A0,0 ∈ BV ([0,m]).
- Parameter µj, for all j = 0, ..., Nτ , is bounded, non-negative and satisfies the
following inequality
0 ≤ µ ≤ µj 6 µ¯.
- Parameter λn := λ(Nn), for all n = 0, ..., NT , is non-negative, bounded and
satisfies the following inequality
0 < λn 6 λ0.
- Parameter vki , for all i ∈ NI and k = 1, ..., Ns belongs to C u¯,Ns+ such that 0 ≤
‖vi,Ns‖∞ ≤ v˜i and |v
k+1
i −vki |
∆s
≤ v∞i for all k = 0, .., Ns − 1.
The following lemma is devoted to proof the positivity.
Lemma 5.1. Let Assumption 5.3.1 be satisfied. The numerical scheme (5.1 - 5.2)
preserves the positivity of the solution under condition (5.3). For all i ∈ NI , n =
0, ..., NT , j = 0, ..., Nτ and k = 1, ..., Ns, one has
(Ai,nk , B
i,n
j,k) > 0 =⇒ (Ai,n+1k , Bi,n+1j+1,k) > 0.
Proof. Let (Ai,n+1k , B
i,n+1
j+1,k) be the numerical solution of (5.1 - 5.2). The absolute
value of this solution, is equal to
|Bi,n+1j+1,k| = |
(1− ∆t
∆s
vki )B
i,n
j,k +
∆t
∆s
vk−1i B
i,n
j,k−1
1 + ∆tδB + ∆tµj
|, (5.5)
|A0,n+1k | = |
A0,nk
1 + ∆tδA + ∆tλn
| and |Ai,n+1k | = |
Ai,nk + 2∆t∆τ
∑
j µ
jBi−1,nj,k
1 + ∆tδA + ∆tλn
|. (5.6)
Under Assumption 5.3.1 , the denominator of (5.5) is strictly positive. Using con-
dition (5.3), one obtains
0 <
∆t
∆s
vki 6 1 for i ∈ NI and k = 1, ..., Ns.
Then, one deduces the positivity of the numerator of equation (5.5). Therefore, by
induction over i, one concludes the positivity of (Ai, Bi) for all i ∈ NI .
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In what follows, we shall use the following convention
i∑
j
= 0 ,
i∏
j
= 1 and Bi−j = 0 if j > i.
Lemma 5.2. Let Assumption 5.3.1 be satisfied. Under condition (5.3), the numer-
ical scheme (5.1 - 5.2) is stable with respect to the discrete norm L1. Furthermore,
for all i ∈ NI and n = 0, ..., NT , one has
‖Bi,n‖1 6M i1‖A0,0‖1, ‖Ai,n‖1 6 N i1‖A0,0‖1,
where M i1 and N
i
1 are positive constants.
Proof. The numerical solution of (5.1 - 5.2) can be written as following ∀ i ∈ NI
Bi,n+1j+1,k = B
i,n
j,k −
∆t
∆s
(vkiB
i,n
j,k − vk−1i Bi,nj,k−1)− (∆tδA + ∆tµj)Bi,n+1j+1,k, (5.7)
and,
A0,n+1k = A
0,n
k − (∆tδB + ∆tλn)A0,n+1k , (5.8)
Ai,n+1k = A
i,n
k + 2∆t∆τ
Nτ∑
j=1
µjBi−1,nj,k − (∆tδB + ∆tλn)Ai,n+1k ∀ i ∈ N∗I .
Using Lemma 5.1, taking the absolute value of equation (5.7) and then summing
over all mesh (j, k), one deduces
Nτ−1∑
j=0
Ns∑
k=1
|Bi,n+1j+1,k| =
Nτ∑
j=1
Ns∑
k=1
Bi,nj,k −
∆t
∆s
Nτ∑
j=0
Ns∑
k=1
(vkiB
i,n
j,k − vk−1i Bi,nj,k−1)
−
Nτ−1∑
j=0
Ns∑
k=1
(∆tδA + ∆tµ
j)Bi,n+1j+1,k.
The boundary condition in (5.1) can used to reduce the second term of the above
equation. It becomes
(
−∆t
∆s
∑Nτ
j=0 v
Ns
i B
i,n
j,Ns
)
, then it can be bounded by 0. By
induction over j and from Assumption 5.3.1, one has
Nτ−1∑
j=0
Ns∑
k=1
|Bi,n+1j+1,k| 6
Ns∑
k=1
Bi,n−Nτ0,k 6 λ0
Ns∑
k=1
Ai,n−Nτk .
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By taking the absolute value of equations (5.8) and then summing over all mesh k,
one obtains
Ns∑
k=1
|A0,n+1k | 6
Ns∑
k=1
|A0,nk |
Ns∑
k=1
|Ai,n+1k | 6
Ns∑
k=1
|Ai,nk |+ 2∆t∆τ µ¯
Nτ∑
j=0
Ns∑
k=1
Bi−1,nj,k for i ∈ N∗I
Finally, by induction over i and n, one deduces
‖Ai,n‖1 6 2iλi0µ¯i∆τ iT i‖A0,0‖1 and ‖Bi,n‖1 6 2iλi+10 µ¯i∆τ iT i‖A0,0‖1.
Therefore, the numerical scheme is stable with respect to the discrete norm L1
where ∀ i ∈ NI
M i1 = 2
iλi+10 µ¯
iT i and N i1 = 2
iλi0µ¯
iT i.
This ends the proof of Lemma 5.2.
Lemma 5.3. Let Assumption 5.3.1 be satisfied. Under condition (5.3), the numer-
ical scheme (5.1 - 5.2) is stable with respect to the discrete norm L∞. Furthermore,
for all i ∈ NI and n = 0, ..., NT , one has
‖Bi,n‖∞ 6M i2‖A0,0‖∞, ‖Ai,n‖∞ 6 N i2‖A0,0‖∞,
where M i2 and N
i
2 are positive constants.
Proof. By using Lemme 5.1 and Assumption 5.3.1, the upper bound of equation
(5.7) over all meshes j and k, can be estimated by
sup
k,j
|Bi,n+1j+1,k| 6 (1 +
∆t
∆s
‖vi,Ns‖∞) sup
k,j
|Bi,nj,k |.
By induction over j, one obtains
sup
k,j
|Bi,n+1j+1,k| 6 λ0(1 +
∆t
∆s
‖vi,Ns‖∞)Nτ+1 sup
k
|Ai,n−Nτk |. (5.9)
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From Lemma 5.1, the induction over n allows to estimate the equations (5.8) by
|A0,nk | 6 |Ak0,0| (5.10)
|Ai,n+1k | 6 2∆t∆τ µ¯
n−1∑
m=0
Nτ∑
j=0
Bi−1,n−mj,k , ∀ i ∈ N∗I
Finally by induction over i, the inequalities (5.9) and (5.10) are estimated by
‖Bi,n‖∞ 6 (2T∆)iλi+10
i∏
l=0
(1 +
∆t
∆s
‖vl‖∞)Nτ+1‖A0,0‖∞,
‖Ai,n‖∞ 6 (2T∆λ0)i
i−1∏
l=0
(1 +
∆t
∆s
‖vl‖∞)Nτ+1‖A0,0‖∞,
for all i ∈ NI and n = 0, ..., NT .
Then, one has ∀ i ∈ NI
M i2 = (2T∆)
iλi+10
i∏
l=0
(1 +
‖vl‖∞
‖vi,Ns‖∞
)Nτ+1,
N i2 = (2T∆λ0)
i
i−1∏
l=0
(1 +
‖vl‖∞
‖vi,Ns‖∞
)Nτ+1.
This ends the proof of Lemma 5.3.
These two lemmas 5.2 and 5.3 ensure that the scheme does not explode even in
large time. Now, we give a lemma that will be used to prove the convergence of the
solution of System (5.1 - 5.2) to the solution of System (4.2 - 4.3).
Lemma 5.4. Let Assumption 5.3.1 be satisfied. Under condition (5.3), one has for
all n > 0 and j > 0,
max
i∈NI
(
Ns−1∑
k=0
|Bi,nj,k+1 −Bi,nj,k |
)
6 α
(
Ns−1∑
k=0
|Ak+10,0 − Ak0,0|
)
+ β‖A0,0‖1,
where α and β are positive constants which are independent on n.
Proof. For all i ∈ NI , one considers the solution of the numerical scheme (5.2) in
the following form
Ai,n+1k = A
i,n
k + 2∆t∆τ
Nτ∑
j=0
µjBi−1,nj,k − EnAi,n+1k , (5.11)
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where En = δB + λ
n.
Let calculate the difference of the previous solutions (5.11) between two consecutive
meshes k and k + 1 by fixing i, n+ 1 and j + 1,
γi,n+1k+1 = γ
i,n
k+1 + 2∆t∆τ
Nτ∑
j=0
µj
(
Bi−1,nj,k+1 −Bi−1,nj,k
)− Enγi,n+1k+1 ,
where |γi,n+1k+1 | := |Ai,n+1k+1 − Ai,n+1k |.
By multiplying each term of the above equation by ς¯ i,n+1k which is the sign of γ
i,n+1
k ,
one obtains
|γi,n+1k+1 | 6 |γi,nk+1|+ 2∆t∆τ
Nτ∑
j=0
µj|Bi−1,nj,k+1 −Bi−1,nj,k |. (5.12)
Now, one considers the solution of the numerical scheme (5.1) in the following form
Bi,n+1j+1,k = B
i,n
j,k −
∆t
∆s
(vkiB
i,n
j,k − vk−1i Bi,nj,k−1)−∆thjBi,n+1j+1,k, (5.13)
where hj := δB + µ
j.
Next, one calculates the difference of the previous solutions between two consecutive
meshes k and k + 1 by fixing i, n+ 1 and j + 1
Bi,n+1j+1,k+1 −Bi,n+1j+1,k = (Bi,nj,k+1 −Bi,nj,k+1)−
∆t
∆s
(vk+1i B
i,n
j,k+1 − vkiBi,nj,k)
+
∆t
∆s
(vkiB
i,n
j,k − vk−1i Bi,nj,k−1)−∆thj(Bi,n+1j+1,k+1 −Bi,n+1j+1,k).
One notes δi,n+1j+1,k+1 := B
i,n+1
j+1,k+1 −Bi,n+1j+1,k. The above equation becomes
δi,n+1j+1,k+1 = δ
i,n
j,k+1 −
∆t
∆s
vk+1i δ
i,n
j,k+1 +
∆t
∆s
vki δ
i,n
j,k −
∆t
∆s
(vk+1i − vki )δi,nj,k+1
− ∆t
∆s
(vk+1i − 2vki + vk−1i )Bi,nj,k−1 −∆thjδi,n+1j+1,k+1.
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One multiplies each term of the above equation by ς i,n+1j+1,k which is the sign of δ
i,n+1
j+1,k,
and then one sums with respect to k = 1, ..., Ns − 1
Ns−1∑
k=1
ς i,n+1j+1,kδ
i,n+1
j+1,k+1 =
Ns−1∑
k=1
ς i,nj,k+1δ
i,n
j,k+1 −
∆t
∆s
Ns−1∑
k=1
vk+1i ς
i,n
j,k+1δ
i,n
j,k+1 +
∆t
∆s
Ns−1∑
k=1
vki ς
i,n
j,k δ
i,n
j,k
+
∆t
∆s
Ns−1∑
k=1
|vk+1i − vki |ς i,nj,k δi,nj,k +
∆t
∆s
Ns−1∑
k=1
|vk+1i − 2vki + vk−1i |Bi,nj,k−1
− ∆t
Ns−1∑
k=1
hjς
i,n+1
j+1,k+1δ
i,n+1
j+1,k+1.
By adding the second and the third term and using Assumption 5.3.1, one gets
Ns−1∑
k=1
ς i,n+1j+1,kδ
i,n+1
j+1,k+1 6
Ns−1∑
k=1
ς i,nj,k+1δ
i,n
j,k+1 −
∆t
∆s
vNsi ς
i,n
j,Ns
δi,nj,Ns +
∆t
∆s
v1i ς
i,n
j,1 δ
i,n
j,1
+ ∆tv∞i
Ns−1∑
k=1
ς i,nj,k δ
i,n
j,k + ∆ti‖Bi,n‖1,
where i is given by
|vk+1i − 2vki + vk−1i | 6 i∆s.
The second term of the previous inequality can be estimated by 0. Since v0i = 0,
the third term is estimated by
∆t
∆s
v1i ς
i,n
j,1 δ
i,n
j,1 ≤ ∆t
(v1i − v0i )
∆s
ς i,nj,1 δ
i,n
j,1 ≤ ∆tv∞i
Ns−1∑
k=1
ς i,nj,k δ
i,n
j,k .
By definition, one has
Ns−1∑
k=1
ς i,n+1j+1,k+1δ
i,n+1
j+1,k+1 =
Ns−1∑
k=1
|δi,n+1j+1,k+1|.
Then using the boundary conditions of (5.1), one obtains an estimation of the
bounded variation
Ns−1∑
k=0
|δi,n+1j+1,k+1| 6
Ns−1∑
k=1
|δi,nj,k+1|+ (1 + 2∆tv∞i )
Ns−1∑
k=1
|δi,nj,k |
+ ∆ti‖Bi,n‖1,
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We assume the following notations
F i,nj =
Ns−1∑
k=0
δi,nj,k , G
i,n =
Ns−1∑
k=0
γi,nk , F
n
j = max
i
BV F i,nj , G
n = max
i
BV Gi,n,
v¯ = max
i
v∞i ,  = max
i
i, u = 2(1 + ∆tv¯), q = ∆tmax
i
‖Bi,n‖1.
Then, the above inequality becomes
max
06i6I
F i,n+1j+1 6 u max
06i6I
F i,nj + q.
By induction over n and j, one obtains
max
06i6I
F i,n+1j+1 6 uNτ+1λ0 max
06i6I
Gi,n−Nτ + q
Nτ∑
p=0
up. (5.14)
Using (5.12), the above inequality becomes
max
06i6I
F i,n+1j+1 6 ruNτ+1 max
16i6I
NT∑
m1=Nτ
Nτ∑
j=1
F i−1,n−m1j + q
Nτ∑
p=0
up
6 ruNτ+1 max
16i6I
NT∑
l1=1
NT∑
m1=Nτ
(ulF i−1,n−m1−l10 + q
l1−1∑
p=0
up) + q
Nτ∑
p=0
up
6 ruNτ+1 max
16i6I
NT∑
l1=1
NT∑
m1=Nτ
(ulF i−1,n−m1−l10 ) + rNT qu
Nτ+1
NT∑
l1=1
l1−1∑
p=0
up + q
Nτ∑
p=0
up
where r = 2∆t∆τ µ¯λ0.
Using the boundary condition of System (5.1) and inequality (5.12), the backward
induction over i, allows to estimate the above inequality in terms of i = 0. Elemen-
tary but lengthy calculus yields
F n+1j+1 6 αG0 + βmax
i
‖Bi,n‖1,
where
α = (2µ¯)IλI+10 u
Nτ+1
∑
l1,...,lI
u
∑I
i=1 li ,
β = EuNτ+1
I∑
i=1
[
(2µ¯λ0T )
i
∑
l1,...,lI
li−1∑
p=0
up+
∑i−1
j=1 lj
]
+ E
Nτ∑
p=0
up, (5.15)
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and li from 1 to NT .
Then from Lemma 5.2, one deduces
F n+1j+1 6 αG0 + β(max
i
M i1)‖A0,0‖1.
This ends the proof of Lemma 5.4.
The following lemma allows to obtain the bounded variation in time and age of the
approximate solution (Ai, Bi). This is necessary to prove the convergence.
Lemma 5.5. Let Assumption 5.3.1 be satisfied. Under condition (5.3), one has for
all n > 0 and j > 0
max
i
(
Ns∑
k=0
|Bi,n+1j+1,k −Bi,nj,k |
)
6 α1
(
Ns∑
k=1
|Ak0,0 − Ak−10,0 |
)
+ β1‖A0,0‖1,
max
i
(
Ns∑
k=0
|Ai,n+1k − Ai,nk |
)
6 β2‖A0,0‖1,
where α1, β1 and β2 are positive constants independent on n.
Proof. let fix i and k. From equations (5.11) and (5.13), the difference of the
solutions between two points (n+ 1, j + 1) and (n, j), is
Bi,n+1j+1,k −Bi,nj,k = −
∆t
∆s
vki (B
i,n
j,k −Bi,nj,k−1)−∆t(
vki − vk−1i
∆s
)Bi,nj,k−1 −∆thjBi,n+1j+1,k,
Ai,n+1k − Ai,nk = 2∆t∆τ
Nτ∑
j=0
µjBi−1,nj,k −∆tEnAi,n+1k .
By taking the absolute value of these equations and then summing over k, one gets
Ns∑
k=0
|Bi,n+1j+1,k −Bi,nj,k | 6
∆t
∆s
v∞i
Ns∑
k=1
|Bi,nj,k −Bi,nj,k−1|+ ∆tv∞i ‖Bi,n‖1
+∆tλ0‖Bi,n+1‖1,
Ns∑
k=0
|Ai,n+1k − Ai,nk | 6 2∆t∆τ µ¯‖Bi−1,n‖1 + ∆t(δB + µ¯)‖Ai,n+1‖1.
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Using Lemmas 5.2, 5.4 and condition 5.3, one obtains
max
i
Ns∑
k=0
|Bi,n+1j+1,k −Bi,nj,k | 6 α
(
Ns∑
k=1
|Ak0,0 − Ak−10,0 |
)
+ β1‖A0,0‖1,
max
i
Ns∑
k=0
|Ai,n+1k − Ai,nk | 6 β2‖A0,0‖1,
where
α1 = α, β1 = (β + ∆tv¯ + ∆tλ0) max
i
M i1,
and
β2 =
(
2∆τ µ¯max
i
M i1 + (δB + µ¯) max
i
N i1
)
∆t.
5.4 Convergence of the scheme in L1
In this section, we use Helly’s Theorem (see Book Bre´zis [97]) in order to obtain
the convergence of the solution of (5.1-5.2).
Theorem 5.6. Let Assumption 5.3.1 be satisfied. Under condition (5.3), the solu-
tion (Ai∆, B
i
∆) is calculated from (5.1-5.2) for all i ∈ NI . Therefore, when the mesh
sizes tend to zeros, we can extract a subsequence which converges to (Ai, Bi). This
limit is a weak solution of System (4.2-4.3) for all i ∈ NI .
Proof. In the first step, we show the convergence of scheme to a limit which is
bounded and its derivative is also bounded. Next, we prove that this limit verifies∫ T
0
∫ m
0
(
dA0∆
dt
+ E(t)A0∆(t, s)
)
Φ0(t, s)dsdt = 0 (5.16)∫ T
0
∫ m
0
(
dAi∆
dt
− 2
∫ ∆
0
µ(τ)Bi−1∆ (t, τ, s)dτ
+E(t)Ai∆(t, s))Φi(t, s)dsdt = 0 (5.17)
∫ T
0
∫ ∆
0
∫ m
0
(
∂tB
i
∆ + ∂τB
i
∆ + ∂s(viB
i
∆)
+ h(τ)Bi∆
)
Ψi(t, τ, s)dsdτdt = 0 (5.18)
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For all test functions Φi ∈ D((0, T )× (0,m)) and Ψi ∈ D((0, T )× (0,∆)× (0,m)),
∀, i ∈ NI . In addition, we denote h(τ) := δB + µ(τ) and E(t) := δA + λ(N(t)).
From Lemma 5.3, the functionsAi∆, B
i
∆ are uniformly bounded in L
∞(0,m), L∞((0,∆)×
(0,m)) respectively for all i ∈ NI . Then, the set of functions (Ai∆, Bi∆) con-
tain an subsequence (Ai∆j , B
i
∆j
) which weak* converges to (Ai, Bi) in L∞(0,m) ×
L∞((0,∆)× (0,m)).
Let ΠAi∆ and ΠB
i
∆ be the interpolation polynomials of degree 1 for the functions
Ai∆ and B
i
∆ respectively. They are defined in the domains (0, T ) × (0,m) and
(0, T )× (0,∆)× (0,m) respectively by
ΠAi∆(t, s) = A
i,n
k + (A
i,n+1
k − Ai,nk )
(t− tn)
∆t
,
ΠBi∆(t, τ, s) = B
i,n
j,k + (B
i,n
j,k+1 −Bi,nj,k)
s− sk
∆s
+ (Bi,n+1j+1,k −Bi,nj,k)
t− tn
∆t
+(Bi,n+1j+1,k+1 −Bi,n+1j+1,k −Bi,nj,k+1 +Bi,nj,k)
(s− sk)(t− tn)
∆t∆s
,
where the mesh size ∆t is equal to ∆τ from the scheme (5.1-5.2).
These functions are bounded and continuous differentiable. From their expressions
and Lemmas 5.4 and 5.5, the total variations are also bounded
TV (ΠAi∆) = ‖
dAi∆
dt
‖L1 = 1
∆t∆s
∑
n,k
∫ tn+1
tn
∫ sk
sk−1
|dA
i
∆
dt
|dsdt,
TV (ΠBi∆) = ‖(∂t + ∂τ )Bi∆‖L1 + ‖∂sΠBi∆‖L1
=
1
∆t∆τ∆s
∑
n,j,k
∫ tn+1
tn
∫ τj+1
τj
∫ sk
sk−1
|∂tBi∆ + ∂τBi∆|dsdt
+
1
∆t∆τ∆s
∑
n,j,k
∫ tn+1
tn
∫ τj+1
τj
∫ sk
sk−1
|∂sBi∆|dsdt.
According to Helly’s Theorem [97], there exits a subsequence of (ΠAi∆,ΠB
i
∆) noted
(Ai∆j , B
i
∆j
) which converges in L1loc((0, T )× (0,m))× L1loc((0, T )× (0,∆)× (0,m)).
Since the subsequence associated weak* converges also in L∞, then one obtains the
convergence of (Ai∆, B
i
∆) to (A
i, Bi) in L1loc((0, T )× (0,m))× L1loc((0, T )× (0,∆)×
(0,m)).
In the second step, we prove that the limit obtained is a weak solution. Let
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Φi and Ψi be the test function in the spaces C
1((0, T ) × (0,∆) × (0,m)) and
C1((0, T )× (0,m)) respectively with compact support. We define for all (t, τ, s) ∈
[tn, tn+1[×[τj, τj+1[×[sk−1, sk[
Φi,n+1k ∼
∫ tn+1
tn
∫ sk
sk−1
Φi(t, s)
∆s∆t
dsdt,
Ψi,n+1j+1,k ∼
∫ tn+1
tn
∫ τj+1
τj
∫ sk
sk−1
Ψi(t, τ, s)
∆s∆τ∆t
dsdτdt.
We multiply (5.13) by ∆t∆sΨi,n+1j+1,k and we sum over n, j, k. For all i ∈ NI , we have
NT−1∑
n=0
Nτ−1∑
j=0
Ns∑
k=1
[
∆t∆s(Bi,n+1j+1,k −Bi,nj,k)Ψi,n+1j+1,k + (∆t)2(vkiBi,nj,k − vk−1i Bi,nj,k−1)Ψi,n+1j+1,k
]
= −(∆t)2∆shjBi,n+1j+1,kΨi,n+1j+1,k. (5.19)
The first term of this sum is equal to
∑
n,j,k
∆t∆s(Bi,n+1j+1,k −Bi,nj,k)Ψi,n+1j+1,k =
∑
n,j,k
−Bi,nj+1,k∆t∆s(Ψi,n+1j+1,k −Ψi,nj+1,k)
+∆t∆s
∑
j,k
(Bi,NTj+1,kΨ
i,NT
j+1,k −Bi,0j+1,kΨi,0j+1,k)
+
∑
n,j,k
−Bi,nj,k∆t∆s(Ψi,n+1j+1,k −Ψi,n+1j,k )
+∆t∆s
∑
n,k
(Bi,nNτ ,kΨ
i,n+1
Nτ ,k
−Bi,n0,kΨi,n+10,k )
Using the definitions of the approximations, one obtains
∑
n,j,k
∆t∆s(Bi,n+1j+1,k −Bi,nj,k)Ψi,n+1j+1,k =
−
∫ T−∆t
0
∫ ∆−∆τ
0
∫ m
0
Bi∆
[
Ψi(t, τ, s)−Ψi(t−∆t, τ, s)
∆t
+
Ψi(t, τ, s)−Ψi(t, τ −∆τ, s)
∆τ
]
dsdτdt
+
∫ ∆−∆τ
0
∫ m
0
[
Bi∆(T, τ, s)Ψi(T, τ, s)−Bi∆(0, τ, s)Ψi(0, τ, s)
]
dτds
+
∫ T−∆t
0
∫ m
0
[
Bi∆(t,∆, s)Ψi(t,∆, s)−Bi∆(t, 0, s)Ψi(t, 0, s)
]
dtds.
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Similarly, the second term of equation (5.19) can be written in the following form
(∆t)2
∑
n,j,k
(vkiB
i,n
j,k − vk−1i Bi,nj,k−1)Ψi,n+1j+1,k
= −
∫ T−∆t
0
∫ ∆−∆τ
0
∫ m
0
vi(s−∆s)Bi∆(t, τ, s−∆s)
(
Ψi(t, τ, s)−Ψi(t, τ, s−∆s)
∆s
)
dtdτds
+
∫ T−∆t
0
∫ ∆−∆τ
0
[
vi(Ns)B
i
∆(t, τ, Ns)Ψi(t, τ, Ns)− vi(0)Bi∆(t, τ, 0)Ψi(t, τ, 0)
]
dtdτ.
Finally, the last term of this sum is equal to
−
∑
n,j,k
(∆t)2hjB
i,n+1
j+1,kΨ
i,n+1
j+1,k
= −
∫ T−∆t
0
∫ ∆−∆τ
0
∫ m
0
h(τ + ∆τ)Bi∆(t+ ∆t, τ + ∆τ, s)Ψi(t, τ, s)dsdτdt.
Using an integration by parts, equation (5.19) is equal to∫ T
0
∫ ∆
0
∫ m
0
(
∂tB
i
∆ + ∂τB
i
∆ + ∂sviB
i
∆ + h(τ)B
i
∆(t, τ, s)
)
Ψi(t, τ, s)dsdτdt = 0,
when the mesh sizes tend to zeros.
Obviously by the same method, we prove that the solution of (5.2) converges to
the weak solution of (4.2-4.3) for all i ∈ NI .
5.5 Continuity of scheme with respect to param-
eters
In this section, we prove some properties of System (5.1 - 5.2) that will be useful in
estimating the parameters.
Lemma 5.7. Let Assumption 5.3.1 be satisfied. Under condition (5.3), there exists
positive constants CAi, CBi independent on Ns, Nτ and NT such that
‖Bi,n+1 − B˜i,n+1‖∞ 6 CBi‖vi,Ns − v˜i,Ns‖∞ ∀ i ∈ NI ,
‖Ai,n+1 − A˜i,n+1‖∞ 6 CAi‖vi−1 − v˜i−1‖∞ ∀ i ∈ N∗I ,
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where Ai,n = Ai,n(vi,Ns), B
i,n = Bi,n(vi,Ns) and A˜
i,n = A˜i,n(v˜i,Ns), B˜
i,n = B˜i,n(v˜i,Ns)
are the solutions of System (5.1 - 5.2).
Proof. We proceed the proof by induction. The first step consists to estimate in
L∞ the difference between Bi,nj,k , B˜
i,n
j,k and the difference between A
i,n
k , A˜
i,n
k for all i
and n. Let
ζ i,n = sup
j,k
|ζ i,nj,k | = sup
j,k
|Bi,nj,k − B˜i,nj,k |,
γi,n = sup
k
|γi,nj,k | = sup
k
|Ai,nk − A˜i,nk |.
From the equations in (5.1-5.2), one calculates the variable ζ i,n and γi,n
ζ i,n+1j+1,k = (1−
∆t
∆s
vki )ζ
i,n
j,k −
∆t
∆s
B˜i,nj,k(v
k
i − v˜ki ) +
∆t
∆s
vk−1i ζ
i,n
j,k−1
+
∆t
∆s
B˜i,nj,k−1(v
k−1
i − v˜k−1i )−∆t(δB + µj)ζ i,n+1j+1,k (5.20)
γi,n+1k = γ
i,n
k + 2∆t∆τ
Nτ∑
j=0
µjζ i−1,nj,k −∆t(δA + λn)γi,n+1k pour i ∈ N∗I
γ0,n+1k = γ
0,n
k −∆t(δA + λn)γ0,n+1k . (5.21)
Using Lemma 5.3 and condition (5.3), the upper bound of equation (5.20) is
ζ i,n+1 6 ζ i,n + ∆t(δB + µ¯)ζ i,n+1 +
∆t
∆s
M2i ‖A0,0‖∞‖vi,Ns − v˜i,Ns‖∞.
By induction over n for all i ∈ NI , one obtains
ζ i,n+1 = ‖Bi,n − B˜i,n‖∞ 6 TM i2‖A0,0‖∞eT (δB+µ¯)‖vi,Ns − v˜i,Ns‖∞.
Then, CBi is equal to TM
i
2‖A0,0‖∞eT (δB+µ¯).
Similarly, by taking the upper bound of equation (5.21) and by induction, one
obtains for all n and i ∈ N∗I
γi,n+1 = ‖Ai,n+1 − A˜i,n+1‖∞ 6 2∆T µ¯N i2‖A0,0‖∞eT (δA+λ0)‖vi−1,Ns − v˜i−1,Ns‖∞.
Therefore, CAi is equal to 2∆µ¯TN
i
2‖A0,0‖∞eT (δA+λ0).
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Lemma 5.8. Let Assumption 5.3.1 be satisfied. Under condition (5.3), there exists
positive constants C1Ai, C
1
Bi independent on Ns, Nτ and NT such that
‖Bi,n+1 − B˜i,n+1‖∞ 6 C1Bi‖µ− µ˜‖∞ ∀ i ∈ NI ,
‖Ai,n+1 − A˜i,n+1‖∞ 6 C1Ai‖µ− µ˜‖∞ ∀ i ∈ N∗I ,
where Ai,n = Ai,n(µ), Bi,n = Bi,n(µ) and A˜i,n = A˜i,n(µ˜), B˜i,n = B˜i,n(µ˜) are the
solutions of System (5.1 - 5.2).
Lemma 5.9. Let Assumption 5.3.1 be satisfied. Under condition (5.3), there exists
positive constants C2Ai, C¯
2
Ai, C
2
Bi and C¯
2
Bi independent on Ns, Nτ and NT such that
‖Bi,n+1 − B˜i,n+1‖∞ 6 C2Bi‖vi,Ns − v˜i,Ns‖∞ + C¯2Bi‖λ− λ˜‖∞ ∀ i ∈ NI ,
‖Ai,n+1 − A˜i,n+1‖∞ 6 C2Ai‖vi,Ns − v˜i,Ns‖∞ + C¯2Ai‖λ− λ˜‖∞ ∀ i ∈ NI ,
where Ai,n = Ai,n(vi,Ns , λ), B
i,n = Bi,n(vi,Ns , λ) and A˜
i,n = A˜i,n(v˜i,Ns , λ˜), B˜
i,n =
B˜i,n(v˜i,Ns , λ˜) are the solutions of System (5.1 - 5.2).
The proofs of these two lemmas are similar to the proof of Lemma 5.7.

Part III
Models of T Cell Proliferation in
Lymphopenia Conditions:
Identification of Parameters
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Chapter 6
Experimental data and theoretical
identifiability
6.1 Introduction
The dynamic nature of immune responses requires the development of appropriate
experimental tools to quantitatively understand the division and death processes
which determine the turnover of immune cells. In the literature, several types of data
have been explored and used in the context of T cell proliferation induced by LIP
(Lymphopenia Induced Proliferation). Using cell dyes, such as Carboxy Fluores-
cein diacetate Succinimidyl Ester (CFSE), is currently one of the most informative
methods for characterizing the dynamics of cell division in the immune system. Fol-
lowing each division, CFSE divides equally between daughter cells, resulting in a
two-fold decrease in the intensity of cellular fluorescence in each successive gener-
ation. This property of CFSE allows accurate tracking of the number of divisions
that a given cell has undergone either in vitro or following transfer in vivo [87].
The Smith-Martin model has been applied widely to CFSE data [2–9], and the
duration of deterministic phase (B-phase), the division rate and the probability of
cell death have been estimated from experimental data mainly based on CFSE cell
division profiles [4–6]. Hogan et al. [10] improved the technique and accuracy of the
parameter estimations from the Smith-Martin model. The DNA binding dye, 7-
Aminoactinomycin D (7AAD), was used with CFSE to distinguish the proliferating
and non-proliferating cells, therefore enabling estimations of the rate of recruitment
of cells from A-state into B-phase.
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In this chapter, we describe the data generated by Hogan et al. [10]. Next, we prove
the identifiability of some parameters in SMCD44 model by using the data of Hogan
et al. [10].
6.2 Experimental data
Data were collected during a previously published study [10]. The behavior of two
different T cell clonotypes was studied in lymphopenic Rag1-/- mice by using CFSE,
7AAD dyes and CD44 expression measured by flow cytometry. Following adoptive
transfer of T cells, cohorts of between three and five host mice were analysed at
different days. At each date, the number of T cells, the proportion of cells actively
replicating their DNA as determined by 7AAD staining, and the intensity of expres-
sion of CD44 on the cell surface were measured in each host and separated according
to the number of divisions performed as assessed by CFSE labeling. Note that the
intensity of CD44 is the MFI (median fluorescence intensity) normalised to CD44
expression on NK cells. In other word, it represents the weight of CD44 expression
(without unit) on the surface of cells in each division.
6.3 Identifiability
In this section, we are interested in the identifiability of the parameters vi, ∀
i = 0, ..., I, λ and ∆ by using the data stated in Section 6.2.
Let us denote the experimental data by
N expi (t, s) :=
∫ ∆
0
Bi(t, τ, s)dτ + Ai(t, s),
where i ∈ NI := {0, ..., I}, t ∈ [0, T ], s ∈ [0,m] and (Ai, Bi) is the solution of
SMCD44 model.
Assumption 6.3.1.
- Functions (v0, ..., vI) are defined in the space K = (C
u¯
+)
I where
C u¯+ = {u ∈ C0([0,m]), u(0) = 0, 0 < u(s) 6 u¯ , ∀ s ∈ (0,m]}.
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- Initial condition A0,0(s) > 0 for all s ∈ (0,m].
Lemma 6.1. Let Assumptions 4.3.1 and 6.3.1 be satisfied. The velocity vi is iden-
tifiable for all i ∈ NI := {0, ..., I}.
Proof. Let us fix (v0, ..., vI) ∈ K and consider a second parameter (v¯0, ..., v¯I) ∈ K
wherein
N expi (t, s; vi) = N
exp
i (t, s; v¯i), ∀ i ∈ NI , (6.1)
and (A¯i(t, s), B¯i(t, τ, s)) is the solution relative to v¯i.
By integrating and summing (6.1) over s and i respectively, one gets
N(t) = N¯(t). (6.2)
By using the implicit solution (4.4), one obtains
A0(t, s) = A¯0(t, s) ∀ s ∈ [0,m]. (6.3)
From (6.1), one gets
∫ ∆
0
B0(t, τ, s)dτ =
∫ ∆
0
B¯0(t, τ, s)dτ .
Furthermore by induction, if we prove vi−1(s) = v¯i−1(s), ∀ i ∈ N∗I and s ∈ [0,m],
one obtains Ai(t, s) = A¯i(t, s) and then from (6.1), one gets
∫ ∆
0
Bi(t, τ, s)dτ =∫ ∆
0
B¯i(t, τ, s)dτ . Therefore, the problem reverts to proving the identifiability of vi
through the following system
∂
∂t
Bi(t, τ, s) +
∂
∂τ
Bi(t, τ, s) +
∂
∂s
[vi(s)Bi(t, τ, s)] = − (δB + µ(τ))Bi(t, τ, s),
Bi(0, τ, s) = 0; Bi(t, 0, s) = λ(N(t))Ai(t, s); vi(0)Bi(t, τ, 0) = 0.
(6.4)
Let B˜i := Bi − B¯i and v˜i := vi − v¯i. Bi and B¯i are the solutions given by (6.4)
relative to vi and v¯i respectively. Then, one has
∂
∂t
B˜i(t, τ, s) +
∂
∂τ
B˜i(t, τ, s) +
∂
∂s
[
v˜i(s)Bi(t, τ, s) + v¯i(s)B˜i(t, τ, s)
]
= −f(τ)B˜i(t, τ, s),
B˜i(0, τ, s) = 0; B˜i(t, 0, s) = 0; v˜i(0)Bi(t, τ, 0) = 0,
Observation :
∫ ∆
0
B˜i(t, τ, s)dτ = 0,
(6.5)
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where f(τ) := δB + µ(τ).
Now, we define the following Lagrangian formulation related to System (6.5).
L (B˜i, v˜i, q˜i) =
∫
Ω
[
∂
∂t
B˜i(t, τ, s) +
∂
∂τ
B˜i(t, τ, s) +
∂
∂s
[
v˜i(s)Bi(t, τ, s) + v¯i(s)B˜i(t, τ, s)
]
+f(τ)B˜i(t, τ, s)]q˜i(t, τ, s)dΩ +
∫
Ω
B˜i(t, τ, s)dΩ,
where Ω = [0, T ] × [0,∆] × [0,m], dΩ = dt dτ ds and q˜i corresponds to the dual
variable. The first derivative of the Lagrangian L with respect to B˜i, gives us the
adjoint equation.
∂
∂t
q˜i(tτ, s) +
∂
∂τ
q˜i(t, τ, s) +
∂
∂s
[v¯iq˜i(tτ, s)] = F (τ)q˜i(tτ, s) + 1,
q˜i(T, τ, s) = q˜i(t,∆, s) = q˜i(t, τ,m) = 0.
(6.6)
Multiplying (6.6) by B˜i(t, τ, s) and integrating over Ω, one obtains∫
Ω
(
B˜i(t, τ, s)−
[
∂v˜i(s)Bi(t, τ, s)
∂s
]
q˜i(t, τ, s)
)
dΩ = 0.
Using the observation in (6.5), one gets
∂
∂s
[v˜i(s)Bi(t, τ, s)] = 0.
Replacing the above equality in (6.5), one has
∂
∂t
B˜i(t, τ, s) +
∂
∂τ
B˜i(t, τ, s) +
∂
∂s
[
v¯i(s)B˜i(t, τ, s)
]
= −f(τ)B˜i(t, τ, s),
B˜i(0, τ, s) = 0; B˜i(t, 0, s) = 0; v¯i(0)Bi(t, τ, 0) = 0.
(6.7)
Integrating along the characteristic curve the PDE of the above system, one obtains
∀ (t, τ, s) ∈ Ω and i ∈ NI
B˜i(t, τ, s) = 0, and then Bi(t, τ, s) = B¯i(t, τ, s). (6.8)
Let Z¯2i (τ) = Z
2
i (τ) + ci(τ), where ci(τ) > 0 for all τ ∈ (0,∆] and i ∈ NI . Then for
a fixed i0 ∈ NI and s = Z¯2i0(τ), one obtains from (6.8) and (4.6)
Bi0(t, τ, s) = Ai0(t− τ, ci0(τ))vi0(ci0(τ)) = 0 ∀ 0 < τ < t and ci0(τ) > 0.
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Using (4.4), one remarks that the previous equality leads to a contradiction with
Assumptions 4.3.1 and 6.3.1 (specifically A0,0(s) > 0 and vi0(s) > 0 for all s ∈
(0,m]). Therefore, one deduces
Z2i (τ) = Z¯
2
i (τ) ∀ 0 ≤ τ < t and i ∈ NI .
Using (6.8) and (4.6), one gets for all s > Z2i (τ) and 0 < τ < t
vi(s− Z2i (τ))
vi(s)
=
v¯i(s− Z2i (τ))
v¯i(s)
. (6.9)
Using (6.9) and the definition of Z2i (τ) and Z¯
2
i (τ) , one obtains∫ τ
0
vi(s(r))
[
v¯i(s(r)− Z2i (r))
vi(s(r)− Z2i (r))
− 1
]
dr = 0.
By deriving the above equation with respect to τ , one gets
vi(s)
[
v¯i(s− Z2i (τ))
vi(s− Z2i (τ))
− 1
]
= 0,
where s := s(τ). Therefore, one concludes vi(s) = v¯i(s), ∀ s ∈ [0,m] and i ∈ NI .
Theorem 6.2. Let Assumptions 4.3.1 and 6.3.1 be satisfied. The parameters vi(s),
λ(N(t)) and ∆ are identifiable for all i ∈ NI , s ∈ [0,m] and t ∈ (0, T ].
Proof. Let fix θ = [(v0, ..., vI) ∈ K,λ,∆] and consider a second parameters θ¯ =[
(v¯0, ..., v¯I) ∈ K, λ¯, ∆¯
]
wherein ∀ t ∈ [0, T ] and s ∈ [0,m],
Ai(t, s; θ)+
∫ ∆
0
Bi(t, τ, s; θ)dτ = A¯i(t, s; θ¯)+
∫ ∆¯
0
B¯i(t, τ, s; θ¯)dτ, ∀ i ∈ NI , (6.10)
where (Ai(., .; θ), Bi(., ., .; θ)) and
(
A¯i(., .; θ¯), B¯i(., ., .; θ¯)
)
are the solutions of SMCD44
model, and are related to the parameters θ and θ¯ respectively.
If ∆¯ ≤ ∆, we consider
B¯∗i (t, τ, s) :=

B¯i(t, τ, s) if τ ∈ [0, ∆¯],
0 if τ ∈ (∆¯,∆].
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Using the integral formulation of (4.6), one gets for all τ ∈ (0,∆]
B0(t, τ, s) = B¯
∗
0(t, τ, s) = 0 ∀ s ≤ min(Z20(τ), Z¯20(τ)).
Replacing the previous equality in (6.10), one obtains for all τ ∈ (0,∆]
A0(t, s) = A¯0(t, s) ∀ s ≤ min(Z20(τ), Z¯20(τ)).
Using the implicit solution (4.4), one obtains∫ t
0
(
λ(N(u))− λ¯(N¯(u))) du = 0. (6.11)
Deriving the previous equality with respect to t,
λ(N(t)) = λ¯(N¯(t)).
By integrating and summing (6.10) over s and i respectively, one gets
N(t) = N¯(t). (6.12)
Then, one deduces λ(N(t)) = λ¯(N(t)) for all t ∈ (0, T ].
Using Lemma 6.1, one deduces vi(s) = v¯i(s) for all s ∈ [0,m] and i ∈ NI . Therefore,
one has ∫ ∆
0
B0(t, τ, s)dτ =
∫ ∆¯
0
B0(t, τ, s)dτ.
Since ∆¯ ≤ ∆, then the previous equality can be written as∫ ∆
∆¯
B0(t, τ, s)dτ = 0.
Under Assumptions 4.3.1 and 6.3.1, one has B0(t, τ, s) > 0 for all s > Z
2
0(τ),
τ ∈ [∆¯,∆] and t large enough (t > ∆). Therefore, one deduces ∆¯ = ∆ from the
previous equality.
6.3.1 Generalisation
In this subsection, we consider the following cases:
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1-) The recruitment rate (λ) depends on the division number i undergone by cells
and the total cell number N := N(t) (noted λi(N)).
2-) The duration of B-phase (∆) depends on the division number i undergone by
cells (noted ∆i).
Then SMCD44 model becomes
(SM iCD44)

dA0(t, s)
dt
= −δAA0(t, s)− λ0(N)A0(t, s),

for i ∈ N∗I ,
dAi(t, s)
dt
= 2
∫ ∆i−1
0
µ(τ)Bi−1(t, τ, s) dτ − δAAi(t, s)− λi(N)Ai(t, s),

for i ∈ NI ,
∂
∂t
Bi(t, τ, s) +
∂
∂τ
Bi(t, τ, s) +
∂
∂s
[vi(s).Bi(t, τ, s)] = − (δB + µ(τ))Bi(t, τ, s),

Bi(t, 0, s) = λ
i(N)Ai(t, s) and vi(0)Bi(t, τ, 0) = 0 for i ∈ NI ,
Bi(0, τ, s) = 0, for i = 0, ..., I and Ai(0, s) = 0, for i ∈ N∗I ,
A0(0, s) = A0,0(s) > 0.
Theorem 6.3. Let Assumptions 4.3.1 and 6.3.1 be satisfied. The parameters vi(s),
λi(N(t)) and ∆i are identifiable for all i ∈ NI , s ∈ [0,m] and t ∈ (0, T ].
Proof. Here, we use the same techniques as in the previous proof. Let us fix θi =
[vi, λ
i,∆i] and consider a second parameter θ¯i =
[
v¯i, λ¯
i, ∆¯i
]
wherein ∀ t ∈ [0, T ] and
s ∈ [0,m],
Ai(t, s; θi) +
∫ ∆i
0
Bi(t, τ, s; θi)dτ = A¯i(t, s; θ¯i) +
∫ ∆¯i
0
B¯i(t, τ, s; θ¯i)dτ, ∀ i ∈ NI ,
(6.13)
where (Ai(., .; θi), Bi(., ., .; θi)) and
(
A¯i(., .; θ¯i), B¯i(., ., .; θ¯i)
)
are the solutions of SM iCD44
model, and are related to the parameters θi and θ¯i respectively.
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By integrating and summing (6.13) over s and i respectively, one gets
N(t) = N¯(t). (6.14)
If ∆¯i ≤ ∆i, we consider
B¯∗i (t, τ, s) :=

B¯i(t, τ, s) if τ ∈ [0, ∆¯i],
0 if τ ∈ (∆¯i,∆i].
Using the integral formulation of (4.6), one gets for all τ ∈ (0,∆i]
Bi(t, τ, s) = B¯
∗
i (t, τ, s) = 0 ∀ s ≤ min(Z2i (τ), Z¯2i (τ)). (6.15)
Now, we proceed by induction.
For i = 0: one has for all τ ∈ (0,∆0]
A0(t, s) = A¯0(t, s) ∀ s ≤ min(Z20(τ), Z¯20(τ)).
Using the implicit solution (4.4), one obtains for all t ∈ (0, T ]∫ t
0
(
λ0(N(u))− λ¯0(N¯(u))) du = 0. (6.16)
Deriving the previous equality with respect to t and using (6.14), one deduces
λ0(N(t)) = λ¯0(N¯(t)) ∀ t ∈ (0, T ].
Using Theorem 6.1, one deduces v0(s) = v¯0(s) for all s ∈ [0,m]. Therefore, equation
(6.13) becomes ∫ ∆0
∆¯0
B0(t, τ, s)dτ = 0.
Under Assumptions 4.3.1 and 6.3.1, one has B0(t, τ, s) > 0 for all s > Z
2
0(τ),
τ ∈ [∆¯0,∆0] and t large enough (t > ∆0). Therefore, one deduces ∆¯0 = ∆0.
For i ∈ N∗I :
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Assuming that the following equalities are satisfied
λi−1(N(t)) = λ¯i−1(N(t)), vi−1(s) = v¯i−1(s) and ∆i−1 = ∆¯i−1,
for all i ∈ N∗I , t ∈ (0, T ] and s ∈ [0,m]. Then Bi−1(t, τ, s) = B¯i−1(t, τ, s), ∀
τ ∈ [0,∆i−1] and s ∈ [0,m]. Let us show that the previous equalities still hold for i.
Using (6.15), equation (6.13) becomes
Ai(t, s) = A¯i(t, s) ∀ s ≤ min(Z2i (τ), Z¯2i (τ)).
By deriving the previous equality with respect to t and by using the ODEs in
SM iCD44 model, one gets
2
∫ ∆i−1
0
µ(τ)Bi−1(t, τ, s) dτ − δAAi(t, s)− λi(N)Ai(t, s)
= 2
∫ ∆¯i−1
0
µ(τ)B¯i−1(t, τ, s) dτ − δAA¯i(t, s)− λ¯i(N¯)A¯i(t, s).
Using the induction hypothesis and (6.14), one deduces for all t ∈ (0, T ]
λi(N(t)) = λ¯i(N(t)).
Using Theorem 6.1, one deduces vi(s) = v¯i(s) for all s ∈ [0,m]. Therefore, equation
(6.13) becomes ∫ ∆i
∆¯i
Bi(t, τ, s)dτ = 0.
As in the case i = 0, for t large enough (t > ∆i), one has Bi(t, τ, s) > 0 for all
s > Z2i (τ) and τ ∈ [∆¯i,∆i]. Therefore, one deduces ∆¯i = ∆i.

Chapter 7
A comparison of two versions of
the Smith-Martin model
7.1 Introduction
A biologically reasonable specific model of cell division is given by the Smith-Martin
model [69]. Based on their quantitative study of the FLM (fraction of labelled
mitoses) curves of dividing cell populations in vitro, Smith and Martin (1973) for-
mulated a simple quantitative description for the process of cell division. In fact,
this description is similar to the model proposed by Burns and Tannock (1970) [98].
The Smith-Martin model divides the complete division cycle into an A-state and a
B-phase. The A-state corresponds to the G0 or G1 phase where the cells are ran-
domly activated to enter and divide in B-phase (S, G2, M phase). This model has
successfully been used for analysing the population dynamics of dividing cells as it
prevents too rapid progression through the cell cycle by introducing the equivalent
of a time delay (i.e a fixed length for the S, G2 and M phases of the cell cycle) [42].
Several authors have developed mathematical models based on the Smith-Martin
model in order to analyse CFSE data [2–9]. Specially, Bernard et al [3] and Ganusov
et al [4] have formulated the Smith-Martin model in terms of PDEs (termed by SM
model). Later on, several studies have been made to improve the prediction of this
model to CFSE data. For example, Yates et al. [7] and Hogan et al. [10] have mod-
ified the SM model by considering that the rate of entry in B-phase depends on
the time evolution [7] or on the total cell number [10]. Their results show that the
modified SM models provides the best description of the observed response by F5
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and OT-1 T cells to lymphopenia.
This chapter is organised as follows. At first, we present the modified SM model
[10] (previously latest version of Smith-Martin model in the literature) and our
reduced SMCD44 model (i.e without the CD44 structure). Next, we describe the
method used to identify numerically several common parameters in both models by
using the CFSE data of OT-1 T cells [10]. Finally, we show the parameters and the
simulations that we obtain from the models, and compare them with experimental
data.
7.2 Materials and methods
7.2.1 Mathematical modeling
In the model of proliferation presented in [7, 10], the authors assume that cells
undergo simple stochastic divisions. As with the Smith Martin model, in their
model, cells are in one of two compartments that imprecise to resting (A-state) or
dividing (B-phase) cells. Cells in A-state are considered to be non dividing cells in
G0 state. These cells can then receive a stochastic trigger to enter the cell cycle
(B-phase) at a rate captured by the parameter, λ. A reduction in λ dependent
on the number of cells (competition for resources) was achieved by making λ =
λ0 exp(−ηN), with the parameter η determining the size of the reduction caused
by increasing the number of competing cells (N). In addition, λ0 is considered
to represent the ability of each clonotype to respond to an unlimited resource, η
can be considered to be proportional to the reciprocal of the resource availability,
and N the total number of cells. The B-phase, the duration of which is described
by the parameter ∆, represents cells in G1, S, G2, and M stages of the cycle,
before returning to G0 (A-state). The time spent in the A-state is exponentially
distributed, such that each cell can make the A → B transition at a rate λ (the
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mean time for cells residing in A-state is 1
λ
). Then, the model is
(SM1)

dA0
dt
= −(λ(N) + δA)A0(t), {A0(0) > 0}
dAi
dt
= 2Bi−1(t,∆)− (λ(N) + δA)Ai(t), {Ai(0) = 0}, i = 1, ..., I

∂
∂t
Bi(t, τ) +
∂
∂τ
Bi(t, τ) = −δBBi(t, τ), i = 0, ..., I
Bi(t, 0) = λ(N)Ai(t), Bi(0, τ) = 0
where (t, τ) ∈ [0, T ]× [0,∆] and
N = N(t) :=
I∑
i=0
Ni(t) :=
I∑
i=0
(
Ai(t) +
∫ ∆
0
Bi(t, τ)dτ
)
.
In the general case, cells are triggered from the A-state, to enter the proliferative
phase, they spend in B-phase a time τ ∈ [0,∆] to divide. Proliferative cell divides
into two daughter cells only when it completes the process of mitosis (∆ is approx-
imately the time to finish the process). More specifically, when a cell divides, it
disappears from the B-phase.
In SM1 model, the Smith-Martin model describes the dynamics of cells that we have
discussed in the previous paragraph, but the mother cells are not removed from the
B-phase after dividing (see the right side of the PDE in SM1 model) that is because
their age become larger than ∆. Indeed, since the age (τ) is defined between 0 and
∆, the mother cells with an age more than ∆, are not counted in the dynamics, but
in fact, they stay in B-phase. This means that ∆ is not really the maximum age of
cells in B-phase, as it is defined in SM1 model.
On the other side, by integrating our SMCD44 model with respect to variable s
(CD44 expression), we derive an age-structured system as SM1 model but with
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additional parameter µ(.). It reads
(SM2)

dA0
dt
= −(λ(N) + δA)A0(t), {A0(0) > 0}
dAi
dt
= 2
∫ ∆
0
µ(τ)Bi−1(t, τ)dτ − (λ+ δA)Ai(t), {Ai(0) = 0}, i = 1, ..., I

∂
∂t
Bi(t, τ) +
∂
∂τ
Bi(t, τ) = −(δB + µ(τ))Bi(t, τ), i = 0, ..., I
Bi(t, 0) = λ(N)Ai(t), Bi(0, τ) = 0
where Ai(t) :=
∫ m
0
A˜i(t, s)ds, Bi(t, τ) :=
∫ m
0
B˜i(t, τ, s)ds and (A˜i, B˜i), ∀ i ∈ NI are
the state variable of System (4.2-4.3).
In this SM2 model, a function µ(.) is introduced in order to remove the mother
cells from B-phase after dividing. Therefore, µ(τ) represents the rate of cells which
divided at age τ and have given rise to two daughter cells in the resting phase (A-
state).
Note that if a cell divides only when its age is close to ∆, the function µ can be
approximated by a non-negative rectangular function with a mean value 1
µ(τ) =

1
h
if ∆− h 6 τ 6 ∆,
0 else,
where 0 < h << ∆.
Furthermore, the cumulative probability that a cell is still in B-phase at time τ ,
having not divided (µ) nor been killed (δB) until this time point, is
Π(τ) = e−
∫ τ
0 (δB+µ(a))da,
and the cumulative probability that a cell has divided until time point τ , is
d(τ) = 1− e−
∫ τ
0 µ(a)da.
As in [10], the recruitment rate of cells from A-state into the B-phase is expressed
in the following form for SM2 and SM1 models,
λ = λ(N(t)) = λ0 e
−η N(t), (7.1)
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where λ0 > 0 represents the ability of each clonotype to respond to an unlimited
resource, and η > 0 determines the size of the reduction caused by increasing number
of competing cells (N) [10].
In contrast to the SM1 model, the model with the removal rate µ (SM2 model)
provides an overview of the incoming and outcoming fluxes of cells in A-state and
B-phase. Then, the purpose here is to estimate numerically the parameters (∆,
λ0, η) of each models (SM1 and SM2) in order to evaluate the difference between
SM1 and SM2 models caused by the function µ(.), and to identify which model fits
better the data of Hogan et al. [10].
7.2.2 Parameter estimation
An important step in using the mathematical approach is the estimation of model
parameters using experimental data. Let N expi,m (tk) be the data set given in (Sec. 6.2)
that represents the total cell number having undergone i divisions at time tk in each
mouse m. The parameters to estimate in SM1 and SM2 models are: ~θ = (λ0,∆, η).
We used weighted sums of squared residuals (SSRs) for optimization with variance
over observed cells with given i at given day as the measurement error function.
7.2.3 Comparison of the models
Comparison of the different models (SM1 and SM2) was done using a cross vali-
dation approach. The whole data set (Sec. 6.2) was separated into two parts each
day of the experiment: a validation set with data for one given mouse, m, and a
training set with the remaining data (M − 1) (M is the total number of mice).
Parameter value were obtained by minimizing the SSR with the training set.
SSR−m =
I∑
i=0
K∑
k=1
M∑
j=1
j 6=m
(
Ni(~θ, tk)−N expi,j (tk)
)2
σ2i (tk)
(7.2)
where
Ni(~θ, tk) = ∆t
(
Ai(tk) + ∆τ
Nτ∑
s=1
Bi(tk, τ
s)
)
are calculated from SM1 and SM2 models. σ
2
i (t), ∆t and ∆τ are the variance and
the mesh size of time and age respectively. Here, i stands for the number of divisions
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(total number I = 8), k is the number of sampling day (with total number K = 5),
j is the number of mouse, M is the total number of mice in the experiment (M = 20
for OT1 cells).
Indeed, we use an optimization algorithm (BCONF [99]) based on the quasi-Newton
method to solve (7.2). Let us explain briefly this algorithm.
Optimization algorithm
From a given starting point (vector) ~θc, an active set IA, which contains the indices
of the variables at their bounds, is built. A variable is called a ” free variable ” if it
is not in the active set. The routine then computes the search direction for the free
variables according to the formula
d = −B−1gc
where B is a positive definite approximation of the Hessian and gc is the gradient
evaluated at ~θc; both are computed with respect to the free variables. The search
direction for the variables in IA is set to zero. A line search is used to find a new
point ~θn,
~θn = ~θc + λd
where λ ∈]0, 1], such that
SSR−mSMj(
~θn) ≤ SSR−mSMj(~θc) + αgTd, α ∈ (0, 0.5) and j = 1, 2
Finally, the optimality condition
‖g(~θn)‖ ≤ , ~Lower < ~θn < ~Upper
is checked, where  is a gradient tolerance. When optimality is not achieved, B is
updated according to the BFGS formula
B ←− B − Bss
TB
sTBs
+
yyT
yT s
where s = ~θn − ~θc and y = gn − gc. Another search direction is then computed to
begin next iteration.
The active set is changed only when a free variable hits its bounds during an itera-
tion or the optimality condition is met for the free variables but not for all variables
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in IA, the active set. In the latter case, a variable that violates the optimality
condition will be dropped out of IA. For more details on the quasi-Newton method
and line search, see Dennis and Schnabel [100].
At the next step, for each mouse m, the comparison reference value (CrV ) cri-
terion is calculated by using the estimated parameter values ~θ∗ using the validation
set
CrVm =
I∑
i=0
K∑
k=1
(
Ni(~θ, tk)−N expi,m (tk)
)2
σ2i (tk)
The CrVm was calculated for each experimental mouse m in the validation set. The
final estimate of the cross validation was
CrV =
1
M
M∑
m=1
CrVm.
The lower value of CrV indicates the better model.
7.3 Results
In the experiment, CFSE-labeled OT-1 T cells was transferred to Rag1−/− recipi-
ents by injection 1.5× 106 cells mouse at the initial date (i.e A0(0) ' 1.5× 106) and
the rate of cell death (δA or δB) observed was very close to zeros for OT-1 T cells
[10]. We therefore omitted δA and δB from SM1 and SM2 models. In addition, the
time division (h) is supposed here small (h = 0.5 hour) with respect to the age of
cells in B-phase (∆ is estimated in hours [10]).
Best-fit parameters for SM1 and SM2 models were determined by minimizing
weighted SSR for LIP by OT-1 cells (Table 7.1).
Model η ∆(hour) λ0 (/cell/hour) CrV
SM1 1.00000E-06 8.51000 3.764693E-02 109.902
SM2 1.97568E-06 7.17858 3.768979E-02 48.0315
Table 7.1: Best-fit parameter estimations for SM1 and SM2 models.
Despite the constraining data sets, the parametrization in Table 7.1 (∆, η and λ0)
of SM1 model is close to those of the previous studies ([7, 10]). From Fig 7.1, the
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SM1 and SM2 models were successful in describing LIP by OT-1 T cells as ap-
parent in the predicted division profiles. Also despite the differences between the
parameterization of SM1 and SM2 model, specific estimates of η and λ0 (1.0E− 06
and 3.764693E − 02, respectively) of SM1 were in close agreement with those of
SM2 ( 1.97568E − 06 and 3.768979E − 02, respectively).
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Figure 7.1: SM2 model fits more the proliferation of OT-1 T cells than SM1 model. Best-fit parameter
estimates from SM1 and SM2 models (see Table 7.1) were used to predict the cell number in each division. At
the indicated time points after transfer, data predicted by SM1 (green) and SM2 (blue) models were compared
with experimental data for OT-1 cells (red).
In contrast, the small difference in the parametrizations of SM1 and SM2 was cap-
tured with distinct values for the parameter ∆ (the duration of B-phase). The
estimated value of ∆ was higher for SM1 (8.51 h) than SM2 (7.17858 h). Then,
the key parameter ∆ is affected by taking into account the dynamic of the dividing
cells. Therefore, it was important to compare SM2 with SM1 model. However, it
was clear that LIP by OT-1 was better modeled with the SM2 than SM1 model,
as reflected in the lower CrV for SM2 model fit (Table 7.1), which is a measure of
goodness of fit (low is better).
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7.4 Conclusion
In the literature, the most mathematical models based on Smith-Martin model
assume that the cells divide in B-phase exactly at age ∆. In contrast, the SM2
model takes into account the small variability in the time of division of cells in
B-phase, and eliminates the assumption of an immediate switch at time ∆. In
this chapter, we interest to compare these two types of modeling by fitting SM1
and SM2 models to the data of OT-1 T cells. By taking into account the small
variability in the time of division, we remark that the duration of B-phase related
to SM2 model becomes shorter than this related to SM1. In contrast, the rate of
entry into division is approximately the same in these two models. Finally, we find
that SM2 model fits better the experimental data (CrV for SM2 is much less than
SM1).

Chapter 8
Identification of the velocity of
CD44 expression
This chapter is based on the article [80].
Abstract. The number of T Lymphocytes (T cells) in the body is under home-
ostatic control. At equilibrium, the majority of naive T cells are non-dividing and
express low levels of the surface protein CD44. In conditions of T cell deficiency
(lymphopenia), naive T cells enter into a proliferative phase, undergoing cell divi-
sion accompanied by a subtle change in their surface expression of CD44. In this
study, we use a mathematical modeling approach to analyse the proliferative response
of transgenic T cells in lymphopenic conditions. Our nonlinear model is composed
of ordinary differential equations and partial differential equations structured by
age (maturity of cell) and CD44 expression. To better understand the evolution of
CD44 expression on the surface of T cells during cell division, we present a nu-
merical analysis to solve a parameter identification problem. Finally, we show the
parameters and the simulations that we obtain from the model and compare them
with experimental data.
8.1 Introduction
Regulation by homeostatic mechanisms ensures that the number and functional
diversity of peripheral T cells is maintained at an approximately constant level.
However, under conditions of lymphopenia, disruption of the homeostatic balance
87
Chapter 7. Identification of the velocity of CD44 expression. 88
can induce naive T cells to undergo cell division. This lymphopenia induced prolifer-
ation (LIP) of naive T cells requires signal from cytokines such as IL-7 (Interleukine
7), and stimulation of the T cell receptor via interaction with self peptide [41]. Un-
der the experimental conditions used in [7], it has been shown that the dividing F5
T cells retained a naive phenotype. However, for some T cells, LIP is accompanied
by a transition to a memory-like phenotype [41] which is indicated by having a
strong CD44 expression on their surface [32, 89].
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Figure 8.1: . Representative dot plots gated on CD8 lymphocytes show CD44 expression versus CFSE
labeling in the lymph nodes of mice that received either OT-1 and F5 T cells (left panel). In the right panel,
the evolution of CD44 expression versus division number for both OT-1 and F5 is presented here. Note that
these figures make reference to the experimental data obtained and reported in [10].
Moreover, Hogan et al [10] have shown that the undivided OT-1 T cells expressed
a similar level of CD44 to naive CD8+ T cells, and began to upregulate expression
of this marker after the4th − 5th division in response to lymphopenia. F5 T cells,
however, retained a low level of CD44 expression throughout division (see Fig 8.1).
In addition, the experiment reported in [10] shows that the expression of CD44 by
OT-1 T cells at approximately 5− 6 divisions in response to lymphopenia indicates
the acquisition of a memory-like phenotype, which is not observed for F5 T cells
under the same conditions.
In the present study, the velocity of CD44 up-regulation is the key parameter that
distinguishes from which divisions OT-1 T cells can be considered as naive or mem-
ory through the mathematical model SMCD44. The purpose of this chapter is then to
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identify numerically this velocity in order to evaluate the prediction of our SMCD44
model with respect to the observation of CD44 expression of OT-1 T cells stated in
the previous paragraphs.
8.2 Parameter identification problem
In this section, we present our methodology for estimating the velocity vi(.) in
SMCD44 model that represents the extent of CD44 expression on the surface of cells
during their divisions.
Note that this velocity depends on each level of CD44 that can be presented on
the cells (s). So, it is much more relevant to interpret the average growth of CD44
per division (or implicitly per ∆, since ∆ is the duration of each division), which
allows to compare the up-regulation of CD44 between the division number. Fur-
thermore, according to [32, 89], memory cells are characterized by having a strong
CD44 expression on their surface. Then, by estimating the parameters vi(s), we
derive the mean growth of CD44 (average velocity) per division which allows us to
distinguish from which division, the cells can be considered as memory cells.
Remark 8.1. In the experiment of Hogan et al. [10], several mice were sacrificed
at each time point. Working with different mice at different time points generated
additional variability making the identifiability of parameters more difficult. There-
fore, we decided to work on a given time point. We chose 7 days because it was a
good compromise between early days where there were too few divisions and later
time points where CFSE is too much diluted to be very easily measured.
Let N expi,s be the total number of cells given by the experimental data set at day
T = 7. In addition we denote by
D = {s, where N expi,s is given by the experimental data }.
Furthermore, by integrating our model with respect to the variable s (CD44 expres-
sion), one gets the SM2 model. Therefore, we can use the estimated parameters
(∆, λ0, η) from the previous chapter and then estimate the velocity vi(s), i = 0..., I.
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Thus we want to minimize the cost function
[P ]
{
min
v∈K
I∑
i=0
∑
s∈D
[
∆s
(∫ ∆
0
Bi(T, τ, s)dτ + Ai(T, s)
)
−N expi,s
]2
,
where the constant ∆s is the mesh size of the CD44 expression, Bi(T, τ, s), Ai(T, s)
are given by (10.1-4.3) and {N expi,s } are the observed data. The parameters (v0, ..., vI)
belong to the space K = (C˜ u¯+)
I where
C˜ u¯+ = {u ∈ C0([0,m]), u(0) = 0, 0 ≤ u(s) 6 u¯ , ∀ s ∈]0,m]}.
8.2.1 The discrete parameter identification problem
Now, we define the parameter identification scheme and the algorithm to identify
the velocity of CD44 up-regulation. The approximate problem of [P ] is defined by
[Pd]
{
min
vNs∈KNs
J(vNs) := min
vNs∈KNs
I∑
i=0
∑
k∈D
[
∆s
(
∆τ
Nτ∑
j=0
Bi,NTj,k + A
i,NT
k
)
−N expi,k
]2
.
The discrete vector vNs ∈ KNs is the set of unknown parameters defined by vNs =
(v0,Ns , ..., vI,Ns). It belongs to the space KNs = (C˜
u¯,Ns
+ )
I where
C˜ u¯,Ns+ = {u(sk) = uk, u0 = 0, 0 ≤ uk 6 u¯, k = 1, .., Ns}.
That is an approximate finite dimensional compact set of K. Hence, one obtains
the following result.
Theorem 8.2. Under Assumption 5.3.1 and condition (5.3), the problem [Pd] ad-
mits at least one optimum.
Proof. Let d < ∞ be the lower bound of the cost function J(vNs). Let {vhNs}h>0,
be a minimizing sequence on the space KNs , such that
d < J(vhNs) 6 d+
1
h
.
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The value of the cost function at the point vhNs = (v
h
0,Ns
, ..., vhI,Ns) is given by
J(vhNs) =
I∑
i=0
∑
k∈D
[
∆s
(
∆τ
Nτ∑
j=0
Bi,NTj,k (v
h
i,Ns) + A
i,NT
k (v
h
i,Ns)
)
−N expi,k
]2
,
where Bi,NTj,k (v
h
i,Ns
) and Ai,NTk (v
h
i,Ns
) are the solution of (5.2)-(5.1).
The sequence {vhNs}h is bounded. According to the Bolzano-Weierstrass theorem,
one can extract a subsequence, termed {vhrNs = (vhr0,Ns , ..., vhrI,Ns)}r>0, which converges
to v∗Ns = (v
∗
0,Ns
, ..., v∗I,Ns) on the space KNs . Then by using Lemma 5.7, one obtains
|Bi,nj,k(vhi,Ns)−Bi,nj,k(v∗i,Ns)| 6 CBi |vhi,Ns − v∗i,Ns| −→h→+∞ 0, ∀ i ∈ NI := {0, ..., I},
|Ai,nk (vhi−1,Ns)− Ai,nk (v∗i−1,Ns)| 6 CAi |vhi−1,Ns − v∗i−1,Ns| −→h→+∞ 0, ∀ i ∈ N
∗
I := {1, ..., I}.
Therefore, one deduces
J(vhNs) =
I∑
i=0
∑
k∈D
[
∆s
(
∆τ
Nτ∑
j=0
Bi,NTj,k (v
h
i,Ns) + A
i,NT
k (v
h
i,Ns)
)
−N expi,k
]2
=
I∑
i=0
∑
k∈D
[
∆s
(
∆τ
Nτ∑
j=0
[(
Bi,NTj,k (v
h
i,Ns)−Bi,NTj,k (v∗i,Ns)
)
+Bi,NTj,k (v
∗
i,Ns)
]
+
(
Ai,NTk (v
h
i,Ns)− Ai,NTk (v∗i,Ns)
)
+ Ai,NTk (v
∗
i,Ns)
)
−N expi,k
]2
−→
h→+∞
I∑
i=0
∑
k∈D
[
∆s
(
∆τ
Nτ∑
j=0
Bi,NTj,k (v
∗
i,Ns) + A
i,NT
k (v
∗
i,Ns)
)
−N expi,k
]2
= J(v∗Ns) = d.
To numerically solve problem [Pd], we use an optimization algorithm based on the
Quasi-Newton method (see [101]). This algorithm needs to compute the adjoint
variables and the gradient of the cost function.
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In the following, we consider the Lagrangian formulation of [Pd] that is
L(W ) =
I∑
i=0
Ns∑
k=0
γkD
[
∆s
(
∆τ
Nτ∑
j=0
Bi,NTj,k + A
i,NT
k
)
−N expi,k
]2
+
NT∑
n=1
Ns∑
k=0
[
A0,nk −
A0,n−1k
1 + ∆tδA + ∆tλn
]
P 0,nk
+
I∑
i=1
NT∑
n=1
Ns∑
k=0
[
Ai,nk −
Ai,n−1k + 2∆t∆τ
∑Nτ
j=1 µ
j−1Bi−1,n−1j−1,k
1 + ∆tδA + ∆tλn
]
P i,nk
+
I∑
i=0
NT∑
n=1
Nτ∑
j=1
Ns∑
k=1
[
Bi,nj,k −
(1− ∆t
∆s
vki )B
i,n−1
j−1,k +
∆t
∆s
vk−1i B
i,n−1
j−1,k−1
1 + ∆tδB + ∆tµj
]
Qi,nj,k
+
I∑
i=0
NT∑
n=1
Ns∑
k=0
[
Bi,n0,k − λn−1Ai,n−1k
]
Qi,n0,k,
where the vector W = (W0, ...,WI), with Wi = (vi, A
i, Bi, P i, Qi) for all i = 0, ..., I.
The variable (P i, Qi) corresponds to the dual variables. γkD is a function in the
following form
γkD =

1 if k ∈ D
0 else
The first derivative of the Lagrangian with respect to Ai,nk and B
i,n
j,k gives us the
adjoint equations.
For i = I, ..., 0; n = NT − 1, ..., 0; j = Nτ − 1, ..., 0 and k = 0, ..., Ns − 1, one
has 
Qi,nj,k =
(1−∆t
∆s
vki )Q
i,n+1
j+1,k+
∆t
∆s
vki Q
i,n+1
j+1,k+1
1+∆tδB+∆tµj+1
+ γi[0,I−1]
2∆t∆τµjP i+1,n+1k
1+∆tδA+∆tλn+1
P i,nk =
P i,n+1k
1+∆tδA+∆tλn+1
+ λnQi,n+10,k
Qi,NTj,k = 2γ
k
D∆s∆τ
[
N expi,k −∆sAi,NTk −∆s∆τ
∑Nτ
j=0B
i,NT
j,k
]
P i,NTk = 2γ
k
D∆s
[
N expi,k −∆sAi,NTk −∆s∆τ
∑Nτ
j=0B
i,NT
j,k
]
Qi,nNτ ,k = Q
i,n
j,Ns
= 0
(8.1)
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where [0, I − 1] := {0, ..., I − 1}.
The first derivative of the Lagrangian with respect to vk0i0 are : ∀ k0 = 0, ..., Ns − 1
and i0 = 0, ..., I.
∂L
∂vk0i0
=
NT∑
n=1
Nτ∑
j=1
∆t
∆s
Bi0,n−1j−1,k0
[
Qi0,nj,k0 −Qi0,nj,k0+1
]
1 + ∆tδB + ∆tµj−1
(8.2)
and
∂L
∂vNsi0
=
NT∑
n=1
Nτ∑
j=1
∆t
∆s
Bi0,n−1j−1,NsQ
i0,n
j,Ns
1 + ∆tδB + ∆tµj−1
(8.3)
The (BCONG/BCONF) routine of IMSL minimizes a function of n variables subject
to bounds on the variables using the BFGS quasi-Newton method [99]. To numer-
ically solve problem [Pd], we use this routine. The strategy can be summarized in
the following algorithm
8.2.1.1 Algorithm
1- Input I, NT , Nτ , Ns, λ0, η, ∆t = ∆τ,∆s.
2- Set initial guess vg0 = (vg00 , ..., v
g0
I ) for the velocity v0 = (v0,0, ..., v0,I).
3- Build a subroutine to calculate (Ai, Bi), ∀ i = 0, ..., I from (5.1) and (5.2).
4- Build a subroutine to calculate (Pi, Qi), ∀ i = 0, ..., I from (8.1).
5- Build a subroutine to calculate the cost function (J) by calling the subroutine
in 3.
6- Build a subroutine to calculate the gradient (8.2-8.3) by calling the subrou-
tines in 3 and 4.
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7- Call BCONG in subject to find v0 = (v0,0, ..., v0,I) by using the subroutines
in 5 and 6.
8- Return v0 = (v0,0, ..., v0,I).
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Figure 8.2: The vertical axis represent the total number of cells(
Ni(T, s) := ∆s
∫∆
0
Bi(T, τ, s)dτ + ∆sAi(T, s)
)
as a function of the intensity of CD44 (i.e normalised
median fluorescence intensity (MFI) of CD44) in each division (i). The solid line depicts the predictions of
the model and the bar depicts the observed data. Note that the horizontal axis is zoomed in each sub-figure
in order to improve the illustration clarity.
8.3 Numerical results
In this section, we present the numerical results for the velocity by using our nu-
merical method defined in the previous section. As in Chapter 7, the rate of entry
into cell division (λ) was a function of the size of the T cells compartment. The
dependence was chosen as λ = λ0e
−ηN(t). Also, the rate of cells which divided at
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age τ , is expressed in the following form
µ(τ) =

1
h
if ∆− h 6 τ 6 ∆,
0 else,
(8.4)
where h = 30 mn is the time division before age ∆.
In addition, the choice of some numerical and optimization parameters (λ0, η,∆)
follows the parameters value estimated in the previous chapter 7. The mortality
(δA and δB) was considered null because no death was observed [10]. According
to Materials and Methods in [10], the initial number of cells is approximately 1.5
million cells per mouse having low intensities of CD44, but their distribution ac-
cording to the CD44 expression is unknown. In this study, we assume that the cells
are distributed homogeneously over an interval of small intensity of CD44. It is
expressed in the following form
A0(0, s
k) =

8× 104 if 0.075 6 k 6 0.12,
0 else.
(8.5)
where
∑Ns
k=0A0(0, s
k) ' 1.5× 106 cells.
By using the algorithm in the previous section, we observe in Fig. 8.2 that the
model fits well the experimental data. Indeed, the cells are up-regulating CD44
during B-phase. In Ai phase (i.e ith division in A-state), cells inherit the same
intensity of CD44 of those that have divided in the previous B-phase (Bi−1 phase).
In Fig. 2, the total cell number Ni(T, s) depends on the number of cells in Bi phase
for all ages (
∫ ∆
0
Bi(T, τ, s)dτ), and implicitly on the divided cells that come from
Bi−1 phase (i.e the mothers cells in Bi−1 phase, give the same intensity of CD44 to
the daughter cells that enter immediately in Ai phase). Then, the peaks predicted
by the model in Fig. 8.2, are due to this complex relationship between A-state and
B-phase over the division number.
To clarify this relationship, we show in Fig. 8.3 the dynamic of cells in Bi phase at
day 7 with respect to their intensity of CD44 and their age, for all i = 0, ..., 8. ”(j)”
depicts in Fig. 8.3, the peak j in each sub-figure (j = 0, .., 12). The dashed arrow
shows that there remains cells from peak ”(j)” (by increasing their age).
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Figure 8.3: Dynamic of cells in Bi phase (i.e ith division in B-phase) at day 7. Z-axes depict the number
of cells in B-phase (Bi(T, τ, s)) as a function of their intensity of CD44 (x-axes) and their age (Y-axes) in each
division (i). The intensity of CD44 is the weight of CD44 expression (normalised median fluorescence intensity)
on the surface of cells in each division (s ∈ [0,m] and m = 2). Note that the scale on the x-axis, is zoomed
in each sub-figure in order to improve the illustration clarity. The maximum age of cells (∆) in B-phase is
estimated in the previous chapter 7 by 7.17 hour. ”(j)” represents the peak j in each sub-figure (j = 0, .., 12).
The dashed arrow indicates that there remains cells from peak ”(j)” (by increasing their age).
In Fig. 8.3 (B0 phase), the number of newborn cells ”(0)” and ”(1)”, decreases
over age because they change their level of CD44, which allow to appear new peak
”(2)”. Note that this new peak has been validated by the experimental data (see
last bar in Fig. 8.2 (i = 0)). Typically, in Fig. 8.3 (B1,..., B8 phases), the peaks in
Bi−1 phase are reproduced in Bi phase in the form of peaks which depict the new-
born cells (the mother cells in Bi−1 phase will divide and give rise to two daughter
cells that enter immediately in Ai phase where some of these daughter cells will be
recruited in Bi phase, as newborn cells). Moreover, the number of newborn cells,
decreases or stabilizes (e.g ”(1)” in B1 phase and ”(2), (3)” in B3 phase) over age,
since it depends on their capacity to change their CD44 expression in each division.
In case of decrease, some peaks increases or new peak appears. Taken together
Fig. 8.2 and Fig. 8.3, we remark that the appearance of new peaks in some panel
(e.g ”(3)”, ”(4)”, ”(5)”, ”(7)”, ”(8)”, ”(11)”, ”(12)” in B1, B2, B3, B5,...,B8 phases
respectively) is observed by the experimental data (see the last bars in Fig. 8.2
(i = 1, 2, 3, 5, ..., 8)). Therefore, the highest peaks predicted by the model where
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there was no experimental data to support them (i = 3, ..., 8 in Fig. 8.2), return
implicitly to those of the previous divisions where they have been observed in some
panel by the experimental data.
Before discussing biologically the velocity obtained, we must prove the robustness
of our algorithm. For this reason, we modify the initial velocity vg in order to
calculate the cost function and the relative error on the estimated parameters (see
Table 11.2). We remark from this table that the error is negligible by changing the
Table 8.1: The algorithm is independent of the initialisation (vg0).
Cost function Value
Jθ(v0; v
g0) 0.5254
Jθ(v1; v
g1) 0.5695
Jθ(v2; v
g2) 0.5961
i ξi(v0,i, v1,i) ξi(v0,i, v2,i)
0 2.0570E − 05 3.9715E − 05
1 2.5403E − 05 2.5101E − 05
2 7.2569E − 05 3.3016E − 05
3 2.7315E − 04 4.7416E − 07
4 4.5836E − 05 4.0277E − 05
5 1.1171E − 04 1.7949E − 05
6 1.4370E − 04 1.4737E − 04
7 5.8189E − 04 6.6271E − 05
8 3.3944E − 04 3.2401E − 04
The notation (vm, v
gm ) represents the velocity estimated vm = (vm,0, ..., vm,I) with an initialization v
gm =
(vgm0 , ..., v
gm
I ), ∀ m = 0, 1, 2. In this test, we suppose an initialization v
g0
i . We took v
g1
i (s) = random × v
g0
i (s)
and v
g2
i (s) = random × v
g0
i (s), for s ∈ [0,m] and i = 0, ..., I (i is the division number). On the left, the tabular
represents the cost functions given by [Pθ] with a different initialisation (v
g0 , vg1 , vg2 ). On the right, ξi(v0,i, vm,i) is
the calculated error between the velocity v0,i and vm,i, ∀ m = 1, 2. This error is equal to ‖v0,i−vm,i‖2‖v0,i‖2 , ∀ m = 1, 2 and
for i = 0, ..., I.
initial velocity. Therefore we can conclude that our algorithm is independent of the
initial velocity.
In addition, we identified the velocity in each division by using the data available in
[10]. The purpose here was to evaluate the reliability of the estimates. Indeed bio-
logical datasets usually contain noise and measurement errors, and they are seldom
complete. For this reason, we tested our estimated parameters by adding random
noise to the experimental data. After repeating the inverse problem to find the
new parameters, we calculate the relative error between the estimated parameters
obtained by the noisy data and the data without noise. This allows us to evaluate
the loss due to random noise and we can see if our algorithm can accommodate the
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Table 8.2: The algorithm supports the noisy data.
Error  Noise 1% 2% 3% 4% 5% 6%
ς0 0.0110 0.0148 0.0191 0.0038 0.0051 0.0075
ς1 0.0180 0.0177 0.0187 0.0165 0.0157 0.0154
ς2 0.0099 0.0011 0.0359 0.0083 0.0020 0.0355
ς3 0.0107 0.0076 0.0148 0.0161 0.0189 0.0085
ς4 0.0025 0.0050 0.0151 0.0103 0.0124 0.0151
ς5 0.0062 0.0128 0.0154 0.0235 0.0334 −
ς6 0.0063 0.0129 0.0006 0.0118 0.0011 0.0133
ς7 0.0392 0.0693 0.0372 0.0375 0.0385 0.0390
ς8 0.0379 0.0392 0.0406 0.0425 0.0446 0.0475
ςi is the relative error on the estimated parameters caused by a random noise in the data. ςi =
‖vi−v∗i ‖2
‖vi‖2 , where v
∗
i
is the velocity estimated by using the noisy data. Noisy data = Nexpi,k + φi × randi(k), where % of noise =
φi∑
k∈D N
exp
i,k
and −1 6 randi(k) 6 1 for k ∈ D, i = 0, ..., I.
noise. We show in Table 8.2 the relative error ςi for i = 0, ..., I. We remark that
the error is very small. This allows us to conclude that the noise slightly affects the
identified velocity.
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Figure 8.4: The velocity (vertical axis) as a function of the observed intensity of CD44 (i.e intensity of
fluorescence CD44) in each division (i) by using the parameters (∆, λ0, η) estimated in the previous chapter.
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Fig. 8.4 shows the numerical result of the identified velocity according to the ob-
served intensity of CD44 in each division.
Naive cells in A-state are recruited to enter the B-phase, and the evolution of CD44
on the surface of these cells is undergone during the proliferative B-phase. From
Fig. 8.3 and 8.4, we observe that some cells may divide without increasing CD44
expression, and other cells increase CD44 by dividing. In cells with few divisions,
the cells with the lowest CD44 expression were those with the highest velocity of
CD44 expression whereas, amongst cells that have experienced numerous divisions,
cells with the highest level of CD44 also had the highest velocity.
To compare the extent of up-regulation of CD44 expression between the divisions,
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Figure 8.5: (8.5a) represents the intrinsic average of CD44 upregulation as a function of division number
i. (8.5b) depicts the percentage of CD44 measured on the surface of cells having undergone i divisions. Accord-
ing to Materials and Methods in [10], the intensity of CD44 (MFI of CD44) was measured on the surface of T
cells for each mouse analysed (between three and five host mice were analysed at each day of the experiment),
and separated according to the number of divisions performed as assessed by CFSE labelling. Fig. (8.5b) is
drawn by calculating the average percentage of CD44 at division i, relative to the different mice analysed in
the experiment.
we show in Fig. 8.5a the intrinsic average velocity as a function to the division
number. We note that the average velocity stabilizes between the division 0 and
5. After division 5, it appears that this average velocity of CD44 plummets. Fur-
thermore, we show in Fig. 8.5b, the percentage of the average median fluorescence
intensity (MFI) of CD44 measured in each division. We remark that this percentage
of CD44 is 32% at division 5, which next is hugely increased at division 6-8 (62%,
78%, 92%). This validates the large increase in the average velocity after division
5 (Fig. 8.5a). Then, we conclude that the cells from the division 6, increase hugely
the CD44 expression on their surface (CD44+) (this is consistent with Figs. 8.2 and
8.3). Therefore, these cells are probably switching to memory phenotype [32, 89].
In Fig. 8.6, the number of cells that have changed their CD44 in Bi phase (solid
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Figure 8.6: Number of cells that have changed their CD44 expression (solid line) as a function of the
total cell number in Bi phase (dashed line) at day 7.
line) and the total number of cells in Bi phase (dashed line) are presented. We re-
mark that the number of cells being able to change their level of CD44 (solid line),
increases over division 0-4. Thereafter (i > 4), the total cell number in B-phase
(dashed line) decreases due to the limited cell number that can reach the maximum
division number (’8’) observed by the experimental data. This implies the decrease
of the number of cells that have changed their CD44.
Furthermore, the majority of cells changing their CD44 expression level is at the
number of divisions where the dashed and the solid line overlay each other. In
the series of first divisions (0-5), the number of cells that have changed their level
of CD44 (solid line), decreases according to the total cell number (dashed line) in
each division (i.e the difference between the solid line and the dashed line, becomes
thicker with respect to division number 0-5). Later on, it appears that the majority
of cells that enter B6,...,B8 phases, have a large capacity to modify their level of
CD44 with a maximum at division 7-8 (this is consistent with Fig. 8.3). Precisely,
54% of cells modifies their level of CD44 expression at division 5. In contrast, at
division 6-8, a large number of cells change their CD44 expression (80% for division
6 and 100% for divisions 7 and 8). Taken together Fig. 8.5a and Fig. 8.6, we
conclude that the majority of cells with a memory phenotype undergo a change in
their CD44 expression.
8.4 Discussion and Conclusion
T cell division depends on TCR signalling but results in distinct patterns of prolif-
eration and differences in development of effector function for many cells. Several
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studies have successfully used mathematical modelling to describe the proliferative
response of F5 and OT-1 T cells to lymphopenia ([7, 10]) and greatly facilitated
our understanding of the cell cycle control involved. Moreover, these studies have
not taken into account the concept of phenotype that characterizes the memory-
like phenotype during the homeostatic process. Indeed, the CD44 is an established
marker that identifies the transition of T cells from naive to memory phenotype
through LIP [18]. In this chapter, we use the mathematical model SMCD44 to bet-
ter understand the program of cell division through LIP of OT-1 T cells. A velocity
is introduced in SMCD44 model to describe the up-regulation of CD44 expression
during the T cell division. In general, the CD44 expression is approximately in-
creased on the surface of cells during B-phase before the mitosis is complete. Then,
this velocity can depend on the level of CD44 presented on the surface of cells and
the division number undergone by these cells.
An important modification in the manner of identifying T cells at a specific stage
of cell cycle (CFSE label with 7AAD) allows us to obtain information about the
intensity of CD44 on the surface of T cells in each division [10]. By applying this
new type of data on our model, we find that we can identify the velocity of CD44
expression. The fit of our model to the observed data of CD44 is simplified by using
the other parameters (∆, λ0, η) from the previous chapter 7. The identified velocity
(Fig. 8.4) allows to derive the average growth of CD44 (Fig. 8.5a), which indicates
the large increase in the intensity of CD44 after division 5.
Furthermore, this average velocity (Fig. 8.5a) and the frequency of cells that have
changed their CD44 expression profile with respect to the total number of cells
(Fig. 8.6), are the keys to explain the transition of cells from naive to memory
phenotype. However, these important keys enable us to deduce that the cells which
are the most likely switching to memory phenotype, are those that have divided 6
times or more. These numerical results are very close to the observations stated in
the introduction of this chapter. This means that the SMCD44 model gives a good
prediction of the number of divisions needed by the cells to acquire memory-like
phenotype. In conclusion, SMCD44 model not only provides some remarkably de-
scription of lymphopenia induced proliferation by T cells but also may be a new
path to better explain the complex relationship between LIP and naive to memory
transition.

Chapter 9
Identification of the recruitment
rate and the rate of division
9.1 Introduction
Despite great advances in immunological research during the last decades, relatively
little is known about the quantitative characteristics of lymphocyte population ki-
netics. For example in the literature, the rate of entry into the proliferative phase
and the division rate are considered to be independent of the level of CD44 on the
surface of cells. Otherwise, it is well known that the CD44 is not only a marker that
identifies the transition of cells from naive to memory phenotype, it also participates
in a wide variety of cellular functions including lymphocyte activation, recirculation
and homing. Hence, the proliferation and the division of T cells can depend on the
CD44 expression located on their surface (i.e. the resting cells enter the prolifer-
ative phase and divide according to their level of CD44). For these reasons, we
are interested in this chapter to connect the CD44 expression with the quantitative
characteristics (i.e. proliferation and division of T cell) of T cell population.
This chapter is divided in two sections. In the first one, we assume that the rate of
entry into division is dependent on the intensity of CD44 located on the surface of
cells. Then, we identify together this rate of entry into division and the velocity of
CD44. In the second one, we assume that the rate of division is dependent on the
intensity of CD44 and then we identify only this rate of division by using the other
estimated parameters from the previous Chapters 7 and 8 .
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9.2 Estimating the recruitment rate and the ve-
locity of CD44
As a consequence of the numerical results of the previous chapter, the cells which are
the most likely to switch to memory phenotype, are those that have divided 6 times
or more. This means that there exists a link between the naiveupslopememory cells (CD44
lowupslopehigh), and their number of divisions. Thus, by combining this interpretation
with the introduction of this chapter, one may assume that the recruitment rate
(λ) is dependent on the total population (N), on the CD44 expression (s) and on
the number of divisions (i) undergone by cells. Precisely, it can be expressed in the
following form
λi(s,N) = λi0(s)e
−ηN , ∀ s ∈ [0,m] and i ∈ NI . (9.1)
where λi0(s) can be described as the ability of cells to respond to an unlimited re-
source according to their level of CD44 (s) and their division number (i).
In what follows, we denote by SM
λi0
CD44, the model SMCD44 when we consider the
recruitment rate as the previous form (9.1).
In this section, we identify together the velocity of CD44 up-regulation (vi) and
the parameters (λi0(s)) by using the other parameters estimated and assumed (∆,
η, µ, A0,0(.)) in the previous chapter.
9.2.1 Parameter identification problem
The identification of the parameters λi0 and vi, ∀ i ∈ NI := {0, ..., I} together
consists in minimizing the following cost function
[P 1]
{
min
(v,λ0)∈K×K
∑
i∈NI
∑
s∈D
[
∆s
(∫ ∆
0
Bi(T, τ, s)dτ + Ai(T, s)
)
−N expi,s
]2
,
where the constant ∆s is the mesh size of the CD44 expression, Bi(T, τ, s) and
Ai(T, s) are given by SM
λi0
CD44 model, and {N expi,s } are the observed data at day
T = 7 described in Chapter 8. The parameters v = (v0, ..., vI) and λ0 = (λ
0
0, ..., λ
I
0)
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are defined in the space K = (C˜ u¯+)
I where
C˜ u¯+ = {u ∈ C0([0,m]), u(0) = 0, 0 ≤ u(s) 6 u¯ , ∀ s ∈]0,m]}.
In what follows in this section, we use the same strategy of the previous chapter 8.
9.2.2 The discrete parameter identification problem
The approximation of λ is
λi(s
k, N(tn)) := λi0,k f
n ∀ k = 0, ..., Ns, n = 0, ..., NT and i ∈ NI ,
where fn := e−ηN
n
.
The approximate problem of [P 1] is defined by
[P 1d ]
{
min
Θ∈KNs×KNs
J(Θ) := min
Θ∈KNs×KNs
∑
i∈NI
∑
k∈D
[
∆s
(
∆τ
Nτ∑
j=0
Bi,NTj,k + A
i,NT
k
)
−N expi,k
]2
,
where Θ := (vNs , λ0,Ns). The discrete vectors vNs and λ0,Ns are the set of unknown
parameters defined by vNs = (v0,Ns , ..., vI,Ns) and λ0,Ns = (λ
0
0,Ns
, ..., λI0,Ns), they
belong to the space KNs = (C˜
u¯,Ns
+ )
I where
C˜ u¯,Ns+ = {u(sk) = uk, u0 = 0, 0 < uk 6 u¯, k = 1, .., Ns}.
Now, we consider the following Lagrangian formulation of [P 1d ]
L1(W ) =
I∑
i=0
Ns∑
k=0
γkD
[
∆s
(
∆τ
Nτ∑
j=0
Bi,NTj,k + A
i,NT
k
)
−N expi,k
]2
(9.2)
+
NT∑
n=1
Ns∑
k=0
[
A0,nk −
A0,n−1k
1 + ∆tδA + ∆tλ00,kf
n
]
P 0,nk
+
I∑
i=1
NT∑
n=1
Ns∑
k=0
[
Ai,nk −
Ai,n−1k + 2∆t∆τ
∑Nτ
j=1 µ
j−1Bi−1,n−1j−1,k
1 + ∆tδA + ∆tλi0,kf
n
]
P i,nk
+
I∑
i=0
NT∑
n=1
Nτ∑
j=1
Ns∑
k=1
[
Bi,nj,k −
(1− ∆t
∆s
vki )B
i,n−1
j−1,k +
∆t
∆s
vk−1i B
i,n−1
j−1,k−1
1 + ∆tδB + ∆tµj
]
Qi,nj,k
+
I∑
i=0
NT∑
n=1
Ns∑
k=0
[
Bi,n0,k − λi0,kfn−1Ai,n−1k
]
Qi,n0,k,
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where the vector W = (W0, ...,WI), with Wi = (vi, λ
i
0, A
i, Bi, P i, Qi) for all i ∈ NI .
The variable (P i, Qi) corresponds to the dual variables. γkD is a function in the
following form
γkD :=

1 if k ∈ D,
0 else.
The first derivative of the Lagrangian with respect to Ai,nk and B
i,n
j,k gives us the
adjoint equations. For i = I, ..., 0; n = NT − 1, ..., 0; j = Nτ − 1, ..., 0 and k =
0, ..., Ns − 1, one has
Qi,nj,k =
(1−∆t
∆s
vki )Q
i,n+1
j+1,k+
∆t
∆s
vki Q
i,n+1
j+1,k+1
1+∆tδB+∆tµj+1
+ γi[0,I−1]
2∆t∆τµjP i+1,n+1k
1+∆tδA+∆tλ
i
0,kf
n+1λn+1
P i,nk =
P i,n+1k
1+∆tδA+∆tλ
i
0,kf
n+1 + λ
i
0,kf
nQi,n+10,k
Qi,NTj,k = 2γ
k
D∆s∆τ
[
N expi,k −∆sAi,NTk −∆s∆τ
∑Nτ
j=0B
i,NT
j,k
]
P i,NTk = 2γ
k
D∆s
[
N expi,k −∆sAi,NTk −∆s∆τ
∑Nτ
j=0B
i,NT
j,k
]
Qi,nNτ ,k = Q
i,n
j,Ns
= 0
(9.3)
where [0, I − 1] := {0, ..., I − 1}.
The first derivative of the Lagrangian (9.2) with respect to vk0i0 and λ
i0
0,k0
are
∀ i0 ∈ NI
∂L
∂vk0i0
=
NT∑
n=1
Nτ∑
j=1
∆t
∆s
Bi0,n−1j−1,k0
[
Qi0,nj,k0 −Qi0,nj,k0+1
]
1 + ∆tδB + ∆tµj−1
, ∀ k0 = 0, ..., Ns − 1,
∂L
∂vNsi0
=
NT∑
n=1
Nτ∑
j=1
∆t
∆s
Bi0,n−1j−1,NsQ
i0,n
j,Ns
1 + ∆tδB + ∆tµj−1
,
and ∀ k0 = 0, ..., Ns − 1
∂L
λi00,k0
=
NT∑
n=1
[
∆tfn
(
Ai0,n−1k0 + 2∆t∆τ
∑Nτ
j=1 µ
j−1Bi0−1,n−1j−1,k0(
1 + ∆tδA + ∆tλ
i0
0,k0
fn
)2
)
P i0,nk0 − fn−1Ai0,n−1k0 Qi0,n0,k0
]
.
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where Bi−l := 0 if l > i.
9.2.3 Numerical results
In this subsection, we present the numerical results of the identified parameters (vi
and λi0) by using the same algorithm 8.2.1.1 of the previous chapter. The division
rate (µ) and the initial conditions (A0,0) are given in 8.4 and 8.5 respectively. Also,
the mortalities, δA and δB are considered zeros because no death was observed in
the experimental data [10]. In addition, we use the parameters (∆, η) estimated in
Chapter 7.
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Figure 9.1: The velocity estimated (vertical axis) as a function of the observed intensity of CD44 (the
weight of CD44 expression on the surface of cells) in each division (i) by using SM
λi0
CD44 model.
Figs. 9.1 and 9.2 show the numerical results of the identified parameters (vi and
λi0) through the SM
λi0
CD44 model. It seems that the velocity of CD44 (Fig. 9.1) is
slightly changed, with respect to what has been identified in the previous chapter
(Fig. 8.4). In addition, we remark in each subfigure of Fig. 9.2 that the peaks
are shifted to higher intensity of CD44 when the division number increases. This is
consistent with Fig. 9.1.
In Fig. 9.3a, we present the average velocity of CD44 estimated by using SMCD44
model (dashed line) and SM
λi0
CD44 model (solid line). The average velocity (solid line)
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Figure 9.2: The parameters λi0 estimated by using SM
λi0
CD44 model. The vertical axis depicts λ
i
0 as a
function of the observed intensity of CD44( horizontal axis) in each division (i).
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Figure 9.3: Fig. 9.3a (solid line) represents the average velocity estimated as a function of division
number (i) through SM
λi0
CD44 model. The dashed line in this figure is reproduced from Fig. 8.5a in order to
evaluate the difference between the average velocities estimated by using SM
λi0
CD44 and SMCD44 models. Fig.
9.3b depicts the average rate of entry into division at day 7 versus the division number (i). The variations of
the average velocity in Fig. 9.3a allow to conclude the naive and memory zones (Fig. 9.3b) according to the
number of divisions undergone by cells.
related to SM
λi0
CD44, slightly increases in the first divisions (division 0 to 5), and the
other one (dashed line) related to SMCD44 model stabilizes in the first divisions.
Therefore, the up-regulation of CD44 in the first divisions, is more significant by
taking into account the CD44 expression and the division number in the rate of
entry into division. Next (from division 6), it appears that these average velocities
of CD44 (dashed and solid lines) plummet. This means that the cells change slightly
their level of CD44 in the first divisions, that is why it can be qualified as naive. In
addition, these cells transits to a memory phenotype when they undergo more than
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6 divisions.
In Fig. 9.3b, the average rate of entry into division at day 7 is presented. We remark
that the cells having undergone few divisions, enter the proliferative phase with a
slow rate, but this rate is higher when the cells undergo more than six divisions.
Taken together the subfigures in Fig. 9.3, we deduce that the naive T cells undergo
cell divisions with a slow rate, while the others memory cells undergo more rapid
divisions.
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Figure 9.4: The vertical axis represent the total number of cells Ni(T, s) :=(
∆s
∫∆
0
Bi(T, τ, s)ds+ ∆sAi(T, s)
)
versus the intensity of CD44 (i.e. normalised median fluorescence
intensity (MFI) of CD44) in each division (i). Here, Ai and Bi is the solution related to SM
λi0
CD44 model. The
solid line depicts the predictions of the model and the bar depicts the observed data. Note that the horizontal
axis is zoomed in each subfigure in order to improve the illustration clarity.
Finally, we present in Fig. 9.4 the fit of SM
λi0
CD44 model to the observed OT-1
T cell. As the explanation of Fig. 8.2, the highest peaks predicted by SM
λi0
CD44
model where there was no experimental data to support them, return implicitly to
those of the previous divisions where they have been observed in some panel by
the experimental data. Taken together Figs. 8.2 and 9.4, we remark that SMCD44
model fits the experimental data better than SM
λi0
CD44 model.
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9.3 Estimating the rate of division
In lymphopenia conditions, naive T cells undergo cell divisions, accompanied with a
change in the cell surface phenotype, including increased CD44 expression. Further-
more, an important functional of the up-regulation of CD44 is the differentiation
and proliferation of cells. Therefore, there exists a link between the cell division
and their CD44 expression. To explore this link, we suppose in this section that the
cells divide according to their level of CD44 and their age in the proliferative phase
(B-phase). Then, we assume the division rate (µ) in the following form
µ(τ, s) =

a(τ)
b(τ)+e−c(τ)s if
∆
2
6 τ 6 ∆, s ∈ [0,m],
0 else.
(9.4)
where a(.), b(.) and c(.) are functions that depend on the age τ . We denote by
SMµCD44 , the model SMCD44 when we consider the division rate (µ) as the previous
form (9.4).
In this section, we identify the division rate µ by using the other parameters (∆,
λ0, η, A0,0(.)) estimated and assumed in Chapter 7. Note that in this section, we
fix the parameters (vi) (by using the estimated parameters (Fig. 8.4) in Chapter
8) in order to prevent the compensations of CD44 between the velocity (vi(s)) and
the division rate µ(τ, s) when they are estimated together.
9.3.1 Parameter identification problem.
To identify the division rate µ, we estimate the coefficients a(.), b(.) and c(.). The
same strategy of the previous section and previous chapter can be used to estimate
the above coefficients. Thus, we want to minimize the following cost function
[P 2]
{
min
(a,b,c)∈(C+)3
∑
i∈NI
∑
s∈D
[
∆s
(∫ ∆
0
Bi(T, τ, s)dτ + Ai(T, s)
)
−N expi,s
]2
.
where the constant ∆s is the mesh size of the CD44 expression, Bi(T, τ, s), Ai(T, s)
are given by SMµCD44 model and {N expi,s } are the observed data at day 7. The
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parameters a, b and c are defined in the space C+ where
C+ := {u ∈ C0([0,∆]), 0 ≤ u(τ) ≤ u¯, ∀ u ∈ [0,∆]}. (9.5)
We define the approximation of µ by
µ(τ j, sk) =

aj
bj+e−cj k
for j = Nτ
2
, ..., Nτ and k = 0, ..., Ns,
0 else.
The discrete parameter identification problem of [P 2] is
[P 2d ]
{
min
ω∈(CNτ+ )3
J˜(ω) := min
ω∈(CNτ+ )3
∑
i∈NI
∑
k∈D
[
∆s
(
∆τ
Nτ∑
j=0
Bi,NTj,k + A
i,NT
k
)
−N expi,k
]2
.
where ω = (aNτ , bNτ , cNτ ). The discrete vectors aNτ , bNτ and cNτ are the set of
unknown parameters, they belong to the space CNτ+ where
CNτ+ = {u(τ j) = uj, 0 6 uj 6 u¯, j = 0, .., Nτ}.
As the previous section, a similar calculus gives us the ingredients (Lagrangian
formulation, adjoint equations and the gradient of the cost function) that we needed
to apply our algorithm 8.2.1.1.
Table 9.1: Best-fit parameter estimations for SMSMµCD44
model.
age (h) parameters a(τ) b(τ) c(τ)
τ = ∆
2
1.1921E-007 1.5162 1.0000E-004
τ = 3∆
5
5.0664E-007 1.5046 1.0000E-004
τ = 7∆
10
1.0000E-006 1.5192 1.0000E-004
τ = 4∆
5
0.0037 1.1815 1.0000E-004
τ = 9∆
10
1.5544 0.5583 8.3440E-005
τ = ∆ 1.8285 1.8248 1.4445
∆ is the duration of the proliferative phase (B-phase). From Chapter 7, the parameter value ∆ has been estimated by
7.17 hours. In this table, we present the estimated parameters (a, b, c) for different age points between ∆2 and ∆.
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9.3.2 Numerical results
In this subsection, we present the numerical results of the identified parameters
(a, b, c) by using the others parameters (λ0, η,∆, A0,0, vi) from Chapters 7 and 8.
The mortalities, δA and δB are considered zeros because no death was observed in
the experiment of Hogan et al. [10].
In Table 9.1, we show the identified parameters for different age points. Fig. 9.5
is devoted to present the division rate (µ) according to the intensity of CD44 in
different age points. We remark in Fig. 9.5 that the division rate is negligible when
Intensity of CD44 (s)
D
iv
isi
on
 r
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e 
(µ)
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x 10−8 τ =0.5* ∆
0 0.5 1 1.5 2
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2.024
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x 10−7 τ =0.6* ∆
0 0.5 1 1.5 2
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Figure 9.5: Division rate as a function of the intensity of CD44 in different age points.
the age of cells in B-phase is below to 4∆
5
(hour), and becomes more important when
their age is near to ∆. In addition, the division rate at age less than ∆, is slightly
large when the cells have more CD44 expression on their surface, but at age ∆, the
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cells are compelled to divide independently of their level of CD44 because ∆ is the
maximum age in the proliferative phase (B-phase).
Furthermore, the figure that depicts the comparison of observed and SMµCD44 model-
predicted OT-1 T cells, is omitted in this section because it is approximatively the
same as in Fig. 8.2. Therefore, the prediction of SMCD44 model is similar to this
of SMµCD44 model, but this latter (i.e SM
µ
CD44 model) provides more details about
the link between the division rate and the CD44 expression.
9.4 Discussion and Conclusion
The number of T lymphocytes in the body is under homeostatic control. At equi-
librium, the majority of naive T cells are non-dividing and express low levels of the
surface protein CD44. In contrast, lymphopenia induces naive T cells to undergo cell
divisions that depend on TCR signaling [18]. Interestingly, lymphopenia-induced
homeostatic proliferation can also be associated with acquisition of a memory phe-
notype, and such cells share both functional and molecular characteristics of con-
ventional memory cells [102, 103]. The CD44 antigen plays an important role in
lymphopenia induced proliferation. It is a multistructural and multifunctional cell
surface molecule involved in cell proliferation, cell differentiation and cell migration
from naive to memory phenotype. These biological properties are an important
motivation to explore the link between the different multifunctions of CD44 using
a mathematical model like the SMCD44 model. In this chapter, we have addressed
the question, how the dynamic of CD44 expression can be linked to the prolifer-
ation, division and migration of cells. In the first section 9.2, a recruitment rate
(λi(s,N(t))) which depends on the CD44 expression, division number and the total
cell number, is considered in SMCD44 model. By using CFSE data with CD44 (see
[10] or Chapter 6), we estimate together the rate of entry into division and the
velocity of CD44 up-regulation. The numerical results show that the rate of entry
into division by the naive cells is much less than that of memory cells. Therefore,
this interpretation represents the relationship between the cell proliferation and mi-
gration from naive (CD44 low) to memory (CD44 high) phenotype. In the second
section 9.3, we estimate the division rate (µ) which depends on the CD44 expression
and the maturity of cells in the proliferative phase. This estimate allows to deduce
that the cells having an important CD44 expression on their surface, have also a
large possibility to divide when their ages are near to ∆. In contrast at age ∆, these
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cells divide independently of their level of CD44.
In conclusion, this chapter gives some interpretations about the link between the
multifunctional of CD44 through different mathematical models (SM
λi0
CD44 and SM
µ
CD44
models). In fact, a question remains in this study which is determination of the best
model among the SMCD44, SM
λi0
CD44 and SM
µ
CD44 models. Indeed, the comparison
between the different models needs supplementary data in order to apply a cross
validation approach as in Chapter 7.
Part IV
Models of T Cell Homeostasis in
Vivo: Mathematical analysis and
Optimal Control
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Chapter 10
Well-posedness of a model of T
cell homeostasis in vivo
10.1 Introduction
The size and composition of the T lymphocyte compartment is subject to strict
homeostatic regulation and is remarkably stable throughout life, despite variable
dynamics in cell production and death during T cell development and immune re-
sponses [40, 104]. Homeostasis is achieved by careful orchestration of lymphocyte
survival and cell division. T cells that have yet to encounter the antigen they recog-
nise are termed naive as they have not been activated to respond. In normal case,
the majority of naive T cells are non dividing and express low level of the surface
phenotype (CD44 low). Under such conditions of T cell deficiency (eg. AIDS),
naive T cells undergo cell division, termed homeostasic proliferation or lymphope-
nia induced proliferation (LIP). This regularization process can also be associated
with acquisition of a memory phenotype (CD44 hight), and such cells share both
functional and molecular characteristics of conventional memory cells [102, 103]. In
vivo, the homeostatic cell division plays a more important role in maintaining naive
T cell homeostasis in humans, even in replete conditions, as cell division is evident
in the naive pool [44, 105], whereas recent thymic emigrants and naive T cells from
cord blood have an enhanced ability to divide in response to IL-7 (Interleukin 7)
signaling [106, 107].
In this context, a standard realistic mathematical model for analysing the kinetics
of the cell cycle in vitro is proposed by Smith and Martin [69]. As it is described
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in the previous chapters, this model consists to separate the phase of the cell cycle
into two phases. Cells in the resting phase (G0, G1) are in the so-called A-state and
B-phase is the state where the cells are in a proliferative phase (S, G2, M). B-phase
has a fixed duration (∆). Cells involve a stochastic recruitment from A-state into
B-phase. After completing the ’deterministic’ B-phase a cell delivers two daughter
cells in the ’stochastic’ A-state from which the cells can be recruited for another
round of division.
Most of the earlier work on modelling the dynamics of T cell has been done with
models resembling the Smith and Martin model with an explicit time delay for the
proliferative phases of the cell cycle [3, 4, 6, 51, 70, 78]. Specially, Bernard et al.
[3], Yates et al. [7] and Hogan et al. [10] have formulated this model in terms of
partial differential equations in order to take into account the continuous age of
cells in the proliferative phase. Next, Ayoub et al [80] (or see Part II and III)
have improved this new version of Smith-Martin model by including a new criteria
(CD44 expression) that represents the transition of T cells from naive to memory
phenotype during the homoeostatic mechanism in vitro (noted SMCD44 model). In
this chapter, we extend the SMCD44 model to an in vivo model by implementing a
rate Λ of export of cells from the thymus (Fig. 10.1). In addition, we consider a
large number of division (I >> 0) in the extended model with a rate of entry into
division depending on the number of division (i) and the total cell number (N).
10.2 The model
The model with an export (Λ) of cells from the thymus is
dA0(t, s)
dt
= Λ− δAA0(t, s)− λ0(N)A0(t, s),

for i ∈ N∗
dAi(t, s)
dt
= 2
∫ ∆
0
µ(τ)Bi−1(t, τ, s) dτ − δAAi(t, s)− λi(N)Ai(t, s),

for i ∈ N
∂
∂t
Bi(t, τ, s) +
∂
∂τ
Bi(t, τ, s) +
∂
∂s
[vi(s)Bi(t, τ, s)] = − (δB + µ(τ))Bi(t, τ, s),
(10.1)
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Figure 10.1: Dynamic of T cells in vivo during the homoeostatic process. Ai and Bi are the number
of T cells, having undergone i divisions in A phase and B phase respectively. Λ is the rate of export of cells
from the thymus. ∆ is the duration of B phase. The rate of entry into division (λi) is described by a function
of the total cell number (N) and division number i, which is linked to all phases and all divisions [10]. µ(τ)
represents the rate of cells which are divided at age τ and have given rise to two daughter cells in the resting
phase [80].
for all s ∈ [0,m] and τ ∈ [0,∆], where m is the maximum intensity of CD44. The
total number of cells is defined by
N := N(t) =
∑
i∈N
(∫ ∆
0
∫ m
0
Bi(t, τ, s)ds dτ +
∫ m
0
Ai(t, s)ds
)
. (10.2)
System (10.1) includes natural mortality rates δA and δB of cells in A-state and
B-phase respectively. Function, µ(τ), denotes the rate of cells which divided at age
τ and have given rise to two daughter cells in the resting phase.
The up-regulation of the CD44 expression on the surface of T cells is represented
in (10.1) by a velocity vi in each division that depends on variable s.
The recruitment rate from A-state into B-phase is denoted by λi. It depends on the
total number of cells N := N(t) and the number of division (i) undergone by cells.
Remark 10.1. According to Yates et al. [7] and Hogan et al [10], T cells can undergo
a finite number of division (I) (8 or 9 division with CFSE labelling). We assume a
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recruitment rate from A-state into B-phase, for all i ∈ N
λi(N) =

λ(N) if i ∈ NI−1 := {0, ..., I − 1}
0 else.
where N := N(t). Therefore, there are no cells after AI phase (i.e Ith division in
A-state).
Boundary conditions and initial conditions of Eqs. (10.1) are defined by, ∀ i ∈ N,
Bi(t, 0, s) = λ
i(N)Ai(t, s),
vi(0)Bi(t, τ, 0) = 0,

A0(0, s) = A0,0(s) > 0,
Bi∈N(0, τ, s) = 0 and Ai∈N∗(0, s) = 0.
(10.3)
The structure of this chapter is organized as follows. At first, Sec. 10.3 is devoted
to derive the integral formulation of System (10.1-10.3). Next, we prove in Sec. 10.4
the local existence and uniqueness of the solution of System (10.1-10.3) by using
the fixed point method. Finally in Sec. 10.5, we conclude the global existence by
using the maximal interval of existence.
10.3 Integral formulation
In this section, we are looking for the well-posedness of the mathematical model
(10.1-10.3). We first state some notion of solution.
Let L1((0,∆), (0,m);Rn) be the Banach space of equivalence classes of Lebesgue
integrable functions, from (0,∆)× (0,m) in Rn with norm:
‖u‖L1((0,∆)×(0,m)) =
∫ ∆
0
∫ m
0
|u(τ, s)|dτds.
Let T > 0. We define two spaces LT and HT respectively by setting
LT := L
∞(0, T, L1((0,∆)× (0,m)))
= {u(t, ., .) ∈ L1((0,∆)× (0,m)) , sup
06t6T
‖u(t, ., .)‖L1((0,∆)×(0,m)) < +∞},
HT := L
∞(0, T, L1((0,m))) = {q(t, .) ∈ L1((0,m)) , sup
06t6T
‖q(t, .)‖L1((0,m)) < +∞}.
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By using Lagrange method and Remark. 10.1, one obtains an implicit solution of
Ai
A0(t, s) = A0,0(s) e
− ∫ t0 (δA+λ(N(u)))du + Λ
∫ t
0
e−
∫ t
r (δA+λ(N(q)))dqdr,
for i ∈ N∗I , Ai(t, s) = 2
∫ t
0
∫ ∆
0
e
−
∫ t
r
(δA + λ
i(N(q)))dq
µ(τ)Bi−1(r, τ, s)dτ dr,
for i > I Ai(t, s) ≡ 0. (10.4)
Now, we consider the following differential equations:
ds1i (t)
dt
= vi(s
1
i (t))
s1i (t0) = s
1
i,0 > 0
,

ds2i (τ)
dτ
= vi(s
2
i (τ))
s2i (τ0) = s
2
i,0 > 0.
(10.5)
where s1i (t; t0; s
1
i,0) and s
2
i (τ ; τ0; s
2
i,0) are the curves witch goes through (t0, s
1
i,0) and
(τ0, s
2
i,0) respectively. The curves, Z
1
i (t) := s
1
i (t; 0; 0) and Z
2
i (τ) := s
2
i (τ ; 0; 0) are the
characteristic through the origin. The solution of (10.5) is given by the following
equations
s1i (t) = s
1
i,0 +
∫ t
t0
vi(s
1
i (z))dz, s
2
i (τ) = s
2
i,0 +
∫ τ
τ0
vi(s
2
i (r))dr.
Using Remark 10.1 and integrating along the characteristic curve the PDE of System
(10.1), one obtains
Bi∈NI−1(t, τ, s) =

0 t ≤ τ, Z1i (t) < s
λ(N(t−τ))Ai(t−τ,ζi) vi(ζi)
vi(s)
f(τ) 0 ≤ τ < t, Z2i (τ) < s
0 Z1i (t) > s, Z2i (τ) > s
Bi>I(t, τ, s) ≡ 0
(10.6)
where ζi := s− Z2i (τ) and f(τ) := e−
∫ τ
0 (δB+µ(r))dr.
Definition 10.2. For all T > 0. (Ai, Bi) is called a global solution of (10.1-10.3)
(in the sense of the expressions (10.4) and (10.6)), if it belongs to L∞(0, T, L1(0,m))
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and L∞(0, T, L1((0,∆) × (0,m))) respectively and it satisfies System (10.4)-(10.6)
respectively.
10.4 Local existence and uniqueness of solution
In this section we shall discuss the local existence of the solution of System (10.4)-
(10.6) and we will make use the following assumption.
Assumption 10.4.1.
- Natural mortalities δA and δB are non-negative constants.
- Rate of export of cells from the thymus Λ is non-negative constant.
- Function µ(.) is bounded, non-negative and satisfies the following inequality
0 ≤ µ ≤ µ(τ) ≤ µ¯, ∀ τ ∈ (0,∆).
- Function λ(N) is non-negative, bounded and Lipschitz continuous with constant
k
|λ(N)− λ(N∗)| 6 k|N −N∗|, N > 0, N∗ > 0.
- The velocity vi is bounded, non-negative for all i ∈ NI−1, satisfies the condition
vi(0) = 0, and 0 < vi ≤ vi(s) ≤ v¯i, ∀s ∈]0,m],
and continuously differentiable with respect to the variable s. In addition, there
exists a positive constant dvi such that
|∂vi
∂s
| 6 dvi , ∀ s ∈ [0,m].
- Initial condition A0,0(.) are non-negative and belongs to the space L
1
+((0,m)).
Remark 10.3.
The integral formulation (10.6) rewrites as
Bi(t, τ, s) = λ(N(t−τ))Ai(t−τ, ζi) f(τ) e−
∫ s
ζi
∂vi(σ)
∂σ
1
vi(σ)
dσ
, ∀ 0 ≤ τ < t and Z2i (τ) < s.
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for all i ∈ NI−1 := {0, ..., I − 1}. Using (10.6) and Assumption 10.4.1, one obtains
‖Bi(t, ., .)‖L1((0,∆)×(0,m)) ≤
∫ t
0
∫ m
Z2i (τ)
λ(N(t− τ))|Ai(t− τ, s− Z2i (τ))|e
dviZ
2
i (τ)
vi ds dτ.
Using Z2i (τ) :=
∫ τ
0
vi(s
2
i (r))dr, one deduces the following estimate
‖Bi(t, ., .)‖L1((0,∆)×(0,m)) ≤
∫ t
0
∫ m
Z2i (τ)
λ(N(t− τ))|Ai(t− τ, s− Z2i (τ))|eCvi τds dτ,
(10.7)
where Cvi :=
dvi v¯i
vi
.
In what follows in this section, we shall use the following convention
i∑
j
= 0,
i∏
j
= 1 and ‖.‖i−j∞ = 1 if j > i.
Before studying local existence of a solution, we give the following preliminary
results.
Lemma 10.4. Let Assumption 10.4.1 be satisfied. For T > 0 and t ∈ [0, T ], any
solution ((A0, B0), ..., (AI−1, BI−1), AI) of (10.4)-(10.6) in the sense of Definition
10.2, satisfies ∀ i ∈ NI
‖Ai‖HT 6
2iµ¯i‖λ‖i∞RA0
δiA
(∏i−1
j=0 Cvj
) (1− e−δAT )i [i−1∏
j=0
(
eCvjT − 1)] := RAi , (10.8)
and ∀ i ∈ NI−1,
‖Bi‖LT 6
2iµ¯i‖λ‖i+1∞ RA0
δiA
(∏i
j=0Cvj
) (1− e−δAT )i [ i∏
j=0
(
eCvjT − 1)] := RBi . (10.9)
where RA0 = e
−δAT‖A0,0‖L1((0,m)) + ΛδA
(
1− e−δAT ).
Proof. We proceed by induction.
For i = 0
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Let T > 0 and t ∈ [0, T ]. By using (10.4), let us integrate A0 from 0 to m
‖A0(t, .)‖L1((0,m)) =
∫ m
0
[
|A0,0(s)| e−
∫ t
0 (δA+λ(N(u)))du + Λ
∫ t
0
e−
∫ t
r (δA+λ(N(u)))dudr
]
ds
6 e−δAt‖A0,0‖L1((0,m)) + Λ
δA
(1− e−δAt),
that implies ‖A0‖HT 6 RA0 . Using (10.7), one has
‖B0(t, ., .)‖L1((0,∆)×(0,m)) ≤
∫ t
0
∫ m
Z20 (τ)
λ(N(t− τ))|A0(t− τ, ζ0)| eCv0τds dτ
≤
∫ t
0
∫ m
Z20 (τ)
λ(N(t− τ))|A0(t− τ, s− Z20(τ))| eCv0τds dτ.
Performing the change of variables σ = s− Z20(τ) and a = t− τ , one obtains
‖B0(t, ., .)‖L1((0,∆)×(0,m)) ≤
∫ t
0
∫ m
0
λ(N(a))|A0(a, σ)| eCv0 (t−a)dσ da,
and one gets
‖B0‖LT ≤
‖λ‖∞
Cv0
(
eCv0T − 1) ‖A0‖HT ,
that implies ‖B0‖LT ≤ ‖λ‖∞RA0Cv0
(
eCv0T − 1). Then, inequalities (10.8) and (10.9)
hold for i = 0.
For i ∈ N∗I−1
Assuming that inequalities (10.8) and (10.9) hold for i, let us show they still hold
for i+ 1. Integrating Ai+1 over (0, m), one has
‖Ai+1(t, .)‖L1((0,m)) 6 2µ¯
∫ m
0
∫ t
0
∫ ∆
0
e
−
∫ t
r
(δA + λ
i(N(q)))dq
|Bi(r, τ, s)|dτ dr ds.
Inequality (10.9) holds for i. Therefore, by using Fubini’s theorem, one can write
‖Ai+1‖HT 6
2µ¯
δA
(
1− e−δAT ) ‖Bi‖LT (10.10)
6 2
i+1µ¯i+1‖λ‖i+1∞ RA0
δi+1A
(∏i
j=0 Cvj
) (1− e−δAT )i+1 [ i∏
j=0
(
eCvjT − 1)] .
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Now, let us integrate the solution Bi+1 along the characteristic. Then one finds
‖Bi+1‖LT 6
‖λ‖∞
Cvi+1
(
eCvi+1T − 1) ‖Ai+1‖HT .
By using the inequality in (10.10), one eventually gets
‖Bi+1‖LT 6
2i+1µ¯i+1‖λ‖i+2∞ RA0
δi+1A
(∏i+1
j=0Cvj
) (1− e−δAT )i+1 [i+1∏
j=0
(
eCvjT − 1)] .
Then, inequalities (10.8) and (10.9) holds for i + 1. Finally, the proof of (10.8) for
I is rather straightforward by using (10.9) for I − 1.
Notation (Ai, Bi;A0,0) stands for a solution (Ai, Bi) with initial condition A0,0.
Lemma 10.5. Let Assumption (10.4.1) be satisfied. Let T > 0 and t ∈ [0, T ]. For
any two solutions (Ai, Bi;A0,0) and (A
∗
i , B
∗
i ;A
∗
0,0) of (10.4)-(10.6) in the sense of
Definition 10.2, the following set of inequalities hold ∀ i ∈ NI−1,
‖Ai − A∗i ‖HT ≤ αie−δAT‖A0,0 − A∗0,0‖L1((0,m)) + kβiA sup
06t6T
|N(t)−N∗(t)|,
‖Bi −B∗i ‖LT ≤
αi‖λ‖∞
(
eCviT − 1)
Cvi
e−δAT‖A0,0 − A∗0,0‖L1((0,m)) + kβiB sup
06t6T
|N(t)−N∗(t)|,
and
‖AI − A∗I‖HT ≤ αIe−δAT‖A0,0 − A∗0,0‖L1((0,m)) + 2µ¯kβI−1B
(
1− e−δAT )
δA
sup
06t6T
|N(t)−N∗(t)|,
where
αi =
[
2µ¯
(
1− e−δAT )
δA
]i
‖λ‖i−1∞
i−1∏
j=0
eCvjT − 1
Cvj
,
βiA =
i−1∑
j=0
[
2µ¯
(
1− e−δAT )
δA
]i−j
‖λ‖i−j−1∞
[
i−1∏
k=j+1
(
eCvkT − 1)
Cvk
](
RA∗j
(
eCv0T − 1)
Cv0
+ TRBj
)
+
[
2µ¯‖λ‖∞
(
1− e−δAT )
δA
]i [i−1∏
j=0
(
eCvjT − 1)
Cvj
]
L, (10.11)
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with L = T
(
e−δAT‖A0,0‖L1((0,m)) + ΛδA
(
1− e−δAT )), and
βiB =
i−1∑
j=0
[
2µ¯‖λ‖∞
(
1− e−δAT )
δA
]i−j [ i∏
k=j+1
(
eCvkT − 1)
Cvk
]
TRBj
+
i∑
j=0
[
2µ¯‖λ‖∞
(
1− e−δAT )
δA
]i−j [ i∏
k=j
(
eCvkT − 1)
Cvk
]
RA∗j
+‖λ‖∞
[
2µ¯‖λ‖∞
(
1− e−δAT )
δA
]i [ i∏
j=0
(
eCvjT − 1)
Cvj
]
L. (10.12)
RAi and RBi are given in the previous Lemma 10.4.
Proof. As in the previous proof, we proceed by induction.
For i = 0
Let us integrate the difference between A0 and A
∗
0 over (0,m)
‖A0(t, .)− A∗0(t, .)‖L1((0,m)) 6 e−δAt
∫ m
0
|A∗0,0(s)||e−
∫ t
0 λ(N(u))du − e−
∫ t
0 λ(N
∗(u))du| ds
+e−δAt
∫ m
0
|A0,0(s)− A∗0,0(s)|e−
∫ t
0 λ(N(u))du ds
+
∫ t
0
Λe−(t−r)δA|e−
∫ t
r λ(N(u))du − e−
∫ t
r λ(N
∗(u))du|dr.
Note that function x −→ e−x is Lipschitz continuous on [0,+∞) with constant 1.
Then by using Assumption (10.4.1), one obtains
‖A0 − A∗0‖HT 6 e−δAT‖A0,0 − A∗0,0‖L1((0,m))
+kT
[
e−δAT‖A∗0,0‖L1((0,m)) +
Λ
δA
(
1− e−δAT )] sup
06t6T
|N(t)−N∗(t)|.
On the other hand, integrating the difference between B0 and B
∗
0 on (0,∆)× (0,m)
one finds
‖B0(t, ., .) − B∗0(t, ., .)‖L1((0,∆)×(0,m))
6
∫ t
0
∫ m
Z20 (τ)
eCv0τ
[
λ(N(t− τ)) |A0(t− τ, ζ0)− A∗0(t− τ, ζ0)|
+|λ(N(t− τ))− λ(N∗(t− τ))| |A∗0(t− τ, ζ0)|
]
ds dτ.
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By using Lemma 10.4 and Assumption (10.4.1), one gets
‖B0 −B∗0‖LT 6 ‖λ‖∞
(
eCv0T − 1)
Cv0
e−δAT‖A0,0 − A∗0,0‖L1((0,m))
+k
(
eCv0T − 1)
Cv0
(‖λ‖∞L+RA∗0) sup
06t6T
|N(t)−N∗(t)|.
Then, the inequalities in the statement of Lemma 10.5 are satisfied for i = 0.
For i ∈ N∗I−1
Assuming that the inequalities in the statement of Lemma 10.5 hold for i. Let
us show they still hold for i+1.
‖Ai+1(t, .) − A∗i+1(t, .)‖L1((0,m))
6 2µ¯
∫ m
0
∫ t
0
∫ ∆
0
e−δA(t−r)
[
|e−
∫ t
r λ(N(q))dq − e−
∫ t
r λ(N
∗(q))dq| |Bi(r, τ, s)|
+e−
∫ t
r λ(N
∗(q))dq |Bi(r, τ, s)−B∗i (r, τ, s)|
]
dτ dr ds.
Therefore
‖Ai+1 − A¯i+1‖HT 6 2µ¯
(
1− e−δAT )
δA
‖Bi −B∗i ‖LT
+2µ¯kTRBi
(
1− e−δAT )
δA
sup
06t6T
|N(t)−N∗(t)|.
By recalling Lemma 10.4, one obtains
‖Ai+1 − A¯i+1‖HT 6 αi+1e−δAT‖A0,0 − A∗0,0‖L1((0,m)) + kβi+1A sup
06t6T
|N(t)−N∗(t)|,
where αi+1 and βi+1A are given in the statement of lemma 10.5.
Also, one has
‖Bi+1(t, ., .) − B∗i+1(t, ., .)‖L1((0,∆)×(0,m))
6
∫ t
0
∫ m
Z2i+1(τ)
eCvi+1τ
[|λ(N(t− τ))| |Ai+1(t− τ, ζi+1)− A∗i+1(t− τ, ζi+1)|
+|λ(N(t− τ))− λ(N∗(t− τ))| |A∗i+1(t− τ, ζi+1)|
]
ds dτ.
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Furthermore
‖Bi+1 −B∗i+1‖LT 6 ‖λ‖∞
(
eCvi+1T − 1)
Cvi+1
e−δAT‖A0,0 − A∗0,0‖L1((0,m))
+k
(
eCvi+1T − 1)
Cvi+1
(
‖λ‖∞L+RA∗i+1
)
sup
06t6T
|N(t)−N∗(t)|.
Finally, using Lemma 10.4
‖Bi+1 −B∗i+1‖LT 6
αi+1‖λ‖∞
(
eCvi+1T − 1)
Cvi+1
e−δAT‖A0,0 − A∗0,0‖L1((0,m))
+kβi+1B sup
06t6T
|N(t)−N∗(t)|,
This ends the proof of the Lemma 10.5.
Now, we will state the main result of this section.
Theorem 10.6. Under Assumption 10.4.1, System (10.4)-(10.6) admits a unique
local solution in [0, T ∗].
Proof. We set up a fixed point method.
At first, define an operator
∧
: ((A0, B0), ..., (AI−1, BI−1), AI) 7−→
(
(Aˆ0, Bˆ0), ..., (AˆI−1, BˆI−1), AˆI
)
wherein
Aˆ0(t, s) = A0,0(s) e
− ∫ t0 (δA+λ(N(u)))du + Λ
∫ t
0
e−
∫ t
r (δA+λ(N(q)))dqdr,
Aˆi∈N∗I (t, s) = 2
∫ t
0
∫ ∆
0
e
−
∫ t
r
(δA + λ(N(q)))dq
µ(τ)Bˆi−1(r, τ, s)dτ dr,
Bˆi∈NI−1(t, τ, s) =

0 t ≤ τ, Z1i (t) < s
λ(N(t−τ)) Aˆi(t−τ,ζi) vi(ζi)
vi(s)
f(τ) 0 ≤ τ < t, Z2i (τ) < s
0 Z1i (t) > s, Z2i (τ) > s
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where ζi := s− Z2i (τ) and f(τ) := e−
∫ τ
0 (δB+µ(r))dr, and
N(t) =
(
I∑
i=0
∫ m
0
Ai(t, s)ds
)
+
(
I−1∑
i=0
∫ ∆
0
∫ m
0
Bi(t, τ, s)dτds
)
,
where (Ai, Bi) is given by System (10.4)-(10.6).
Let M := (HT × LT )I−1 ×HT and define a norm on M as follows
‖u‖M =
I−1∑
i=0
sup
06t6T
∫ ∆
0
∫ m
0
|Bi(t, τ, s)| ds dτ +
I∑
i=0
sup
06t6T
∫ m
0
|Ai(t, s)| ds, (10.13)
for all u := ((A0, B0), ..., (AI−1, BI−1), AI) ∈M .
We shall show that the operator
∧
is a map from M into M and it is strict contrac-
tion for T small enough.
(1)
∧
: M 7−→M
Let u and uˆ :=
(
(Aˆ0, Bˆ0), ..., (AˆI−1, BˆI−1), AˆI
)
lie in M and satisfy (10.4)-
(10.6). By using (10.13), one can write
‖uˆ‖M =
I−1∑
i=0
‖Bˆi‖LT +
I∑
i=0
‖Aˆi‖HT .
Substituting (10.8) and (10.9) in the previous equality, one obtains
‖uˆ‖M ≤
(
I−1∑
i=0
RBˆi
)
+
(
I∑
i=0
RAˆi
)
.
Then for T < +∞, one gets ∧ maps M into M.
(2) It remains to show that
∧
is a contraction for T small enough
Let u, uˆ, u¯ :=
(
(A¯0, B¯0), ..., (A¯I−1, B¯I−1), A¯I
)
and ¯ˆu :=
(
(
¯ˆ
A0,
¯ˆ
B0), ..., (
¯ˆ
AI−1,
¯ˆ
BI−1),
¯ˆ
AI
)
in M and satisfies (10.1-10.3).
Then, the norm in M of the difference between uˆ and ¯ˆu is
‖uˆ− ¯ˆu‖M =
I−1∑
i=0
‖Bˆi − ¯ˆBi‖LT +
I∑
i=0
‖Aˆi − ¯ˆAi‖HT .
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Solutions, uˆ and ¯ˆu having the same initial condition (Aˆ0,0 ≡ ¯ˆA0,0). Lemma
10.5 allows us to estimate the previous equality by
‖uˆ− ¯ˆu‖M 6 Θ sup
06t6T
|N(t)− N¯(t)|
6 Θ‖u− u¯‖M ,
where
Θ = Θ(T ) = k
[
2µ¯βI−1B
(
1− e−δAT )
δA
+
I−1∑
i=0
(
βiA + β
i
B
)]
.
Note that limT→0 Θ(T ) = 0 (see (10.11-10.12) for βiA and β
i
B). Then, there
exists at least T ∗ > 0 where Θ(T ∗) < 1, which implies that
∧
is a strict
contraction.
This complete the local existence and uniqueness proof.
10.5 Global existence
Remark 10.7. If u is a solution of (10.1-10.3) in [0, T ] and uˆ is a continuous extension
of u in [T, T + Tˆ ] such that
Ai(t, s) = Aˆi(t− T, s), ∀i ∈ NI , and Bi(t, τ, s) = Bˆi(t− T, τ, s), ∀i ∈ NI−1,
then u is a solution in [0, T + Tˆ ].
In the next, we introduce the maximum interval of existence of a solution.
Definition 10.8. The maximal interval of existence of a solution, denoted by
[0, Tmax] is the interval with the property that there exists u ∈ (HT ×LT )I−1×HT ,
solution of (10.1-10.3) for each T ∈ (0, Tmax).
Lemma 10.9. Let Assumption 10.4.1 be satisfied and let u be a solution of System
(10.1-10.3) in [0, Tmax). If Tmax <∞, then
lim
t→Tmax
‖Ai(t, .)‖L1((0,m)) =∞, ∀i ∈ NI . (10.14)
lim
t→Tmax
‖Bi(t, ., .)‖L1((0,∆)×(0,m)) =∞, ∀i ∈ NI−1. (10.15)
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Proof. Assume there exists r1 > 0 and r2 > 0 such that ‖Bi(t, ., .)‖L1((0,∆)×(0,m)) 6 r1
and ‖Ai(t, .)‖L1((0,m)) 6 r2 for all t ∈ [0, Tmax), it suggests that there exists a
sequence (tn)n∈N satisfying limn→∞ tn = Tmax. Then, one has
sup
n∈N
‖Bi(tn, ., .)‖L1((0,∆)×(0,m)) 6 r1,
sup
n∈N
‖Ai(tn, .)‖L1((0,m)) 6 r2.
Such that u is a solution of (10.1-10.3) in [0, tn]. From Remark (10.7), let u
tn be a
solution in [tn, tn + ], ∀  > 0. According to local uniqueness, one gets a solution
u on the larger interval [0, Tmax + ). It leads to a contradiction with the maximal
interval [0, Tmax). Therefore, (10.14) and (10.15) are hold.
Obviously, we can state the global existence of the solution as follows
Theorem 10.10. Let Assumption 10.4.1 be satisfied, there exists a unique solution
of System (10.4-10.6) for all T ∈ (0,∞).
Proof. Suppose that there exists a maximal interval [0, Tmax) of the solution u. By
the above lemma, limt−→Tmax ‖Ai(t, .)‖L1((0,m)) =∞ and
limt→Tmax ‖Bi(t, ., .)‖L1((0,∆)×(0,m)) = ∞. In contrast, one has from Lemma 10.4 for
i = 0
‖A0(t, .)‖L1((0,m)) 6 e−δAt‖A0,0‖L1((0,m)) + Λ
δA
(
1− e−δAt) ,
‖B0(t, ., .)‖L1((0,∆)×(0,m)) 6
‖λ‖∞
(
eCv0 − 1)
Cv0t
[
e−δAt‖A0,0‖L1((0,m)) + Λ
δA
(
1− e−δAt)] .
That’s mean for t −→ Tmax:
lim
t
‖A0(t, .)‖L1((0,m)) <∞ and lim
t
‖B0(t, ., .)‖L1((0,∆)×(0,m)) <∞.
It is a contradiction. Then the conclusion Tmax =∞ holds.
Corollary 10.11. Let Assumption 10.4.1 be satisfied and let Λ = 0, there exists a
unique solution of System (4.4)-(4.6) for all T ∈ (0,∞).
Proof. By using Theorem 10.10, one deduces directly the global existence of a so-
lution for System (4.4)-(4.6).

Chapter 11
Asymptotic behaviour for an
age-structured model describing
the T cell homeostasis in vivo
This chapter is based on the article [81].
Abstract. In this study, we consider a model of T cell proliferation in vivo which is
structured by age and CD44 expression. This model is rewritten as an age-structured
model system without the CD44 structure, and we investigate its asymptotic be-
haviour. We find that there exists one or three stationary solutions when cells
undergo at least five divisions and only one stationary solution when cells undergo
at most three divisions, the limiting case with four divisions is numerically handled.
By applying the Lyapunov method, we prove in some cases of uniqueness that the
stationary solution is globally asymptotically stable.
11.1 Introduction
Despite great advances in immunological research during the last decades, many
questions remain in the modeling of T cell proliferation in condition of cell defi-
ciency. Indeed, understanding the process of T cell homoeostasis in vivo stays a
very important subject to address. For example, the asymptotic behaviour of T cells
is one of the important keys to analyse the homoeostatic process in vivo. In this
133
Chapter 10. Asymptotic behaviour for an age-structured model. 134
chapter, we rewrite System (10.1-10.3) as an age-structured model system (without
CD44 expression), and we investigate its asymptotic behaviour.
11.2 Reduced in vivo model
Integrating System (10.1-10.3) with respect to the variable s (CD44 expression), we
derive an age-structured system characterized by cascade. It reads
dA0(t)
dt
= Λ− δAA0(t)− λ0(N)A0(t),
dAi(t)
dt
= 2
∫ ∆
0
µ(τ)Bi−1(t, τ) dτ − δAAi(t)− λi(N)Ai(t) for i ∈ N∗,
∂
∂t
Bi(t, τ) +
∂
∂τ
Bi(t, τ) = −(δB + µ(τ))Bi(t, τ) for i ∈ N,
Bi(t, 0) = λ
i(N)Ai(t),
Bi∈N(0, τ) = 0 and Ai∈N∗(0) = 0,
A0(0) =
∫ m
0
A˜0,0(s) ds := A0,0 > 0.
(11.1)
where A0,0 is a positive constant, Ai(t) :=
∫ m
0
A˜i(t, s)ds, Bi(t, τ) :=
∫ m
0
B˜i(t, τ, s)ds
and (A˜i, B˜i), ∀ i ∈ N are the state variables of (10.1-10.3).
Remark 11.1. According to Yates et al [7] and Hogan et al [10], T cells can undergo
a finite number of division (I) (8 or 9 division with CFSE labelling). We assume a
recruitment rate from A-state into B-phase, for all i ∈ N
λi(N) =

λ0N if i ∈ NI−1 := {0, ..., I − 1}
0 else.
where λ0 > 0. Therefore, there are no cells after AI phase (i.e Ith division in
A-state).
In Table 11.1, we describe the parameters used in System (11.1).
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Table 11.1: Parameters for (11.1).
Parameters Description
∆ Duration of the proliferative phase (B-phase)
µ(τ) Division rate at age τ
λ0 Weight rate of entry into division
Λ Rate of export of cells from the thymus
I Maximum division number undergone by cells
δA, δB Natural mortality rates of cells in A-state and B-phase respectively
The total cell number is
N := N(t) =
∑
i∈N
(
Ai(t) +
∫ ∆
0
Bi(t, τ)dτ
)
. (11.2)
Remark 11.2. If Λ is equal to 0, one gets an in vitro model defined in Part II and
III (or see [80]). Then, the total number of cells decreases to zero and the unique
stationary solution is the trivial one. Therefore, to study the asymptotic behaviour
in case of non trivial equilibrium, the rate of export of cells Λ from the thymus must
be a strictly positive constant.
In what follows, we shall make use of the following assumption.
Assumption 11.2.1. - δA = δB = δ > 0, Λ > 0.
- Function µ(.) is bounded, non-negative and satisfies the following inequality
0 ≤ µ ≤ µ(τ) ≤ µ¯, ∀ τ ∈ (0,∆).
- Function λi(N) is non-negative and satisfies Remark 11.1.
- Initial condition A˜0,0(.) is non-negative and belongs to L
1
+(0,m).
By integrating the PDEs in (11.1) with respect to τ and using (11.2), the ODEs
in (11.1) and Assumption (11.2.1), one obtains an ordinary differential equation
related to the total number of cells (N). Hence, it reads as following
dN(t)
dt
= Λ +
∑
i∈N∗
∫ ∆
0
µ(τ)Bi−1(t, τ)dτ − δN(t). (11.3)
In this chapter, we are interested in the asymptotic behaviour of the dynamic of
T cells in vivo without CD44 expression (i.e the reduced System (11.1)). This
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work is organised as follows. Section 11.3 is devoted to prove the existence of a
global attractor and to give some properties which are used in the asymptotic study
of System (11.1). Next, we look in Section 11.4 for the existence and uniqueness
of stationary solution for System (11.1). Finally, Section 11.5 is divided in two
subsections. In the first one, we prove the global stability of the stationary solution
in some cases of uniqueness by using the Lyapunov method. Next, we illustrate in
the second subsection some numerical simulations of the dynamic of System (11.1)
in order to complete the analytical results of the first subsection.
11.3 Global attractor for System (11.1)
The aim of this section is to prove the existence of a unique bounded dissipative
semiflow associated to System (11.1). Let
WI =

(A,B) ∈ RN × L1+((0,∆),RN);

N0
N1
:
:
NI

≤

Λ
δ
2Λµ¯
δ2
:
:
2IΛµ¯I
δI+1


,
where A = {Ai, i ∈ N}, B = {Bi, i ∈ N} and Ni := Ai +
∫ ∆
0
Bi(τ)dτ, ∀ i ∈ NI .
Lemma 11.3. Let Assumption 11.2.1 be satisfied. The set WI is positively invariant
with respect to System (11.1).
Proof. Let bi(t) :=
∫ ∆
0
Bi(t, τ)dτ , ∀ i ∈ NI . By integrating the PDE of System
(11.1) with respect to the age τ , one obtains for i ∈ NI
dbi
dt
= λi(N)Ai(t)− δbi(t)−
∫ ∆
0
µ(τ)Bi(t, τ)dτ.
Then, one deduces that Ni(t) satisfies
dN0(t)
dt
= Λ− δN0(t)−
∫ ∆
0
µ(τ)B0(t, τ)dτ ≤ Λ− δN0(t),
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and for all i ∈ N∗I ,
dNi(t)
dt
= 2
∫ ∆
0
µ(τ)Bi−1(t, τ)dτ − δNi(t)−
∫ ∆
0
µ(τ)Bi(t, τ)dτ
≤ 2
∫ ∆
0
µ(τ)Bi−1(t, τ)dτ − δNi(t). (11.4)
Therefore lim supt→+∞N0(t) ≤ Λδ . If N0(t) ≤ Λδ is satisfied for some t = t0 ∈ R,
than it is satisfied for all t > t0. Hence, one obtains the following estimate∫ ∆
0
B0(t, τ)dτ ≤ Λ
δ
.
Replacing the above estimate in (11.4), one has for i = 1
dN1(t)
dt
≤ 2Λµ¯
δ
− δN1(t),
and therefore lim supt→+∞N1(t) ≤ 2Λµ¯δ2 . As in the case i = 0, if N1(t) ≤ 2Λµ¯δ2 is
satisfied for some t = t1 > t0, then it holds for all t > t1. By induction, one gets
Ni(t) ≤ 2iΛµ¯iδi+1 , for all t > t∗, with t∗ = maxi∈NI ti.
To prove the existence of a global attractor which is used in the asymptotic study,
we shall deal with (11.1) using an integrated semi group approach.
Integrated semigroup formulation. This approach has been introduced by
Thieme [108] in the context of age structured equations. We also refer to [109–115].
Let us introduce the Banach space
χ = RN × RN × L1 ((0,∆),RN) ,
endowed with the usual product norm, and set
χ0 := RN × {0RN} × L1
(
(0,∆),RN
)
,
χ+ := RN+ × RN+ × L1+
(
(0,∆),RN
)
,
χ0+ := χ0 ∩ χ+.
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Let the following operators be defined by
φ : RN 7−→ RN
A 7−→ δφA ,
ψ : RN 7−→ RN
A 7−→ λ(N)ψA ,
$ : L1
(
(0,∆),RN
) 7−→ L1 ((0,∆),RN)
B 7−→ (δ + µ(.))$B
with (δφA)i = δAi, (λ(N)ψA)i = λ
i
0NAi and ((δ + µ(.))$B)i = (δ + µ(.))Bi, ∀
i ∈ N.
Now, one considers the linear operator E : D(E) ⊂ χ 7−→ χ defined by
E

A

0RN
B


=

−δφA

−B(0, .)
−B′ − (δ + µ(.))$B


,
where
D(E) = RN × {0RN} ×W 1,1
(
(0,∆),RN
)
,
and W 1,1 is a Sobolev space. Note that the domain of operator E is not dense in χ
because of the identify
D¯(E) = RN × {0RN} × L1
(
(0,∆),RN
) 6= χ.
Finally let us introduce the non-linear map F : D¯(E) 7−→ χ defined by
F

A

0RN
B


=

Λ˜− λ(N(t))ψA(t)

λ(N(t))ψA(t)
0L1


with Λ˜ =

Λ
2
∫ ∆
0
µ(τ)B0(t, τ)dτ
2
∫ ∆
0
µ(τ)B1(t, τ)dτ
...

.
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Let u(t) =

A(t)(
0RN
B(t, .)
) and u0 =

A(0)(
0RN
B(0, .)
). Then we can reformulated
System (11.1) as the following abstract Cauchy problem
du(t)
dt
= Eu(t) + F (u(t)), t > 0 and u(0) = u0 ∈ χ0+. (11.5)
From results in Thieme [108], Magal [110] (see Magal and Ruan [111] for more
results), we derive that the above abstract Cauchy problem generates a unique
globally defined and positive semiflow.
Theorem 11.4. Let Assumption 11.2.1 be satisfied. Then there exists a unique
strongly continuous semiflow {U(t) : χ0+ 7−→ χ0+}t>0 such that for each u0 ∈ χ0+,
the map u ∈ C ([0,∞) : χ0+) defined by u = U(.)u0 is a mild solution of (11.5).
Furthermore {U(t)}t>0 satisfies the following properties:
(i) Let U(t)u0 = (A(t), (0RN , B(t, .)))
T , then the following Volterra integral for-
mulation holds true for all i ∈ NI−1
Bi(t, τ) =

0 t < τ
λ0N(t− τ)Ai(t− τ) e−
∫ τ
0 (δ+µ(r))dr τ 6 t
coupled with the Ai equations of (11.1).
(ii) Ai ≡ 0, ∀ i > I and Bi ≡ 0, ∀ i > I.
(iii) There exist t∗ > 0 such that for all t > t∗, Ni(t) ≤ 2iΛµ¯iδi+1 , ∀ i ∈ NI .
Proof. The proof of this result is standard. Indeed, one may check that operator E
satisfies the Hille-Yosida property. Then standard methodologies apply to provide
the existence and uniqueness of mild solution for System (11.1). (see [110–113] for
more details). Next, the Volterra integral formulation (i) is also standard in the
context of age structured equation. By using Remark 11.1, one deduces (ii). Also
from Lemma 11.3, one deduces the estimates in (iii).
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From Lemma 11.3, one deduces that the set
M =


A(
0RN
B
) ∈ X0+;

N0
N1
:
:
NI

≤

Λ
δ
2Λµ¯
δ2
:
:
2IΛµ¯I
δI+1


is positively invariant absorbing set under U ; in other words
U(t)M ⊆M.
By using the result of Hale [116], one concludes that {U(t)}t>0 is bounded dissipative
on χ0+. Furthermore, the semiflow is asymptotically smooth (see Webb [117], Magal
and Thieme [118], Thieme and Vrabie [119]). Also from Hale [116], we obtain the
following theorem of the existence of global attractors.
Theorem 11.5. There exists a non-empty set A ⊂ χ0+ such that
(i) A is invariant under the semiflow {U(t)}t>0.
(ii) The subset A attracts the bounded set of χ0+ under the semiflow U .
The attractor A consists of complete orbits of U , meaning that for any point
(A(0), 0RN , B(0, .)) ∈ A, there is a solution {(A(t), 0RN , B(t, .)), t ∈ R} of equation
(11.5) which passes through (A(0), 0RN , B(0, .)) at time t = 0.
Further estimate: Without loss of generality, one may restrict ourselves to the
subdomain M . Hence one may assume that
N(t) =
I∑
i=0
Ni(t) ≤
I∑
i=0
2iΛµ¯i
δi+1
:= N+. (11.6)
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Lemma 11.6. Let Assumption 11.2.1 be satisfied. The domain
M0 =


A

0RN
B


∈ χ0+; A0 > Λ
δ + λ0N+
and

N0
N1
:
:
NI

≤

Λ
δ
2Λµ¯
δ2
:
:
2IΛµ¯I
δI+1


is positively invariant and is an absorbing set for U restricted to M . Furthermore,
A ⊆M0.
Proof. Let u0 =

A(0)(
0RN
B(0, .)
) ∈ M0 be given and let us denote for each t > 0,
U(t)u0 := (A(t), 0RN , B(t, .))
T the orbit passing through u0.
By using (11.6) and the A0 equation in (11.1), one obtains
dA0(t)
dt
> Λ− (δA + λ0N+)A0(t). (11.7)
Since u0 ∈M0, then A0(0) > Λδ+λ0N+ , and therefore, one has
A0(t) >
Λ
δ + λ0N+
.
This completes the proof of Lemma 11.6.
Finally in this section, we give a result that will be used to prove our stability result.
Lemma 11.7. For each (A, 0RN , B) ∈ A, there exists A−i > 0 for all i ∈ NI and
B−i > 0 for all i ∈ NI−1 such that
Ai > A
−
i and
∫ ∆
0
Bi(τ)dτ > B
−
i .
Proof. Let (A, 0RN , B) be the solution of equation (11.5) with initial condition
(A(0, .), 0RN , B(0, ., .)) ∈ A. Since the solution is in the attractor, the previous
lemma implies
A0(t) >
Λ
δ + λ0N+
> 0,
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for all t > 0. Thus, for sufficiently small A−0 > 0, one has A0(t) > A−0 , for all t > 0.
Equation (11.3) can be written as
dN
dt
> Λ− δN(t).
Then, for a given large t∗, one has
N(t) > N− := min{Λ
δ
,N(t∗)}. (11.8)
Thus, by (11.8) and (i) of Theorem 11.4, one obtains for all t > t∗∫ ∆
0
B0(t, τ)dτ > λ0N−A−0 β, where β :=
∫ ∆
0
e−
∫ τ
0 (δ+µ(r))drdτ.
Therefore for sufficiently small B−0 > 0, one has
∫ ∆
0
B0(t, τ)dτ > B
−
0 .
From (11.6), one has
dA1(t)
dt
> 2µ
∫ ∆
0
B0(t, τ)dτ − (δ + λ0N+)A1(t) =⇒ A1(t) >
2µB−0
(δ + λ0N+)
:= A−1 .
By induction, one may check
Ai(t) >
2µB−i−1
(δ + λ0N+)
> A−i ,
∫ ∆
0
Bi(t, τ)dτ > λ0ΛN−A−i β > B−i ,
∀ i = 2, ..., I − 1, and for i = I
AI(t) >
2µB−I−1
δ
> A−I .
where A−i and B
−
i are sufficiently small. This completes the proof of Lemma 11.7.
11.4 Stationary solution for System (11.1)
In what follows,
I, d :=
∫ ∆
0
µ(τ)e−
∫ τ
0 (δ+µ(r))dr and ρ :=
2δ2
λ0Λ
, (11.9)
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are the key parameters to study the asymptotic behaviour of System (11.1). Param-
eter d can be described by the cumulative rate of cells that will divide in B-phase.
1
ρ
= 1
2δ2
λ0Λ is an aggregated parameter related to λ0Λ, the recruitment rate of
exported cells coming from the thymus and passing from A-state to B-phase, see
Remark 11.1, whose dimension is cell × hour.
Let A¯i for all i ∈ NI and B¯i(.) for all i ∈ NI−1 be a stationary solution of Sys-
tem (11.1)
Λ− δA¯0 − λ0N¯A¯0 = 0,
2
∫ ∆
0
µ(τ)B¯i−1(τ)dτ − δA¯i − λ0,iN¯A¯i = 0, ∀ i ∈ N∗I := {1, ...I}
dB¯i(τ)
dτ
+ (δ + µ(τ))B¯i(τ) = 0, ∀ i ∈ NI−1 := {0, ..., I − 1}
B¯i(0)− λ0N¯A¯i = 0.
(11.10)
Then, one has
A¯0 =
Λ
δ + λ0N¯
, A¯i =
2
∫ ∆
0
µ(τ)B¯i−1(τ)
δ + λ0N¯
, ∀ i ∈ N∗I ,
B¯i(τ) = λ0N¯A¯i e
− ∫ τ0 (δ+µ(r))dr, ∀ i ∈ NI−1
wherein
N¯ =
I−1∑
i=0
(∫ ∆
0
B¯i(τ)dτ
)
+
I∑
i=0
A¯i. (11.11)
A recursive argument yields
A¯i =
2iΛλi0N¯
idi(
δ + λ0N¯
)i+1 , B¯i(τ) = 2iΛλi+10 N¯ i+1dic(τ)(
δ + λ0N¯
)i+1 , ∀ i ∈ NI−1 and A¯I = 2IΛλI0N¯ IdI
δ
(
δ + λ0N¯
)I ,
(11.12)
where c(τ) := e−
∫ τ
0 (δ+µ(r))dr and d is given in (11.9). Note that
0 < d ≤ 1− e−
∫∆
0 µ(r)dr < 1. (11.13)
Constant d is much smaller than 1
2
when using realistic parameters from [4, 6, 7,
10, 80].
Theorem 11.8. Let Assumption 11.2.1 be satisfied. System (11.1) admits one or
three stationary solutions for all I ∈ N∗. Uniqueness holds when one of the following
conditions is fulfilled
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1-) I = 1, 2 or 3 for all d ∈ (0, 1) and ρ > 0.
2-) 0 < d ≤ 1
2
for all I ∈ N∗ and ρ > 0.
3-) I ≥ 4, ρ ≥ ρ(I) for a suitably large ρ(I) > 0 given in (11.18) below and all
d ∈ (1
2
, 1).
4-) I ≥ 4, ρ > 0 and d ∈ (1
2
, 1) satisfying
2d
(1− 2d)2
[
1 + (2d)I (2Id− I − 1)] < (ρ+ 2)2
ρ
cf. (11.9) for (d, ρ).
(11.14)
Proof. According to (11.12), it is sufficient to prove the existence of one or three
stationary solutions for N¯ . At equilibrium, dN¯
dt
= 0, then (11.3) leads to the following
equality
N¯ =
Λ
δ
+
I∑
i=1
2i−1λi0N¯
idiΛ
δ
(
δ + λ0N¯
)i . (11.15)
The mean value theorem applied to [0,+∞) ensures that (11.15) admits at least
one positive root. Next, performing a change of variable (ω := λ0
δ
N¯ and ρ := 2δ
2
λ0Λ
),
one obtains
ρω = 2 +
I∑
i=1
2iωidi
(1 + ω)i
(11.16)
Proof of 1-)
For I = 1: (11.16) reduces to a quadratic polynomial equation, ρω2 +a1ω+a2 = 0,
with a2 = −2 yielding a unique positive root.
For I = 2: (11.16) reduces to a cubic polynomial equation P3(ω) = ρω
3 + a1ω
2 +
a2ω+a3 = 0, with a3 = −2 < 0 so that P3 has 1 or 3 positive roots. Descartes’s rule
of signs requires three sign changes to get three positive solutions, that is a1 < 0
and a2 > 0. Elementary algebra shows that a1 = 2 [ρ− (1 + d+ 2d2)] < 0 and
a2 = [ρ− 2(2 + d)] > 0 imply 2d2− d− 3 > 0 that is impossible because 0 < d < 1.
This shows uniqueness for I = 2.
For I = 3: (11.16) reduces to a 4th order polynomial equation P4(ω) = ρω
4+a1ω
3+
a2ω
2 + a3ω + a4 = 0, with a4 = −2 < 0 so that P4 has 1 or 3 positive roots.
• When a1 > 0, Descartes’s rule of signs requires three sign changes to get three
positive solutions, that is a2 < 0 and a3 > 0. Elementary algebra shows that
a2 = 3ρ− 6− 4d− 4d2 < 0 and a3 = ρ− 6− 2d > 0 imply 12 + 2d− 4d2 < 0 that
is impossible because 0 < d < 1.
• When a1 = 3ρ − 2 − 2d − 4d2 − d3 < 0 then one also has a3 = ρ − 6 − 2d <
Chapter 10. Asymptotic behaviour for an age-structured model. 145
0. Assuming P4 possesses three positive roots then Rolle’s Theorem asserts its
derivative polynomial P
′
4 has at least two positive roots.
Now P
′
4(ω) = 4ρω
3 + 3a1ω
2 + 2a2ω + a3 and a3 < 0 implies P
′
4 has 1 or 3 positive
roots. As a consequence when a1 < 0 if P4 has 3 positive roots then P
′
4 also has 3
positive roots.
Setting Q4(ω) = −14P
′
4(−ω) = ω3 + α1ω2 + α2ω + α3, one may use Routh-Hurwitz
criterion to check whether Q4 has 3 negative roots.
First α1 = − 34ρa1 > 0, α3 = − 14ρa3 > 0. Elementary but lengthy algebra yields
α1 × α2 − α3 < 0 because 0 < d < 1. Indeed
α1 × α2 − α3 := R(ρ) = 25ρ2 + β1ρ+ β2,
where
β1 := 60 + 50 d+ 72 d
2 + 72 d3,
β2 := −36− 60 d− 120 d2 − 216 d3 − 144 d4 − 96 d5.
Polynomial R(ρ) reaches its maximum value at ρ = β1
50
.
R(ρ) ≤ R(β1
50
) ≤ H(d) := d
2
25
(−215− 1440 d− 504 d2 + 192 d3 + 1296 d4)
Finally, one remarks that 0 < d < 1 ⇒ R(β1
50
) < 0. Then, Q4 cannot have three
negative roots. As a consequence uniqueness holds for I = 3.
Proof of 2-) Assume I ≥ 4. Performing a change of variable in (11.16), u := 2ωd
1+ω
,
one gets
PI+1(u) := u
I+1 + (1− 2d)uI + ...+ (1− 2d)u2 + (2− 2d+ ρ)u− 4d = 0. (11.17)
Using Descartes’s rule of signs and (11.13), polynomial PI+1 for all I ∈ N∗ admits
one or three positive roots (see Fig. 11.1) that satisfies 0 < u < 2d (u = 2ωd
1+ω
⇔ ω =
u
2d−u).
If 1− 2d > 0, PI+1 has only one sign change in its coefficients and admits only one
positive root.
Proof of 3-) (Estimating the sign of the derivative of (11.17)) The first
derivative of (11.17) is P
′
I+1(u) = (I + 1)u
I + (1 − 2d)∑Ij=2 juj−1 + (2 − 2d + ρ).
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Figure 11.1: The first five subfigures represent the implicit plot of the level set PI+1(u) = 0 as a function
of (d, u) when I = 5, 6, 7, 8, 9 and ρ constant. The last one (PI+1) is drawn for a large I = 10, 15, 20, 25, 30
and ρ = 6.5. The vertical lines (red lines) show the existence of three stationary solutions for some values of d.
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Since u > 0 and 0 < d < 1
2
, one has
P
′
I+1(u) ≥ HI(u) + ρ, HI(u) := (I + 1)uI −
I∑
j=2
juj−1.
Polynomial HI(u) reaches its minimum value in the range u > 0 at some u
min
I , so
does HI(u) + ρ. Therefore if the following condition is fulfilled
ρ ≥ ρ(I) := −HI(uminI ), (11.18)
polynomial PI+1 is strictly increasing and has a unique positive root.
Proof of 4-) (Fixed point method) From (11.16), let
f(ω) :=
1
ρ
(
2 +
I∑
i=1
2iωidi
(1 + ω)i
)
, ω > 0
Stationary solutions correspond to solutions of ω = f(ω). We shall prove that
(i) f is a map from [0, H] to [2
ρ
, H] where
H :=
2
ρ
[
1 +
d(1− 2IdI)
1− 2d
]
. (11.19)
(ii) If (11.14) is fulfilled then f is a strict contraction i.e 0 < |Df(ω)| < 1 for
2
ρ
≤ ω ≤ H.
The proof of (i) is rather straightforward, using 0 ≤ ω
1+ω
≤ 1. This implies that any
positive fixed point of f belongs to [2
ρ
, H].
Proof of (ii): The derivative of f is
f
′
(ω) =
1
ρ
I∑
i=1
i2idi
[
ωi−1
(1 + ω)i+1
]
> 0. (11.20)
Chapter 10. Asymptotic behaviour for an age-structured model. 148
Since ω ∈ [2
ρ
, H] and d ∈ (1
2
, 1), one has
f
′
(ω) ≤ 1
ρ(1 + 2
ρ
)2
I∑
i=1
2idii =
2dρ
(2 + ρ)2
(
I∑
i=1
(2d)i
)′
2d
=
2dρ
(2 + ρ)2(1− 2d)2
[
1 + (2d)I (2Id− I − 1)] := ϕ(d, I, ρ),
where (ϑ(x))
′
x =
dϑ(x)
dx
. From condition (11.14), one gets (ii). Therefore, one deduces
the existence and uniqueness of ω by referring to Picard’s fixed point theorem.
Remark 11.9. Case I = 4. According to (11.18) in the proof of item 3-) of Theorem
11.8, H4(u) reaches its minimum value at u = 1. Then if ρ ≥ ρ(4) := −H4(1) = 4,
polynomial P5 has a unique positive root. For
1
2
< d < 1 the left hand side of (3.6)
is larger than 10 so that (11.14) is fulfilled uniformly in d when 0 < ρ < 0.763932022
in which case uniqueness holds according item 4-). Furthermore graphical analysis
suggests that P5 has a unique positive root when 0 < ρ < 4 and
1
2
< d < 1 (Fig.
11.2), and System (11.1) has a unique stationary solution for I = 4.
Zoom 2D−−−−−−−→
Figure 11.2: Implicit plot of the level set P5(u) = 0 as a function of 0 < d < 12 , 0 < ρ < 4 and
0 < u < 2. These figures ensure that graphically System (11.1) admits a unique stationary solution when
I = 4.
Remark 11.10. According to item 2-) in Theorem 11.8 and Remark 11.9, the param-
eter condition (11.14) for uniqueness, is relevant only when I > 5 and d ∈ (1
2
, 1).
Furthermore, if d tends to 1
2
or 1, then the contraction in item (ii) of the previous
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proof, depends on the values of ρ and I > 5. Indeed, one has
lim
d→ 1
2
f
′
(ω) ≤ lim
d→ 1
2
ϕ(d, I, ρ) =
ρI(I + 1)
2(ρ+ 2)2
,
lim
d→1
f
′
(ω) ≤ lim
d→1
ϕ(d, I, ρ) =
2ρ
(ρ+ 2)2
[
1 + 2I(I − 1)] .
In Fig. 11.1, graphical analysis shows that uniqueness of a stationary solution is
dependent on the values of d ∈ (1
2
, 1), I > 5 and ρ > 0. On the other hand, the
sufficient conditions (11.14) and (11.18) which depend on (d, I, ρ), allow to conclude
algebraically to two different uniqueness results.
Now, we provide graphical examples of the analytical uniqueness results given by
items 3-) and 4-) in Theorem 11.8 with respect to numerical results of uniqueness,
for I > 5 and d ∈ (1
2
, 1).
Figure 11.3: Implicit plot of the level set PI+1(u) = 0 (dashed line) as a function of (d, u) for I = 8 (left)
and I = 25 (right) and various values of ρ. In both subfigures bold solid lines depict the subset of d ∈ ( 12 , 1)
where uniqueness follows from item 4-). In left subfigure I = 8; item 3-) yields ρ(8) ' 80 and uniqueness holds
for ρ = 140 and for all d ∈ ( 12 , 1) (dotted line), while it does not apply for ρ = 70. In right subfigure I = 25
then ρ(25) ' 9.0E + 06 so that item 3-) does not apply for the data set used; note that multiple stationary
solutions are possible for a larger d. Log-scale is used in y-axis on the right subfigure.
In Fig. 11.3, we present the implicit plot of the level set PI+1(u) = 0 (dashed line)
as a function of 1
2
< d < 1, 0 < u < 2 when I = 8 and 25 and various values of ρ.
For I = 8, bold solid lines depicts the subset of d ∈ (1
2
, 1) where uniqueness follows
from item 4-). Item 3-) yields ρ(8) ' 80 and uniqueness holds for ρ = 140 and for
all d ∈ (1
2
, 1) (dotted line), while item 3-) does not apply for ρ = 70.
For I = 25 then ρ(25) ' 9.0E + 06 and item 3-) does not apply for the data set
used. In contrast, bold solid lines depicts the subset of d ∈ (1
2
, 1) where uniqueness
follows from item 4-). Note that multiple stationary solutions are possible for a
larger d.
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11.5 Global stability of the stationary solution
when d ∈ (0, 12)
Through this section, we use normalised variables xi ∀ i ∈ NI and y defined by
xi := xi(t) =
Ai(t)
A¯i
; y := y(t) =
N(t)
N¯
.
11.5.1 Main analytical result
Theorem 11.11. Let Assumption 11.2.1 be satisfied and fix d ∈ (0, 1
2
). Then, the
unique stationary solution noted Eq is globally asymptotically stable if the parameters
satisfy the following condition
ρ > 2d
1− 2d
(
1 + d
I−1∑
i=0
(2d)i
)
. (11.21)
Proof. Let (Ai∈NI (t), Bi∈NI−1(t, .)) be a complete solution to (11.1) that lies in the
attractor A ⊆M0. From Lemma 11.7, one knows there exits δ1i , δ′1,i, δ2i , δ′2,i, δ3 and
δ′3 such that
δ1i <
Ai(t)
A¯i
< δ′1,i, δ
2
i <
Bi(t, τ)
B¯i(τ)
< δ′2,i, δ3 <
N(t)
N¯
< δ′3 (11.22)
for t ∈ R and τ ∈ (0,∆).
Let g(x) := x − 1 − ln(x). Then g : (0,∞) → R+ has global minimum at x = 1,
g(1) = 0. It follows from (11.22) that g(xi), g(y) and g(
Bi(t,τ)
B¯i(τ)
) are bounded. Let
VAi(t) := g (xi) , ∀ i ∈ NI , VN(t) := g (y)
and
VBi−1(t) :=
∫ ∆
0
αi−1(τ)g
(
Bi−1(t, τ)
B¯i−1(τ)
)
dτ, ∀ i ∈ N∗I
where c(r) := e−
∫ r
0 (δ+µ(x))dx, ω = λ0
δ
N¯ ,
αi−1(τ) =
∫ ∆
τ
(2 + ω)ψi−1µ(r)c(r)dr, ψi−1 =
Λλ0
δ
(
2i−1di−1ωi−1
(1 + ω)i
)
. (11.23)
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Since g(Bi(t,τ)
B¯i(τ)
) and αi(τ) are bounded. Then, VBi is finite for each t, i ∈ N∗I .
For u = (A0, ..., AI , B0, ..., BI−1), let
V [u](t) =
I∑
i=0
A¯i
N¯
VAi(t) +
I∑
i=1
VBi−1(t) +
λ0N¯
δ
VN(t) (11.24)
One notes that, when restricted to A, function V is bounded. Furthermore, V
reaches its minimum value at the stationary solution Eq.
In the following calculations, one uses the substitutions from (11.10). For clarity of
presentation, one computes separately the derivatives of VA0 , VAi for all i ∈ N∗I−1,
VAI , VN and VBi for all i ∈ N∗I . Using the first equality in (11.10) to replace Λ, one
obtains
dVA0
dt
=
(
1− A¯0
A0(t)
)
1
A¯0
dA0
dt
=
(
1− A¯0
A0(t)
)
1
A¯0
[
δA¯0
(
1− A0(t)
A¯0
)
+ λ0N¯A¯0
(
1− A0(t)N(t)
A¯0N¯
)]
= δ
[
2− A0(t)
A¯0
− A¯0
A0(t)
]
+ λ0N¯
[
1− A¯0
A0(t)
− A0(t)N(t)
A¯0N¯
+
N(t)
N¯
]
= −δg(x0)− (δ + λ0N¯)g( 1
x0
)− λ0N¯g(x0y) + λ0N¯g(y).
Using (11.10), one obtains, ∀ i ∈ N∗I−1
dVAi
dt
= −δg(xi)− (δ + λ0N¯)g( 1
xi
)− λ0N¯g(xiy) + λ0N¯g(y)
−2
∫ ∆
0
µ(τ)B¯i−1(τ)
A¯i
(
1− A¯i
Ai(t)
)(
1− Bi−1(t, τ)
B¯i−1(τ)
)
dτ
One notes the last term of the above equation by Pi(t). It can be written as
Pi(t) = −2
∫ ∆
0
µ(τ)B¯i−1(τ)
A¯i
(
1− A¯i
Ai(t)
)(
1− Bi−1(t− τ, 0)
B¯i−1(0)
)
dτ
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Using σ = t− τ to replace τ , one gets
Pi(t) = −2
∫ t
t−∆
µ(t− σ)B¯i−1(t− σ)
A¯i
(
1− A¯i
Ai(t)
)(
1− N(σ)Ai−1(σ)
N¯A¯i−1
)
dσ
= −2
∫ t
t−∆
µ(t− σ)B¯i−1(t− σ)
A¯i
(
1− 1
xi(t)
− xi−1(σ)y(σ) + xi−1(σ)y(σ)
xi(t)
)
dσ
= −2
∫ ∆
0
µ(τ)B¯i−1(τ)
A¯i
g
(
xi−1(t− τ)y(t− τ)
xi(t)
)
dτ
+(δ + λ0N¯)g(
1
xi
) + 2
∫ ∆
0
µ(τ)B¯i−1(τ)
A¯i
g (xi−1(t− τ)y(t− τ)) dτ
Then the derivative of VAi , ∀ i ∈ N∗I−1 becomes
dVAi
dt
= −δg(xi)− λ0N¯g(xiy) + λ0N¯g(y) + 2
∫ ∆
0
µ(τ)B¯i−1(τ)
A¯i
g (xi−1(t− τ)y(t− τ)) dτ
−2
∫ ∆
0
µ(τ)B¯i−1(τ)
A¯i
g
(
xi−1(t− τ)y(t− τ)
xi(t)
)
dτ
Also the derivative of VAI is
dVAI
dt
= −δg(xI) + 2
∫ ∆
0
µ(τ)B¯I−1(τ)
A¯I
g (xI−1(t− τ)y(t− τ)) dτ
−2
∫ ∆
0
µ(τ)B¯I−1(τ)
A¯I
g
(
xI−1(t− τ)y(t− τ)
xI(t)
)
dτ
Next, one calculates the derivative of VBi−1 , ∀ i ∈ N∗I
dVBi−1
dt
=
d
dt
∫ ∆
0
αi−1(τ)g
(
Bi−1(t, τ)
B¯i−1(τ)
)
dτ =
d
dt
∫ ∆
0
αi−1(τ)g
(
Bi−1(t− τ, 0)
B¯i−1(0)
)
dτ.
Using σ = t− τ to replace τ , one obtains
dVBi−1
dt
=
d
dt
∫ t
t−∆
αi−1(t− σ)g
(
Bi−1(σ, 0)
B¯i−1(0)
)
dτ
= −αi−1(∆)g (xi−1(t−∆)y(t−∆)) + αi−1(0)g (xi−1y)
+
∫ ∆
0
α
′
i−1(τ)g
(
Bi−1(t, τ)
B¯i−1(τ)
)
dτ
Now, using equations (11.23) to replace αi(0) and α
′
i(τ), one finds
dVBi−1
dt
= −αi−1(∆)g (xi−1(t−∆)y(t−∆)) + ψi−1(2 + ω)d g(xi−1y)
−
∫ ∆
0
(2 + ω)µ(τ)c(τ) ψi−1 g (xi−1(t− τ)y(t− τ)) dτ.
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Finally, one calculates the derivative of VN . Using Λ = δN¯−
∑I
i=1
∫ ∆
0
µ(τ)B¯i−1(τ)dτ ,
one obtains
dVN
dt
=
(
1− N¯
N(t)
)
1
N¯
dN
dt
=
(
1− N¯
N(t)
)
1
N¯
[
δN¯
(
1− N(t)
N¯
)
−
I∑
i=1
∫ ∆
0
µ(τ)B¯i−1(τ)
(
1− Bi−1(t, τ)
B¯i−1(τ)
)
dτ
]
= −
I∑
i=1
∫ ∆
0
µ(τ)B¯i−1(τ)
N¯
(
1− 1
y(t)
− xi−1(t− τ)y(t− τ)− xi−1(t− τ)y(t− τ)
y(t)
)
dτ
+δ
[
2− N(t)
N¯
− N¯
N(t)
]
.
Then,
dVN
dt
= −δg (y)− δg
(
1
y
)
+
(
I∑
i=1
∫ ∆
0
µ(τ)B¯i−1(τ)
N¯
dτ
)
g
(
1
y
)
+
I∑
i=1
∫ ∆
0
µ(τ)B¯i−1(τ)
N¯
g (xi−1(t− τ)y(t− τ)) dτ
−
I∑
i=1
∫ ∆
0
µ(τ)B¯i−1(τ)
N¯
g
(
xi−1(t− τ)y(t− τ)
y(t)
)
dτ
From (11.3), one gets
dVN
dt
= −δg (y)− Λ
N¯
g
(
1
y
)
+
I∑
i=1
∫ ∆
0
µ(τ)B¯i−1(τ)
N¯
g (xi−1(t− τ)y(t− τ)) dτ
−
I∑
i=1
∫ ∆
0
µ(τ)B¯i−1(τ)
N¯
g
(
xi−1(t− τ)y(t− τ)
y(t)
)
dτ
Next, one calculates W1 :=
λ0N¯
δ
dVN
dt
+
∑I
i=0
A¯i
N¯
dVAi
dt
W1 = −
I∑
i=1
∫ ∆
0
µ(τ)B¯i−1(τ)
[
λ0
δ
g
(
xi−1(t− τ)y(t− τ)
y(t)
)
+
2
N¯
g
(
xi−1(t− τ)y(t− τ)
xi(t)
)]
dτ
−A¯0(δ + λ0N¯)
N¯
g
(
1
x0
)
− δ
N¯
I∑
i=0
A¯ig(xi)−
I∑
i=1
λ0A¯i−1g (xi−1y)− λ0
(
N¯ −
I−1∑
i=0
A¯i
)
g(y)
−Λλ0
δ
g
(
1
y
)
+
I∑
i=1
∫ ∆
0
(2 + ω) ψi−1 µ(τ)c(τ) g (xi−1(t− τ)y(t− τ)) dτ.
From equation (11.12), one remarks that λ0A¯i−1 = ψi−1, ∀ i ∈ N∗I . Finally, we
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combine W1 with
∑I
i=1
dVBi−1
dt
to get dV [u](t)
dt
.
dV [u](t)
dt
= −
I∑
i=1
∫ ∆
0
µ(τ)B¯i−1(τ)
[
λ0
δ
g
(
xi−1(t− τ)y(t− τ)
y(t)
)
+
2
N¯
g
(
xi−1(t− τ)y(t− τ)
xi(t)
)]
dτ
−A¯0(δ + λ0N¯)
N¯
g
(
1
x0
)
− δ
N¯
I∑
i=0
A¯ig(xi)−
I∑
i=1
ψi−1 [1− d(2 + ω)] g (xi−1y)
−λ0
(
N¯ −
I−1∑
i=0
A¯i
)
g(y)− Λλ0
δ
g
(
1
y
)
− αi−1(∆)g (xi−1(t−∆)y(t−∆)) .
From (11.19), one has −1 + d(2 + ω) ≤ −1 + d(2 +H) and from condition (11.21),
one has
ρ >
2d
(
1 + d
∑I−1
i=0 (2d)
i
)
1− 2d ⇔ d ≤
1
2 +H
.
Then, one gets −1 + d(2 + H) ≤ 0. Therefore dV [u](t)
dt
≤ 0 and V is a Lyapunov
functional on A.
Hence, we infer that t 7→ V [u](t) is decreasing along the entire solutions of U .
To conclude our proof, let {tn}n>0 be an increasing sequence tending to −∞ as
n → ∞ and consider the sequence of map un(t) = u(t + tn). Note that one has
V [un](t) = V [u](t+ tn). Then we may assume that un(t)→ uˆ(t) as n→∞ locally
uniformly for t ∈ R where {uˆ(t)}t∈R ⊂ A is an entire solution of U . Since V is
decreasing, one obtains that
V [uˆ](t) ≡ lim
t→−∞
V [u](t) = sup
t∈R
V [u](t). (11.25)
Let uˆ = (Aˆ, 0, Bˆ)T . Since V [u] is bounded, then from (11.25), we deduce that
V [uˆ](t) ≡ 0 and uˆ ≡ Eq. Hence 0 ≤ V [u](t) ≤ 0 for t ∈ R and u(t) ≡ Eq.
Finally, we illustrate condition (11.21) by a graphical analysis (Fig. 11.4) of the level
set F (d, ρ) := ρ− 2d
1−2d
(
1 + d
∑I−1
i=0 (2d)
i
)
= 0. Dark (green) depicts F (d, ρ) > 0 and
the light (orange) represents F (d, ρ) < 0. Furthermore, these figures show the zone
where condition (11.21) is satisfied (i.e the zone where the Lyapunov functional
proposed in the previous proof, leads to obtain the global stability of Eq). We
remark that this condition covers a larger interval of d when ρ is large.
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Zoom−−−−−−−→
Figure 11.4: Implicit plot of the level set F (d, ρ) := ρ− 2d1−2d
(
1 + d
∑I−1
i=0 (2d)
i
)
as a function (d, ρ) for
I = 9. Condition (11.21) is satisfied in the green region, i.e, it is the zone where the derivative of the Lyapunov
functional (
dV [u](t)
dt ) is guaranteed to be negative. Note that these subfigures do not qualitatively change for
all I ∈ N∗.
11.5.2 Additional numerical results
In this subsection, we present some numerical simulations in order to complete the
analytical results of the previous subsection (d ∈ (0, 1
2
)), and next we give some
simulations for System (11.1) when there are three stationary solutions.
According to [7, 10, 80], it is assumed that the cells take a time approximatively ∆
to complete the process in B-phase. Then, the mother cells divide in B-phase when
their age around ∆. Therefore, the rate of cells that divided at age τ can be defined
as follows
µ(τ) =
Ψ(τ)
1− ∫ τ
0
Ψ(r)dr
,
where Ψ(τ) := 1
σ
√
2pi
e−
1
2(
τ−∆
σ )
2
is a normal distribution with a mean ∆ and variance
σ2.
Remark 11.12. The parameter condition (11.21) seems to be only a technical con-
dition that we cannot overcome. Apparently from numerical computations, the
unique equilibrium Eq for all d ∈ (0, 12) continue to be globally stable even if condi-
tion (11.21) is not fulfilled.
First, we provide numerical simulations to illustrate the dynamic of System (11.1)
when d ∈ (0, 1
2
). The choice of numerical and optimization parameters follows the
second column in Table 11.2 (Value 1), where d = 0.470254 and ρ = 3.24. In this
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case, uniqueness of stationary solution is guaranteed by Theorem 11.8, and accord-
ing to Fig. 11.4, the point (d, ρ) is in the light region. Then, condition (11.21) is
not fulfilled with this choice of parameters (Table 11.2 - Value 1).
Table 11.2: Default values of the parameters used for simulations.
Parameters Value 1 Value 2 Unit
I 9 17 -
∆ 10 10 hour
σ2 2 2 -
Λ 42.06 42.06 cell/hour
δ 2.0× 10−2 7.0× 10−4 1/hour
λ0 10
−8 5.87× 10−6 -
Note. Values indicated in the second column (Value 1) lead to a unique stationary
solution (d = 0.470254 and ρ = 3.24). Moreover these values in the second column
do not fulfil condition (11.21). In the third column (Value 2), parameters values
lead to three stationary solutions (d = 0.56007 and ρ = 2.33).
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Figure 11.5: Solution N(t) converges to the unique stationary solution (N¯ = 3928) for different ini-
tialisation (A0,0). Damped oscillations (right subfigure) can be observed when the initialisation A0,0 is larger
than N¯ . Parameter values are given by Table 11.2 (Value 1).
In Fig. 11.5, we represent the total number of cells as a function of time. We re-
mark that N(t) converges to the unique stationary solution for several initialisations
(A0,0). This numerical result illustrates Remark 11.12: System (11.1) has a unique
stationary solution and it is numerically asymptotically stable when d ∈ (0, 1
2
).
Moreover when the initialisation A0,0 is greater than N¯ , damped oscillations (right
subfigure in Fig. 11.5) can be observed in the first 3 days. This phenomenon prob-
ably needs further analysis.
Second, we provide numerical simulations to illustrate the dynamic of System (11.1)
when d ∈ (1
2
, 1). Parameter values are given by the third column in Table 11.2
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(Value 2), where d = 0.56007, ρ = 2.33 and I = 17. By solving (11.17), one may
check the existence of three stationary solutions (N¯1 = 6403785, N¯2 = 6404499,
N¯3 = 6417034) for this choice of parameters (Table 11.2 - Value 2). In Fig. 11.6,
we numerically show that each of these three stationary solutions has a non-empty
basin of attraction. Convergence is slow compared to the case 0 < d < 1
2
(see
Fig. 11.5), and reached for carefully selected initial conditions. The stability or
instability of each stationary solution will be studied in a forthcoming work.
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Figure 11.6: Numerical simulations for System (11.1) when d = 0.56007, ρ = 2.33 and I = 17.
Parameter values are given by Table 11.2 (Value 2). Solution N(t) converges to one of the three stationary
solutions depending on the choice of the initial condition (A0,0). Numerical simulations are tested until time
106 (hour), and are presented here until 2.2 × 104 - 3.5 × 104 hour, where the convergence is numerically
reached. Note that the y-axis in the two bottom subfigures is presented in log-scale for sake of clarity.
11.6 Conclusions and future work
In this study, we extend the in vitro model proposed by [80] to an in vivo model.
Next, we derive an age-structured system (11.1) and we study its asymptotic be-
haviour. An analysis of System (11.1) shows that there exists one or three stationary
solutions when the cells undergo more than five divisions. Precisely, uniqueness of
a stationary solution is guaranteed in this case (i.e I > 5) when the parameter
conditions (11.14) or (11.18) are satisfied. Also uniqueness is obtained when the
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cells undergo at most four divisions or if the parameter d is less than 1
2
. To study
the large time behaviour when 0 < d < 1
2
, a key tool was a Volterra-type Lyapunov
functional that included an integral over all maturity of cells in B phase, similar
to the functionals used in [114, 115]. Note that the Lyapounov functional used in
this study is not defined on the entire state space. One may observe that simi-
lar difficulty also arise in [120–122]. To circumvent this difficulty, we only use the
Lyapunov functional on the global attractor. Then, we deduce that the unique sta-
tionary solution is globally asymptotically stable if the parameter condition (11.21)
is satisfied. A numerical computational suggests that the unique stationary solution
in case of 0 < d < 1
2
, continues to be stable even if condition (11.21) is not fulfilled
(a similar technical problem arises also in [114]). In addition, we remark from Fig.
11.3 and Fig. 11.4 that the algebraic results presented in this chapter, cover a large
region of the numerical results when the parameter ρ is large.
Furthermore, Fig. 11.1 shows that there exists three stationary solutions for a spe-
cific set of parameters (ρ, d) (when the cells undergo several divisions (I > 5)). This
means that if with a few cell divisions, the size of T cells returns to the normal level,
the immune system has a unique steady state, else it has three steady state. This
phenomenon can provide an interesting biological signification of the homeostasis
of T cells in some cases. This will be studied in a forthcoming work. Finally, in-
spired by the analysis of System (11.1), a further work is to study the asymptotic
behaviour of System (10.1-10.3) which includes the concept of phenotype (CD44)
in the homeostasis process.
Chapter 12
An optimal strategy for rebuilding
immunity in conditions of T
lymphopenia
12.1 Introduction
Throughout adult life, the size and composition of the peripheral lymphocyte pool is
tightly regulated and, in the absence of disease, is maintained at relatively constant
levels [40, 79]. The correct representation of the T-cell pool is essential to maintain
adequate immune competence against pathogens, since it has to maintain a suffi-
ciently diverse repertoire of naive T cells to recognize a broad range of antigens,
while efficient immune responses against previously encountered pathogens depend
on the memory T-cell pool. For these demanding tasks, homeostatic mechanisms
have evolved to maintain distinct populations of naive and memory cells and to
retain an appropriate mixture of CD4+ helper T cells and CD8+ cytotoxic T cells.
A few general principles govern the physiologic response to perturbation of the
balance of T cell. For example, viral infection (e.g. HIV), or drugs used in per-
itransplant induction therapy or cancer chemotherapy, are the main factors that
disrupt the balance of T cell. This perturbation result in Lymphocytopenia or lym-
phopenia (i.e. it is the condition of having an abnormally low level of lymphocytes
in the blood) which induces a rapid proliferation in vivo of T cells with a recruit-
ment of naive T cells from the thymus.
Rapoport et al. [123] have developed a strategy that rebuild the immunity in
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lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer.
In their study, they offers a platform to help restore impaired adaptive immunity
in cancer patients. After high-dose chemotherapy, innate immunity, composed of
granulocytes, natural killer cells, and monocytes, is generally restored within a
few weeks. Adaptive immunity, however, acquired over the individual’s lifetime
exposure to infections and vaccines, is lost as a result of the high-dose prepara-
tive regimen and is not overcome by the infusion of the memory B and T cells
contained in the ”autologous graft”1. Rapoport et al. [123] show that mature T
cells in cancer patients can be ex vivo (in vitro) expanded, and that their infu-
sions in the early post-transplant period accelerate the numerical recovery of T
cells with a broad repertoire. The combination of antigen-primed T cells and early
post-transplantation booster vaccinations led to enhanced immunity to the specific
pathogen. In this context, the optimal memory T cells (i.e. T cells with CD44 high)
transferred in vivo by vaccination which support the homeostatic in vivo expansion
of T cells and led to enhanced immunity to the specific pathogen, stay unclear.
As proved in the last decades, the use of mathematical models in immunology has
allowed great advances, not only on the theoretical side, but also on the side of the
management of actual public health policies. In this study, we consider a model of
T cell homeostasis in lymphopenia conditions (like the model proposed in Chapter
10 (see also [81])) but with a more realistic parameter) in order to address the prob-
lem of determining an optimal strategy that lead to enhanced immunity during the
homeostatic process. Next section is devoted to reformulate the model proposed in
Chapter 10 to a more realistic version. In Section 12.3 we discuss the cost function
and we derive the optimality conditions. Finally, in Section 12.4, we perform some
simulations to compute the optimal vaccination.
12.2 The model
In condition of T cell deficiency (e.g. viral infection, or drugs used in peritransplant
induction therapy or cancer chemotherapy), naive T cells (CD44 low) are delivered
from the thymus in order to undergo division. In this study, the modeling of T cell
homeostasis in vivo is based on the Smith-Martin model. The model equations used,
considered an A-state (resting) and a B-phase (proliferative) where cells undergo
division. The number of times cells transfer between the A-state to the B-phase
1the transfer of tissue from one site to another on the same body
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is indexed by i which reflects the number of times a cell has undergone division.
The time since entering the B-phase (either the first time or any subsequent time)
is measured by τ which reflects the maturity of the cells at this stage and has a
maximum value of ∆. Since we are interested in this study to enhanced immunity to
the specific pathogen (or in another word by ”memory T cells”), we take into account
the level of CD44 on the surface of cells which is the natural marker that indicates
the naive (CD44 low) and memory (CD44 high) cells. Then, both the cells in A-
state and B-phase are indexed by s ∈ [0,m], the intensity of CD44 expression (m
is the maximum intensity of CD44). In this work, the model of T cell proliferation
in vivo, including a rebuilding strategy of immunity is governed by the following
system
dA0(t, s)
dt
= Λ(s)− δA0(t, s)− λ(N)A0(t, s) + χ0(s)u0(t),

for i ∈ N∗I := {1, ..., I}
dAi(t, s)
dt
= 2
∫ ∆
0
µ(τ)Bi−1(t, τ, s) dτ − δAi(t, s)− λ(N)Ai(t, s) + χi(s)ui(t),

for i ∈ NI := {0, ..., I}
∂
∂t
Bi(t, τ, s) +
∂
∂τ
Bi(t, τ, s) +
∂
∂s
[vi(s).Bi(t, τ, s)] = − (δ + µ(τ))Bi(t, τ, s),
(12.1)
where Ai and Bi are the number of cells in Ai phase and Bi phase respectively. I
stands to the maximum division number undergone by cells.
Boundary conditions and initial conditions of Eqs. (12.1) are defined by, ∀ i ∈
NI := {0, 1, ..., I},
Bi(t, 0, s) = λ(N)Ai(t, s),
vi(0)Bi(t, τ, 0) = 0,

A0(0, s) = A0,0(s) > 0,
Bi∈NI (0, τ, s) = 0 and Ai∈N∗I (0, s) = 0.
(12.2)
The A-state is described by an ODE equation with source terms from the B-phase.
The different A-state components are given by Ai(t, s) for i = 0, 1, ... (depending
on how many times the cells have undergone division). For i = 0 the growth of the
A0 component comes from an export rate of cells Λ from the thymus. For i > 0
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the growth of the Ai components comes from the doubling of the cells in the Bi−1
component (with the same s value, integrated over τ ∈ [0,∆]) as they undergo cell
division. The equations for the B-phase is given by PDE structured by the intensity
of CD44 (s) and the age (τ). In contrast to the model proposed in the previous
chapter, we consider in (12.1) that the rate of export of cells from thymus (Λ) is
depend on the CD44 expression since the cells exported from the thymus have low
level of CD44 (naive cells).
In (12.1), the different parameters have the following meaning
- Constant δ is the natural mortality rate in A-state and B-phase.
- Function µ(τ) is the division rate at age τ .
- Function λ(N) is the recruitment rate from A-state into B-phase that depend
on the total population N
N := N(t) =
I∑
i=0
(∫ m
0
Ai(t, s)ds+
∫ ∆
0
∫ m
0
Bi(t, τ, s)ds dτ
)
.
- Function vi(s) is the velocity of CD44 upregulation.
- Function χi represents the distribution of CD44 on the surface of cells in Ai
phase.
- Function ui(t) represents the vaccination strategy to rebuild the immunity
during the T cell homeostasis, i.e, the number of T cells (having undergone i
divisions), transferred in vivo per unit time.
Recruitment of cells from A-state into the B-phase occurs at a rate λ. As the
cellular population increases, the amount of resources per cell is decreasing and
the recruitment rate is reduced. A smaller division rate corresponds to the smaller
transfer rate λ of the model [10]. Recruitment rate is then defined by
λ = λ(N) = λ0e
−η N ,
where the parameter η determining the size of the reduction caused by increasing
number of competing cells (N). In addition, λ0 is considered to represent the ability
of each clonotype to respond to an unlimited resource.
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According to [7, 10, 80], the cells take a time approximatively ∆ to complete the pro-
cess in B-phase. Then, the mother cells divide in B-phase when their age is close
to ∆. Then, the function µ can be approximated by a non-negative rectangular
function with a mean value 1.
µ(τ) =

1
h
if τ ∈ [∆− h,∆],
0 else,
where 0 < h << ∆.
In (12.1), the cells are up-regulating CD44 during B-phase. In Ai phase (i.e. ith
division in A-state), cells inherit the same intensity of CD44 of those that are di-
vided in the previous B-phase (Bi−1 phase). Then, the cells in Ai phase increase
their level of CD44 according to the division number i. This is due to the velocity
of CD44 upregulation. Then according to the upregulation of CD44 in the exper-
imental data [10], the distribution of CD44 on the surface of cells in Ai phase can
be approximated by
χi(s) =
1√
2pi
e−
1
2(
s−(i+1)c
i+1 )
2
.
Furthermore, this function can be written as
χi(s) = (i+ 1) gi(s),
where gi is a Gaussian function which can be described by the probability density
function of a normally distributed random variable with expected value µi = (i+1)c
(c is a positive constant) and variance σ2i = (i + 1)
2. In other words, the function
χi(s) can be interpreted as the levels of CD44 that can be detected on the surface
of Ai cells (i.e. Cells in Ai phase) in each division.
We note that in System (12.1), the term χi(s)ui(t) can be described by the number
of T cells, transferred in vivo per unit time which have undergone i divisions and
have a level s of CD44 on their surface.
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By using Lagrange method, one obtains an implicit solution of Ai
A0(t, s) = A0,0(s) e
− ∫ t0 (δ+λ(N(u)))du +
∫ t
0
(Λ + χ0(s)u0(r)) e
− ∫ tr (δ+λ(N(q)))dqdr,(12.3)
and for i ∈ N∗I ,
Ai(t, s) = 2
∫ t
0
∫ ∆
0
e
−
∫ t
r
(δ + λi(N(q)))dq
(µ(τ)Bi−1(r, τ, s) + χi(s)ui(r)) dτ dr.
Now, we consider the following differential equations:
ds1i (t)
dt
= vi(s
1
i (t))
s1i (t0) = s
1
i,0 > 0
,

ds2i (τ)
dτ
= vi(s
2
i (τ))
s2i (τ0) = s
2
i,0 > 0.
(12.4)
where s1i (t; t0; s
1
i,0) and s
2
i (τ ; τ0; s
2
i,0) are the curves witch goes through (t0, s
1
i,0) and
(τ0, s
2
i,0) respectively. The curves, Z
1
i (t) := s
1
i (t; 0; 0) and Z
2
i (τ) := s
2
i (τ ; 0; 0) are the
characteristic through the origin. The solution of (12.4) is given by the following
equations
s1i (t) = s
1
i,0 +
∫ t
t0
vi(s
1
i (z))dz, s
2
i (τ) = s
2
i,0 +
∫ τ
τ0
vi(s
2
i (r))dr.
Integrating along the characteristic curve the PDE of System (12.1-12.2), one ob-
tains
Bi∈NI−1(t, τ, s) =

0 t ≤ τ, Z1i (t) < s
λ(N(t−τ))Ai(t−τ,ζi) vi(ζi)
vi(s)
f(τ) 0 ≤ τ < t, Z2i (τ) < s
0 Z1i (t) > s, Z2i (τ) > s
(12.5)
where ζi := s− Z2i (τ) and f(τ) := e−
∫ τ
0 (δ+µ(r))dr.
12.3 Strategy to enhance immunity
As we have already discussed in the previous Section, in our model (12.1) the
strategy to rebuild the immunity during the T cell homeostasis, is quantified by
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ui(t). The purpose of this strategy of transferred cells in vivo, is to maximize the
memory T cells (CD44 high) during the homeostasis process in order to acquire an
excellent memory against pathogens. To reach this goal with an optimal strategy,
we should maximize the number of cells in B-phase having an important level of
CD44, and minimize the number of T cells transferred in vivo. Specifically, we
consider the following functional
Φ(u∗i ) = max
ui∈Ki
Φ(ui), (12.6)
with,
Φ(ui) :=
I∑
i=0
φi(ui) :=
I∑
i=0
[∫ T
0
∫ ∆
0
∫ m
shigh
Bi(t, τ, s)dsdτ −
∫ T
0
u2i (t)dt
]
,
where shigh is the minimum intensity of CD44 required by cells to be qualified as
CD44 high (memory phenotype), and
Ki = {ui ∈ L∞(0, T ) | 0 ≤ ui(t) ≤ umaxi }.
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12.3.1 The optimality system
For the optimal vaccination strategy (12.6), we introduce the formal Lagrange func-
tion
L(Ai, Bi, Pi, Qi, ui) = Φ(ui)
+
∫ T
0
∫ m
0
(
dA0(t, s)
dt
− Λ(s) + (δ + λ(N))A0(t, s)− χ0(s)u0(t)
)
P0(t, s)ds dt
+
I∑
i=1
∫ T
0
∫ m
0
[
dAi(t, s)
dt
− 2
∫ ∆
0
µ(τ)Bi−1(t, τ, s) dτ + (δ + λ(N))Ai(t, s)
−χi(s)ui(t)]Pi(t, s)ds dt
+
I∑
i=0
∫ T
0
∫ ∆
0
∫ m
0
[
∂
∂t
Bi(t, τ, s) +
∂
∂τ
Bi(t, τ, s) +
∂
∂s
[vi(s).Bi(t, τ, s)]
+ (δ + µ(τ))Bi(t, τ, s)]Qi(t, τ, s)ds dτ dt
+
I∑
i=0
∫ T
0
∫ m
0
[Bi(t, 0, s)− λ(N)Ai(t, s)]Qi(t, 0, s)ds dt,
with multipliers Pi ∈ L2 ((0, T )× (0,m)) and Qi ∈ L2 ((0, T )× (0,∆)× (0,m)).
Let us now consider the variables ui, Ai, Bi, Pi, Qi for all i ∈ NI , as independent
and compute and set equal to zeros the derivatives of L, with respect to the five
variables. After some computations, one obtains for all i ∈ NI
∂
∂t
Qi(t, τ, s) +
∂
∂τ
Qi(t, τ, s) + vi(s)
∂
∂s
Qi(t, τ, s) = (δ + µ(τ))Qi(t, τ, s) + 1[shigh,m](s),
dPi(t, s)
dt
= −δPi(t, s) + λ(N) [Pi(t, s)−Qi(t, 0, s)] ,
complemented by the transversality conditions
Pi(T, s) = 0, Qi(T, τ, s) = 0, Qi(t,∆, s) = 0, Qi(t, τ,m) = 0,
in addition to the state equations (12.1). System (12.7) supplemented by the
transversality condition is called the adjoint system of the optimal control prob-
lem.
When computing the derivative of the Lagrangian with respect to the first state
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variable, one obtains the gradient of Φ.
∇u:=(u0,...,uI)(Φ) =
I∑
i=0
[
2ui(t) +
∫ m
0
χi(s)Pi(t, s)ds
]
. (12.7)
Based on (12.7) and (12.7), one can approximate the optimal vaccination strategy
using a discretization of the following algorithm.
1-) Choose a control ui(t) randomly.
2-) Compute the solution of the state equations (12.1).
3-) Compute the solution of the adjoint equation (12.7).
4-) Compute the gradient of Φ, by (12.7).
5-) Compute the new control using a nonlinear gradient method.
6-) Project the control on the admissible domain (constraints).
7-) If the norm of the gradient of φ is less than some tolerance then stop; else
return to 1-).
12.4 Numerical results
Actually, we have used the procedure given in the previous subsection, to run numer-
ical simulations and illustrate the effect of the optimal vaccination on the number
of proliferative cells. More specifically, in discretizing the algorithm just described,
we used a semi-implicit scheme to solve the state equations; the nonlinear renewal
equation (Bi(t, 0, s) = λ(N)Ai(t, s)) was solved explicitly. Besides, the cost function
was descretized using the trapezoidal rule and a discret Lagrange function was also
obatined by using the trapezoidal rule and the discretized state equation. From this
discretized Lagrangien we derive, in the discrete context, a discrete adjoint equation
that we use in the computations.
12.4.1 Parameters used in the numerical computation
Now, we describe the form of the parameters and their value used in the numerical
computation.
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According to [124], the thymic emigrants (i.e. Cells exported from the thymus)
have slightly lower CD44. Then, we assume that the rate of export of cells from the
thymus is
Λ(s) =

α if slow0 6 s 6 slow1 ,
0 else,
where α is a positive constant, s0 and s1 are two low levels of CD44. In the numerical
simulations, Λ(s) is approximated by
Λ(sk) ' Λk =

α if klow0 6 k 6 klow1 ,
0 else,
(12.8)
In this study, we consider the case of a young patient having a deficiency on T cells
which is caused for example by a high-dose of chemotheray. From [125], the median
combined production of naive T cells through cell division and thymic export is
estimated by ∼ 1.0 × 109 cells per day (4.167 × 107 cells/hour) at the age of 20
years. Thus, we consider that our System (12.1-12.2) starts from age 20 years (i.e
the initial time t = 0 for System (12.1-12.2) corresponds to age 20).
Moreover,
∑Ns
k=0 Λ
k ' Λ := 4.167× 107 (Ns is length of discrete vector that depicts
the intensity of CD44). Then from (12.8), α ' Λ
klow1 −klow0
.
In addition, the choice of some numerical and optimization parameters follows
[10, 125] and Chapters 6 and 7. Indeed, we summarize in the following Table
12.1 the value of the parameters used in the simulations.
12.4.2 Results
In Fig. 12.1, we represent the optimal vaccination strategy ui as a function of time
and division number. We remark that the strategy to maximize the memory cells
(CD44 high), consists to transfer in vivo (by a vaccination) at the initial time, a
high dose of resting cells having undergone 5-7 divisions. Later on, this dose should
be reduced over time, which can be realistic.
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Figure 12.1: Left subfigure represents the optimal strategy ui as a function of the continuous time from
0 to 7 days. The right one depicts the average optimal strategy (
∫ t+1
t
ui(r)dr) during one week. Note that the
optimal vaccination given in the right subfigure is more realistic, since for a treatment of one week, one dose
in each day is more practical for patients than a continuous dose.
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Figure 12.2: Comparison of the number of proliferative cells with (solid line) and without (circle) an
optimal vaccination (Fig. 12.1) at each division (i), as a function of time (days) (
∫∆
0
∫m
0
Bi(t, τ, s)ds dτ).
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Table 12.1: Table of parameters.
Parameters Value References
I 8 [10]
m 2 [10]
shigh 1.0 [10]
∆ 7.12 (hour) Chapter 7
h 30 (minute) Chapter 7
δ 0.012 (1/hour) [51]
λ0 3.768979E − 02 (1/cell/hour) Chapter 7
η 1.97568E − 06 Chapter 7
vi(s) Fig. 7.4 Chapter 8
Λ 4.167× 107 (cells/hour) [125]
klow0 1 Fixed
klow1 4 Fixed
c 2.1 Fixed
According to Chapter 8 (see also [80]), the velocity of CD44 upregulation (vi) in
(12.1) is the key parameter to identify the component naive and memory during T
cell homeostasis. This important key allows to deduce that the cells after 6 divi-
sions are probably switching to memory phenotype. By applying this interpretation
to Fig. 12.1, we understand why the optimal strategy consists to transfer in vivo,
resting cells having performed 5-7 divisions.
Finally, in Fig. 12.2, we present the simulations of (12.1) with and without the
optimal vaccination strategy given in Fig. 12.1. We remark that there are no effect
on the number of proliferative cells in the first divisions 0-5 by vaccination. In
contrast, it is clear from division 6 that the proliferative cells (memory cells) with
the vaccination strategy, are increased with respect to those without vaccination.
12.5 Conclusion
In this study, we are interested to analyse the homeostatic mechanism of T cell
under lymphopenia conditions, through a mathematical model. Indeed, we have
presented in Chapter 10 a model that describes this mechanism in vivo, but with
a simple vital parameters defined by constant rates (e.g the rate of exported cells
from the thymus Λ). To give the model a more realistic aspect, we consider in this
chapter that the thymic emigrants rate (Λ) is dependent on the level of CD44, since
the cells exported from the thymus have a naive phenotype (i.e. having low level
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of CD44). In addition, we applied in this in vivo model, a vaccination strategy
(expressed in the model by χi(s)ui(t)) in order to enhanced immunity during the
homeostatic process. Furthermore, a cost function is proposed here in order to
maximize the memory T cells (CD44 high) and minimize the vaccination strategy.
Then, we set up a numerical method to find the optimal control ui(t) which can be
described by the optimal number of resting T cells (having undergone i divisions)
transferred in vivo. From Fig. 12.1, we found that the optimal strategy consists to
transfer in vivo, resting cells having performed 5-7 divisions. Finally, we presented
in Fig. 12.2 the effect of vaccination on the number of proliferative cells.

Chapter 13
Discussions, conclusions and
future works
13.1 Discussions and conclusions
In this thesis, we have developed mathematical models describing the T cell prolif-
eration in vitro and in vivo, under lymphopenic conditions.
Firstly, we have started by an in vitro model (SMCD44) in order to analyse the
experimental data at hand (recent published data [10]). The SMCD44 model is
based on the Smith-Martin model which is used widely in the literature. This
model is composed on ODEs and PDEs that represent the dynamic of cells between
the resting and proliferative phases (A-state and B-phase respectively) during LIP
(lymphopenia induced proliferation). By using CFSE data with CD44 generated
by Hogan et al. [10], we found that the velocity of CD44 upregulation vi, the rate
of entry into division λ and the duration of B-phase ∆ are identifiable through
SMCD44 model.
In the literature, one remarks that most mathematical models based on the Smith-
Martin model assume that the cells divide in B-phase exactly at age ∆. In contrast,
SMCD44 model takes into account the small variability in the time of division be-
tween cells, and eliminates the assumption of an immediate switch at time ∆. In
the present work, we interested to compare these two types of modeling by fitting
SM1 (latest version of Smith-Martin model widely used) and SM2 (our SMCD44
model without the CD44 structure) models to the data of OT-1 T cells. By taking
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into account the small variability in the time of division, we remarked that the
duration of B-phase related to SM2 model becomes shorter than the one related
to SM1. In contrast, the rate of entry into division is approximately the same in
these two models. Finally, we concluded that LIP by OT-1 was better modeled with
SM2 than SM1 model, as reflected in the lower CrV for SM2 model fit (Table 7.1),
which is a measure of goodness of fit (low is better).
By estimating the velocity vi, we remarked that the average velocity (Fig. 8.5a)
and the frequency of cells that have changed their CD44 expression profile (Fig.
8.6), are the keys to explain the transition of cells from naive to memory phenotype
through LIP. However, these important keys enabled us to deduce that the cells
which are the most likely switching to memory phenotype, are those that have di-
vided 6 times or more. These numerical results are very close to the results observed
in the biological experiment of [10]. This may be an important validation to our
SMCD44 model.
On the other side, we have taken into account the multistructural and multifunc-
tional of CD44 (i.e. CD44 participates in cell proliferation, cell differentiation and
cell migration from naive to memory phenotype) in SMCD44 model. Indeed, we
considered that the recruitment rate (λi(s,N(t))) and the division rate µ(τ, s) are
depend on the intensity of CD44 on cells. In this context, numerical results show
that the rate of entry into division by naive cells is much less than this of memory
cells. In addition, another result allows to deduce that the cells having an impor-
tant CD44 expression on their surface, have also a large possibility to divide when
their age is near to ∆. Otherwise at age ∆, these cells divide independently of their
level of CD44. Therefore, these interpretations clarify the relationship between the
multifunctional of CD44 during LIP.
In conclusion, SMCD44 model not only provides some remarkably description of
lymphopenia induced proliferation by T cells but also may be a new path to better
explain the complex relationship between LIP and naive to memory transition.
Secondly, we extended the SMCD44 model to an in vivo model by implement-
ing a rate Λ of export of cells from the thymus. In this part of our work, the
mathematical analysis of the in vivo model was our interest. Indeed, we proved the
global existence of the in vivo model by using Fixed point method.
Next, we derived an age-structured system (11.1) from the in vivo model (10.1-10.3),
and we investigated its asymptotic behaviour. An analysis of System (11.1) shows
that there exists one or three stationary solutions when the cells undergo more than
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five divisions. Precisely, uniqueness of a stationary solution is guaranteed in this
case (i.e I > 5) when the parameter conditions (11.14) or (11.18) are satisfied. Also
uniqueness is obtained when cells undergo at most four divisions or if the parameter
d is less than 1
2
. To study the large time behaviour when 0 < d < 1
2
, a key tool
was a Volterra-type Lyapunov functional that included an integral over all matu-
rity of cells in B-phase, similar to the functionals used in [114, 115]. Note that the
Lyapounov functional used in this study is not defined on the entire state space.
One may observe that similar difficulty also arise in [120–122]. To circumvent this
difficulty, we only used the Lyapunov functional on the global attractor. Then, we
deduced that the unique stationary solution is globally asymptotically stable if the
parameter condition (11.21) is satisfied. A numerical computation suggests that
the unique stationary solution in the case 0 < d < 1
2
continues to be stable even if
condition (11.21) is not fulfilled (a similar technical problem arises also in [114]).
In addition, we remarked from Fig. 11.3 and Fig. 11.4 that the algebraic results
presented in Chapter 11, cover a large region of the numerical results when the
parameter ρ is large.
Then the existence of one or three stationary solutions means that if with a few cell
divisions, the size of T cells returns to the normal level, then the immune system has
a unique steady state, else it could have three steady state. This phenomenon can
provide an interesting biological signification of the proliferation of T cells under
conditions of lymphopenia.
Thirdly, we reformulated System (10.1-10.3) to a more realistic version which
includes a vaccination strategy in order to enhanced immunity during the home-
ostatic process. We have remarked that the strategy to enhanced immunity (i.e.
maximizing memory cells (CD44 high)), consists to transfer in vivo (by vaccination)
at the initial time, a high dose of resting cells having undergone 5-7 divisions. Later
on, this dose should be reduced over time, which can be realistic.
13.2 Future works
T cell homeostasis stays a very important subject in Biology and Medicine, since it
is induced in several diseases (e.g HIV, Cancer,...) that are almost without pertinent
solutions until now. In our work, we have used a mathematical approach in order
to respond to some questions concerning the proliferation of T cells under abnormal
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conditions. To improve these responses, some works remain in this study.
In the context of the in vitro model proposed in Parts II and III: we
have estimated the key parameters (vi(s), λi(s,N(t)) and µ(τ, s)) that define the
proliferation of T cells in vitro by using the data at day 7 (see Chapter 8 and 9).
Indeed, in the experiment of Hogan et al. [10], several mice were sacrificed at each
time point. Working with different mice at different time points generated additional
variability making the identifiability of parameters more difficult. In our work, we
have chosen the data at day 7 because it was a good compromise between early days
where there were too few divisions and later time points where CFSE is too much
diluted to be very easily measured. In this context, we hope to get another exper-
imental data without large variability between the different time points, in order
to improve our estimated parameters. In addition, we interest in a future work to
study the theoretical identifiability of the parameters by using only one observation.
In the context of the in vivo model proposed in Part IV: we have studied
the asymptotic behaviour for a reduced model without the concept of phenotype
(CD44). Our analysis show that there exist one or three stationary solutions which
may depend on the divisions number undergone by cells (I). In some cases of
uniqueness (0 < d < 1
2
), we have concluded that the unique stationary solution
is asymptotically globally stable. In a future work, we will interest to study the
stability of the other uniqueness cases. Moreover in the case of existence of three
stationary solutions, the stability or instability of each one of them may be an inter-
esting mathematical and biological subject which it will be treated in a forthcoming
work. Finally, inspired by the analysis of the reduced model (11.1), a further work is
to study the asymptotic behaviour of the complete in vivo model (10.1-10.3) which
includes the concept of phenotype (CD44) in the homeostasis process.
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